
























Submitted in partial fulfillment of the  
requirements for the degree of  
Doctor of Philosophy  
under the Executive Committee  






































Cell Memory in the Mitogen-Activated Protein Kinase Signaling Pathway 
 
Eugenia Lyashenko  
Abstract 
 
Cells process information from their environment, such as the stimuli to grow, divide, or die, 
via cell signaling. Deregulated processing of extracellular stimuli can lead to aberrant cell responses 
and cause cancer. Given that the in vivo cell environment constantly changes, it is important to 
understand how cells incorporate the context of their environment into their decision making 
processes.  
The idea of responding to relative, not absolute, changes in stimuli was first proposed in 
studies of human perception   and   became  known   as  Weber’s   Law.   Although,   evidence   of  Weber’s  
Law at the molecular level has been previously presented in studies of several organisms, to the best 
of our knowledge, it has never been explored in the case of relative sensing of extracellular stimuli in 
mammalian signaling cascades. 
The Mitogen-Activated Protein Kinase (MAPK) signaling pathway has been implicated in 
multiple human diseases, including cancers, and therefore cell signaling through this pathway is an 
important subject of research. Here we present a theoretical framework and an experimental 
validation  of   the  mechanism  of  Weber’s  Law   in   the  ability  of   cells   to  sense   relative  changes   in   the  
levels of extracellular stimuli in the MAPK signaling pathway. In particular, in this work we consider 
relative sensing in levels of Epidermal Growth Factor (EGF) in the MAPK pathway.  
We derive an analytical model of steady state behavior of the MAPK signaling pathway 
stimulated with constant doses of EGF. We demonstrate a mechanism that produces phosphorylation 
responses  proportional  to  relative  changes  in  ligand  concentrations.  The  mechanism  of  Weber’s  Law  
presented here entails the retention of memory of the dose of the past chronic stimulation with EGF. 
The molecular mechanisms responsible  for  Weber’s  Law  in  MAPK  signaling  are  likely  to  contribute  to  
many other receptors signaling systems. Therefore, the mechanism of relative sensing of extracellular 
 
 
ligand concentrations derived here can be generalized beyond the EGF-activated MAPK signaling 
pathway to many other cell signaling systems. 
This thesis also presents a probabilistic framework to explore the parameter space of a 
detailed mechanistic ODE model of EGFR signaling cascades. The application of the model 
simulation allows us to generate probabilistic predictions of EGFR system behavior and to explore 
structure-to-function   relationships   between   the   model’s   parameter   space   and   EGFR   system  
responses. 
 Overall, this work suggests an alternative view on the role of cellular endocytosis in the 
MAPK signaling in vivo. Specifically, traditionally viewed as a mechanism to downregulate and 
terminate cell signaling, endocytosis may enable cells to dynamically adjust their sensitivity to 
extracellular stimuli, and hence allow cells to integrate information about the past stimulations into the 
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Chapter One: Introduction to Cell Signaling in Mammalian Cells and 
Relative Sensing of EGF in EGFR Signaling  
 
Cell signaling is crucial to the proper functioning and survival of organisms, just as language 
is essential for the proper functioning of human societies. Cell signaling enables cells to sense 
information in their environment and communicate with other cells. Although manifested differently, 
cell signaling is present across all types of organisms, ranging from simplest unicellular organisms 
such as yeast and bacteria, to higher organisms, such as humans. Yeast, for example, signal to each 
other by secreting and responding to pheromones mating factors (Herskowitz, 1995). Bacteria use 
cell signaling to sense nutrient gradients and move to their source, thus gaining evolutionary 
advantage in stringent conditions (Mesibov & Adler, 1972). Higher organisms consist of multiple types 
of tissues. As such, their cells are expected to communicate among themselves and to respond in a 
coordinated way to stimuli in order to maintain tissue identity and homeostasis. Hence, one would 
expect cells in higher organisms to have a much more sophisticated machinery of signaling cascades 
to allow complex communication than do lower organisms.  
It has been suggested that developing elaborate signaling cascades and the ability of cells to 
respond in a coordinated way allowed evolution from unicellular to multicellular organisms (Alberts B, 
Johnson A, Lewis J, et al, 2002). Through gene duplication and divergence, higher organisms were 
able to develop elaborate signaling cascades which then allowed cells to carry out diverse cellular 
functions and respond efficiently to changing environment facing the organism, thus providing survival 
advantage.  
Multiple studies have elucidated the biochemical details of signaling cascades in mammalian 
cells. However, much less is known about how quantitative information from cell environment is 
translated in cell decision through cell signaling in mammals (Albeck, Mills, & Brugge, 2013). In 
addition, it is still not well understood how cells manage to reliably perform their functions while 
operating in chaotic environments with diverse stimuli. How does cell signaling accurately relate 
information from cell exterior into cell decisions despite the molecular noise? What features of the 




signaling? Even less is known about quantitative aspects of cells signaling and how cells encode 
those features. The main challenge is that many of the cell mechanisms are intertwined dynamic 
processes. The overall picture is further complicated by the fact that it is still difficult to measure time-
varying abundances or signaling molecules in vivo (Fisher & Lakshmanan, 1990; Goentoro et al., 
2006). 
Cell signaling is mediated by signaling molecules secreted by cells throughout the organism. 
Signaling molecules, such as various growth factors, are recognized and bound by designated cell-
surface receptors. Upon ligand binding, receptors undergo activation and initiate series of reactions in 
the cell interior, ultimately, leading to changes in metabolism, cell shape, motility, or expression of the 
genes necessary to carry out the response intended by the signaling molecule (Alberts B, Johnson A, 
Lewis J, et al, 2002). Interestingly, cell surface receptors serve as an interface between cells and their 
environment and establish specificity and precision between signaling molecules and elicited 
responses (Shankaran, Resat, & Wiley, 2007). 
In higher organisms there are multiple receptor-enabled sensory systems. G-protein coupled 
receptors are an example of the largest family of cell-surface receptors. Although they are found in all 
eukaryotes, in higher organisms the GPCR mediate a myriad of diverse functions such as vision and 
olfactory sensing in human (Alberts B, Johnson A, Lewis J, et al, 2002). Many different signaling 
molecules can bind to these receptors; in addition, the same ligand can activate multiple types of 
receptors (Collins, Caron, & Lefkowitz, 1992). Moreover, signaling cascades initiated by these 
receptors can overlap on multiple intermediate components as well as on downstream targets. 
Overall, the reuse of the signaling components in many different signaling cascades could allow cells 
to implement more efficiently various functions. In addition, the differential   dynamics   of   target’s  
responses might distinguish between different stimulants in cell environment, and thus encode 
different cell decisions. For example, in PC12 cells, pERK can be activated by different ligands (EGF 
and NGF) (Sasagawa, Ozaki, Fujita, & Kuroda, 2005a), and the produced responses may differ in 
their dynamics (transient vs sustained), leading to different cellular phenotypes (growth vs 




fate, regulating signaling response is important for cell survival in a time- and composition-varying 
environment. What are some underlying mechanisms which allow cells to function effectively?  
Cells have developed various mechanisms to cope with changing extracellular stimuli (Lodish 
H, Berk A, Zipursky SL, et al, 2000) and to retain the memory of previous stimulations. At the 
signaling molecule level, cells can buffer effective duration and doses of the stimulants either by 
converting short-lasting treatments into long-lasting response or by depleting stimuli from cell 
environment attenuating treatment. Ligand depletion can be mediated through ligand-induced 
internalization and degradation of the cell surface ligand-receptor complexes. For example, 
Erythropoietin receptors, which maintain production of red blood cells, effectively internalize Epo 
ligand from the cell surface and this mechanism is partially what enables EpoR to sense a very wide 
range of Epo concentrations (Becker et al., 2010).  
Amplification of levels of intermediate signaling components helps to extend the effect of 
signaling molecules long after the stimulus has been cleared from the cell surface. Such amplification 
can be realized through action of positive feedback loops activated in response to ligand treatment. 
Ca2+ regulated kinase cascades serve as an example of cell retention of information about the 
stimulus (Alberts B, Johnson A, Lewis J, et al, 2002). 
Another way to realize cell memory is via turning on gene transcription in response to ligand 
stimulation. As a downstream target of signaling cascades, gene transcription thus extends the 
effects of signaling molecule to the longer time scale necessary to produce gene response. 
Alternatively, to deal with extracellular stimuli, cells can regulate their own signaling 
components. Specifically, if the signaling molecules persist in cell environment, the cells can 
attenuate and adapt its responses to the constant level of stimulation. Adaptation or desensitization is 
defined as a reversible process in which the prolonged stimulation with constant levels of input over 
time  decreases  cell’s   response   to   that   level  of  stimuli   (Alberts B, Johnson A, Lewis J, et al, 2002). 
Adaptation would allow cells to respond to relative, rather than absolute, changes in stimulus and 
would allow cells to maintain their sensitivity over wide range of background stimuli doses. 
One cell mechanism to implement adaptation is ligand-induced temporarily inactivation of 




Goldbeter, Devreotes, & Knox, 1986) (Figure 1). For example, cell surface receptors in bacterial 
chemotaxis in response to sensing nutrient become methylated, which reduces their activity and 
ultimately, decreases the rate of bacterial tumbling in response to stimuli (Alon, Surette, Barkai, & 
Leibler, 1999). Thus, through adaptation, bacteria cells are able to slow down at a higher 
concentration of nutrient, independently of the absolute levels at the source.  
Another mechanism of desensitization and adaptation acts through production of inhibitory 
proteins downstream in the signaling cascade. Ligand-induced gene expression of Dual Specificity 
Phosphatases (Avraham & Yarden, 2011) which dephosphorylate components of the activated MAPK 
kinase cascade, thus can lead to attenuation of signaling through the cascade.  
In addition, cells can adapt and adjust their sensitivity to subsequent stimulations with the 
same ligand by altering the number of cell surface receptors specific to the ligand (Alberts B, Johnson 
A, Lewis J, et al, 2002). This adjustment presents one common and effective way to control cell 
adaptation to extracellular stimuli on multiple downstream targets by regulating the signaling cascade 
at the receptor level, rather than at the level of multiple individual downstream targets (although the 
two mechanisms are not mutually exclusive). 
 
Figure 1.1: Five ways in which target cells can become desensitized to a signal molecule. Adapted from 
Alberts B, Johnson A, Lewis J, et al. New York: Garland Science; 2002. “General Principles of Cell 
Communication”. 
 
Receptor internalization, recycling and degradation are molecular processes which regulate 




receptor complex, followed by either recycling or degradation of receptors. For some receptor 
sensory systems stimulations with ligand can lead to receptors mobilization to cell surface, as in the 
case of EpoR signaling (Becker et al., 2010), whereas in other cases, it can lead to removal of 
receptors from the cell surface, as in EGF-induced ErbB signaling (Citri & Yarden, 2006). The 
outcomes of such regulation depend on multiple entangled dynamic processes such as receptor 
activation, internalization, recycling, degradation, kinetics of which, in turn, is determined by the 
biochemical properties of ligand-receptor interactions and other reactions. 
As was previously mentioned, desensitization is a reversible phenomenon, thus, upon 
removal of the stimulus from the cell environment, cells can recover their sensitivity to subsequent 
stimulations. Time to recover the sensitivity can depend on the properties of the sensory system and 
may affect the precision with which cells respond to subsequent or overlapping signals. Hence, 
regulating the amount of receptors on the cell surface can help cells be attuned to their environment 
over time. Since levels of extracellular stimuli can change rapidly, whereas cell response can take 
longer time scale to the time necessary for gene expression, it might be important to have machinery 
to synchronize and coordinate cell decisions to the available stimuli on cell surface. Moreover, 
understanding the quantitative relationship between the responses of downstream targets and cell 
fate outcomes can help elucidate mechanisms of cell functioning in vivo when cells are exposed to 
repeated stimuli over time.  
In this thesis we study quantitative aspects of cell signaling in mammalian cells, focusing on 
the case of signaling through Epidermal Growth Factor (EGF) Receptors, also referred to as ErbB 
receptors. ErbB receptors, among other ligands on the cell exterior, can bind epidermal growth factor 
(EGF), a molecule stimulating cells to grow and divide. Since the ErbB receptors regulate cell growth 
and division, they have been implicated in multiple cancers and are, thus, an important therapeutic 
target. It is essential to understand how cells process consecutive signals to grow and divide, as over-





Figure 1.2: Schematics of signaling through EGFR receptors  
(source: http://www.ebi.ac.uk/training/online/course/reactome-quick-tour/what-reactome) 
 
Epidermal Growth Factor (EGF) belongs to the family of growth factors – the signaling 
proteins cells use for communication. They mostly operate as local intermediaries at low 
concentrations (about 10-9-10-11 M). The responses to growth factors take time on the order of hours 
and generally require intracellular signaling which leads to changes in gene expression (Alberts B, 
Johnson A, Lewis J, et al, 2002).  
The ErbB family receptors are receptor tyrosine kinases. Each receptor consists of an 
extracellular ligand-binding domain, a transmembrane domain, and a tyrosine kinase domain on the 
intracellular side (Citri & Yarden, 2006). Upon ligand binding, ErbB receptors form dimers with other 
ErbB receptors. This leads to autophosphorylation of their tyrosine kinase domains and receptor 
activation. Active receptor dimers then recruit scaffold and adaptor proteins, thus inducing a series of 
downstream phosphorylation reactions. ErbB signaling ultimately results in the activation of AKT and 







can produce responses with various dynamic profiles and lead to distinct cell decisions. However, it is 
still not well understood how exactly ErbB signaling dynamics encode cell fate decisions and what are 
the fundamental quantitative features of its signaling. 
ErbB receptor internalization and dephosphorylation by phosphatases are the main known 
mechanisms controlling ErbB signaling dynamics at the receptor level. A key characteristic feature of 
the EGFR internalization is that the rate of EGF-induced internalization of receptors is several times 
faster than the rate of basal ligand-free internalization of receptors. Hence, fast ligand-induced 
internalization leads to the rapid attenuation of signaling. Depending on the EGF ligand dose and the 
rate of receptors production, removal of significant number of receptors can render cells temporarily 
insensitive to consecutive EGF stimuli. This insensitivity can be advantageous if cell is in the middle 
of responding to previous stimuli to grow, in which case processing an additional activation signal 
might be redundant. Traditionally, rapid endocytosis of active receptors has been viewed as a 
mechanism to completely desensitize the cells to consequent ligand stimulations. Such view was 
derived based on cell signaling studies in which cells were treated with very high, non-physiological 
levels of stimuli, leading to activation of most receptors and their removal from cell surface (Becker et 
al., 2010). However, in vivo, cells are more likely to be exposed to lower doses of stimuli and thus, it 
is more plausible that the biological role of endocytosis is not to completely desensitize cells to re-
stimulation, but to adjust cell sensitivity to consequent ligand stimulations taking into account previous 
ligand stimulations. 
Since internalization and degradation of receptors requires an assembly of a scaffold and 
vesicles to transport receptors, this mechanism of receptor downregulation operates on the timescale 
of minutes to an hour (Sigismund et al., 2012). Dephosphorylation by phosphatases, on the other 
hand, is a rapid process taking seconds (Kleiman, Maiwald, Conzelmann, Lauffenburger, & Sorger, 
2011). Various phosphatases are known to act on phosphor-EGFR throughout different cellular 
compartments. Overall, phosphatases are considered to be important in inhibiting receptor activation 
at low levels of stimuli, thus preventing the system from reacting to extracellular noise (Reynolds, 
Tischer, Verveer, Rocks, & Bastiaens, 2003). Interestingly, phosphatases can decrease the amount 




exactly internalization and dephosphorylation cooperate together in downregulating ErbB signaling 
receptors and what are the possible advantages of using both mechanisms to affect cell functioning in 
its environment.  
Given the complexity of the regulation of EGFR signaling through various dynamic 
mechanisms, as well as the intricacies in assessing ErbB system experimentally, it is, thus, not 
surprising that until now there were not many quantitative studies focusing on physiological properties 
of EGFR signaling, going beyond short-lived transient phosphorylation responses and gene 
expression. 
Our main result is a discovery that cells can retain memory of EGF doses during signaling via 
the number of remaining EGFR receptors on the cell surface, the quantitative description of this 
feature of cell behavior and a property of relative sensing in input levels emergent from the presented 
cell memory phenomenon. Through a combination of experimental and modeling approaches, we 
show how the abundance of EGFR is able to retain information about the EGF doses in chronic 
stimulations with EGF. This non-trivial quantitative relationship led us to hypothesize that EGFR 
signaling might be attuned to sense relative, not absolute, increases in EGF levels. By regulating 
number of EGF receptors on cell surface, cells are able to adjust their sensitivity to extracellular EGF 
signals. Hence, in this way cells are able to eventually desensitize, or decrease their responses to 
constitutively present doses of ligand, and respond only to fold-changes in the background ligand 
doses.  
We develop an analytical model of steady state EGFR signaling and with it we derive a 
mechanism of relative sensing in EGF levels, arising from the property of EGF memory retention. In 
addition, we develop a detailed mechanistic ODE model and use probabilistic methods to address the 
problem of model parameter space unidentifiability and generate probabilistic predictions of system 
behaviors. Finally, we validate predictions of the two models experimentally. 
Ability to respond to relative, and not absolute, changes in levels of stimuli is described by 
Weber’s  Law and was originally postulated in studies of human perception (Weber, 1905). Evidence 




In the late 19th century, German physician Ernst Heinrich Weber conducted quantitative 
experiments on human perception (Weber, 1905). Weber postulated that our ability to perceive 
absolute changes in background stimuli diminishes as background magnitude of the stimuli 
increases.   Weber’s   Law   in   sensory   systems   states   that   the   just   noticeable   change   in   stimulus,  
required to elicit system response, is proportional to the background of the stimulus.  Weber’s Law can 
be formulated as follows. Let 𝛥𝑅  be amount of stimulation that needs to be added to produce 
detectable difference in response, and let 𝑅  be the amount of existing stimulation, then 
 𝛥𝑅/𝑅   =   𝑘  
where 𝑘 is a constant specific to the considered sensory system. 
Weber’s   scholar,   Theodor  Gustav  Fechner,   generalized   the   initial   law  and  derived   that   the  
maximal amplitude of the response to a change in input stimulus is inversely proportional to the 
background input level. In other words, the Weber-Fechner’s   Law   suggests   that   our   perception   of  
stimulus intensity is proportional to logarithm of the stimuli. Mathematically, the law can be 
represented as: 
𝑦   =   𝑐   ∗   𝛥𝑅/𝑅     
where 𝑦  stands for the maximum response to a change in signal 𝛥𝑅 and 𝑐 is a constant. 
Weber’s   and   Fechner’s   work   indicates   that   the   relative   sensing   applies   to   most   human  
senses of perception, and each particular sensory system will have its own specific proportionality 
constant, called Weber’s  Fraction. For example, in weight sensing this constant is 0.03, meaning that 
one is unable to distinguish between distinct weights unless they differ by at least 3% from each 
other. In the case of vision this constant is 0.01, meaning that one is unable to distinguish between 
lengths of two lines unless they differ by at least 1% (Nachev, Stich, & Winter, 2013). 
In this thesis, we will use mostly the second interpretation of the Weber’s  Law,  concerning  the  
maximal amplitude of the responses. Note that this interpretation concerns only maximal amplitude of 
the responses, and does not require that the times when these maximums are achieved are the 
same. 
We quantify cell responses to EGF by measuring activation of the downstream EGFR targets, 




doses of the chronic initial EGF stimulation, after the system adapts, pERK responses to same fold-
change inputs are very similar within the physiological range of initial EGF treatments. Thus, being 
able to generate similar pERK responses to same fold-changes in EGF can allow neighboring cells 
coordination in cell decisions in spite of variations in background EGF levels, which might occur, for 
example, due to uneven distribution of ligand in tissues. 
It is biologically plausible that the machinery behind EGF-induced signaling has evolved to be 
attuned to operate in physiological levels of EGF in mammalian tissues and implement ratio-sensing 
in EGF stimuli. By implementing ratio-sensing in the growth hormone levels, cells in the tissue get 
advantage in the face of time-varying and noisy EGF levels and hence might benefit the entire 
organism.  
In conclusion, this thesis demonstrates how by studying dynamics of EGFR signaling we 
discovered a non-trivial quantitative feature of this singaling system. Specifically, we revealed how 
retaining information about past EGF doses in the number of remaining EGFR receptors enables 
cells to carry out relative sensing of EGF levels. The implications of this thesis will lead to better 
understanding of the quantitative aspects of mammalian cell signaling to the in vivo cells environment 
of time-varying inputs, and thus help to design better therapeutic strategies optimized to cell 
functioning in tissues.  
Chapter 2 of this thesis gives an overview of biological concepts related to EGFR receptors, 
EGF in physiological conditions, general background on cell signaling and some previous quantitative 
studies of receptors signaling systems. Chapter 3 describes construction of the detailed mechanistic 
ODE model of ErbB signaling and the computational methods used in this work to sample and 
explore model parameter space, including Markov Chain Monte Carlo simulations. Chapter 4 
presents main results of the thesis: first, it describes probabilistic predictions of ErbB system 
behaviors from simulating the detailed mechanistic ODE model of ErbB signaling; second, it presents 
analytical model of ErbB system at steady state to chronic stimulation with EGF and derives Weber’s  
Law property in sensing EGF inherent to the simplified analytical model based on several 
fundamental, but general assumptions regarding signaling through activated EGFR receptors. 




studies of cell memory and to the generalizability of the discovered phenomenon of  Weber’s  Law  in  
sensing levels of extracellular stimuli to other receptor sensory systems, such as signaling through 




Chapter Two: Background on EGFR signaling 
 
Section 2.1: The ErbB receptors 
The Epidermal Growth Factor family of receptors, also referred to as the ErbB receptors, is a 
family of receptor tyrosine kinases implicated in many cancers. The ErbB family of receptors is 
therefore one of the most well studied receptors signaling systems (Herbst, 2004; Citri & Yarden, 
2006). Each receptor is a transmembrane protein, consisting of a ligand-binding extracellular domain, 
a membrane-tethering transmembrane domain and an intracellular tyrosine kinase domain. There are 
four types of ErbB receptors: ErbB1 (EGFR), ErbB2 (HER2), ErbB3, and ErbB4. The ErbB types are 
distinguished by their preferred ligands, as well as by their tyrosine kinase activities. This thesis 
focuses on the signaling through ErbB1, or EGFR, as it is an important regulator of cell fate decisions 





Figure 2.1: Simplified diagram of the ErbB signaling network model. Adapted from (Chen et al., 2009) 
Section 2.2: The ErbB pathways in cancer 
Aberrant signaling through ErbB receptors can cause uncontrolled cell growth and proliferation, and 
thus lead to cancer (Arteaga & Engelman, 2014). The over-activation of the ErbB receptors can arise 
at various levels in the cellular pathways and through multiple mechanisms. At the receptors level, 
abnormal signaling may be caused by receptors mutations, their overexpression, or their activation by 
an autocrine or a paracrine ligand secretion (Kleiman, 2010). In addition, the over-activating 
mutations in the downstream signaling targets of ErbB, as well as the loss-of-function mutations in the 





Given the myriad ways that the abnormal ErbB signaling can lead to oncogenesis, it is not 
surprising that the ErbB and their pathways are an important target for the anti-cancer therapies. 
First, the receptors themselves can be targeted by the antibodies that prevent receptors dimerization 
and activation, or induce their downregulation through yet to be understood mechanisms. An example 
of such drug is Herceptin, a monoclonal antibody inhibiting ErbB2 receptors. Herceptin has 
revolutionized breast cancer treatment in the past decades (Cobleigh et al., 1999). Next, to attenuate 
ErbB phosphorylation various classes of small molecule inhibitors of ErbB kinase domains have been 
developed (Arteaga & Engelman, 2014). The downstream targets of the ErbB receptors signaling 
have been targeted as well. For example, small molecule kinase inhibitors of B-Raf are successful in 
treating melanoma carrying specific B-Raf mutations (Karasarides et al., 2004). Ras has been 
actively pursued as an anti-cancer drug target, for its role in the phosphorylation signaling cascades 
and its ability to induce cell death through mechanisms bypassing caspases activation (Skouta, 
Hayano, Shimada, & Stockwell, 2012). 
Interestingly, unexpected outcomes of low dose inhibitor treatments have been reported from 
the studies of EGFR signaling dynamics: low dose EGFR inhibitor pre-treatment might prevent 
receptors internalization and lead to their sustained signaling (Citri & Yarden, 2006; Kleiman et al., 
2011). Hence, a better understanding of how the inhibitors of ErbB pathway affect the ErbB signaling 
dynamics and cell physiology will be helpful in optimizing drug dosage and in developing improved 
treatment strategies. 
Section 2.3: EGF in the physiological context 
Understanding the effects of EGF, and growth factors in general, on the physiology of living 
organisms is challenging for several reasons (M. S. Murphy, 1998). First, the biological effects of the 
growth factors can be context-dependent and specific to each species (Hirai M, Gamou S, Minoshima 
S, 1988). Second, the regulation of the growth factor production and the expression of their 
designated receptors in vivo are influenced by intertwined dynamic cell processes. Interactions 
between the growth factors and other molecules in the local tissue environment further obscure the 
study of growth factors effects in vivo. Moreover, the growth factors can act at various distances from 




juxtacrine mechanisms. Lastly, the relationship between the growth factors and their effects on living 
organisms is highly interlaced: each individual growth factor can have many physiological effects, 
while multiple distinct growth factors can produce the same effect (M. S. Murphy, 1998). 
EGF stimulates cells to grow, divide, or differentiate. EGF is a 6kDA molecule that binds to 
the EGFR and other receptors on cell surface and initiates cell signaling. EGF is produced and 
present in multiple human tissues (Kajikawa et al., 1989; Birk et al., 1999). Studies have suggested 
that the main purpose of EGF in adult mammals is to maintain their epithelial surfaces (Fisher & 
Lakshmanan, 1990), although EGF also plays a role in mammary tissue development and 
homeostasis (Yarden & Pines, 2012). On the other hand, a growth inhibition by EGF has also been 
reported in some cell lines, such as A431 (Hirai M, Gamou S, Minoshima S, 1988). Recent studies 
explored the effect of growth factors stimulation at a single cell level. It was suggested that the growth 
factor concentration determines the probability a cell will make a certain cell fate decision (Birtwistle 
et al., 2012). 
 Epithelial organs secrete EGF into the lumen (Singh & Harris, 2005). In mammalian tissues, 
EGF doses can vary across four orders of magnitude (Fisher & Lakshmanan, 1990). In humans, EGF 
is estimated to range from 0.015-0.036 ng/ml in plasma, and up to 280ng/ml in prostatic fluids. In 
general, 10ng/ml EGF dose is considered to   be   a   “high-physiological”   dose   (Chen et al., 2009; 
Osborne, Hamilton, Titus, & Livingston, 1980). Interestingly, such definition stems from the fact that in 
many cells EGF near 10ng/ml elicits a saturating response on pERK. The phosphorylation and 
activation of ERK are considered to be a better proxy for the cell fate decisions, rather than the 
activation of pEGFR itself. In addition, even low EGF doses are able to produce significant activation 
of the downstream cascades (Uyemura, Takagi, Yanagida, & Sako, 2005) though it is difficult to 
detect the pEGFR activation distinguishable from the basal levels in such stimulations. Hence, 
physiologically relevant doses of EGF are often defined mostly based on the mitogenic effect on 
activating pERK. However, most recent studies suggest that unlike the nanomolar EGF 
concentrations used in studies of EGFR, the picomolar ranges of EGF doses might be functioning in 




Despite the advances in experimental techniques in biology, quantifying levels of extracellular 
diffusible molecules in vivo remains challenging (Goentoro et al., 2006). Moreover, the physiological 
temporal profiles of the EGF levels can be very diverse. For example, in the organism development, 
EGF doses can change exponentially with time or in fold changes over the days (Fisher & 
Lakshmanan, 1990). In some tissues, cells can be exposed to chronic EGF stimulations with more or 
less constant levels of EGF over time (Alberts B, Johnson A, Lewis J, et al, 2002). In addition, EGF 
can be secreted in pulses with various time intervals on the order of hours in between the pulses 
(McEwen, 2001). However, it has been suggested that instead of abrupt pulses in EGF, cells are 
more likely to experience more gradual changes in EGF levels in vivo due to a slow process of EGF 
diffusion in the blood and tissues (Lazova & Ahmed, 2011).  
In vivo EGF can act through autocrine, paracrine, and juxtacrine signaling (Singh & Harris, 
2005). In the autocrine   signaling   cells   release   signaling   molecules   that   bind   to   the   cell’s   own  
receptors or to those of the neighboring cells. In this way, a cell can signal to itself or to its 
neighboring cells (Alberts B, Johnson A, Lewis J, et al, 2002). The autocrine signaling is most 
effective when many nearby cells of the same type start producing and responding to the autocrine 
signals together, thus generating a group response. This signaling mode is important in many 
contexts, including in development and in maintenance of tissue homeostasis. In general, the 
autocrine activation of neighboring cells can take several hours, as producing and secreting an 
signaling molecule can be a slow process and might require certain time to accumulate sufficient 
levels of the signaling molecule to trigger cell response (Toettcher, Weiner, & Lim, 2013). EGF 
concentrations in the vicinity of autocrine and paracrine signaling cells can reach nanomolar ranges 
(Rouger et al., 2014). 
 
Section 2.4: Kinetics of the EGF binding and EGFR receptor dimerization  
EGFR can recognize and bind different ligands, including EGF, TNF-alpha, and other 
molecules (Yarden, 2001). Different affinities of the ligands towards EGFR monomers or dimers can 
produce different biological effects of the ligand stimulation (Macdonald-Obermann & Pike, 2014). In 




signaling outcomes. For example, it has been shown that TNF-a, an EGFR ligand, dissociates from 
the internalized receptors in endosomes, and thus directs the receptors towards their recycling to cell 
surface; whereas, EGF does not dissociate from the receptors in endosomes and targets them for 
degradation (Reddy, Wells, & Lauffenburger, 1998). 
The EGF ligand binding to receptor monomers induces a change in their conformation, 
leading to their rapid dimerization and activation (Lemmon & Schlessinger, 2010). It has been 
suggested that EGF binds preferentially to unoccupied EGFR receptor monomers leading to their 
rapid dimerization, or to unoccupied receptor dimers, and that the affinity towards the one-EGF 
occupied dimer is significantly lower (Macdonald & Pike, 2008). The equilibrium constant of EGF 
unbinding to EGFR has been estimated to be on the order of ~3nM (Chen et al., 2009). 
Section 2.5: Mechanisms of ErbB receptor signaling down-regulation 
In this section we give an overview of some of the receptor signaling attenuation strategies 
relevant to the EGFR based on the literature evidence and on the setup of our experimental system. 
Downregulation of signaling through ErbB can be realized via the following mechanism:  
1) Receptor-mediated ligand depletion from the cell surface;  
2) Removal of receptors from the cell surface and their consequent degradation in lysosomes;  
3) Action of phosphatases; 
4) Inactivating phosphorylation;  
First, our experimental system setup lets us exclude ligand depletion as a signal decay mechanism. 
Indeed, in our setup the EGF concentration is maintained almost constant over the time of 
observation, up to six hours after the initial EGF addition. 
Inhibitory post-translational modifications (PTM) can temporarily remove receptors from the 
signaling pool. Such signal downdregulation mechanisms have been reported for various receptors 
sensory systems: for example, in bacteria chemotaxis the CheY receptors can be reversibly inhibited 
by methylation (Vladimirov & Sourjik, 2009). Inactivating PTM for ErbB have previously been 
mentioned in the literature (Countaway, Nairn, & Davis, 1992). However, to the best of our 




Therefore, the ErbB receptors internalization, degradation and action of ErbB phosphatases 
are the main mechanisms that terminate signaling in our system. The activated EGFR are being 
constantly dephosphorylated by the RTK phosphatases, as has been shown experimentally for the 
MCF-10A and other cell lines used in this work (Kleiman et al., 2011). The EGFR can be internalized 
from the cell surface by a slow basal internalization and degradation process; however, a much faster 
ligand-induced EGFR internalization is a characteristic feature of the ErbB receptors signaling 
(Becker et al., 2010). In addition, several types of ErbB internalization have been reported, based on 
their dependence on clathrin (Sigismund et al., 2012). 
Why would cells need to simultaneously use two different mechanisms, namely, receptors 
sequestration and dephoshorylation, to downregulate EGFR signaling? One possible explanation is 
that receptors internalization and degradation is a slow process on the order of minutes to hours, as it 
requires assembly of protein scaffolds and vesicles to shuttle the receptors into the cell interior; 
whereas, action of phosphatases is a rapid process on the order of seconds, and thus can remove 
receptors phosphorylation much faster. 
Section 2.5.1: Internalization, degradation, and recycling of EGFR 
 
ErbB receptors internalization is a complex dynamical process. Receptor internalization can 
depend on various factors, such as a nature of the ligand (Roepstorff et al., 2009), ligand 
concentration (Sigismund et al., 2013), types of the receptors forming the dimers (Hendriks, 2003), 
intracellular machinery (Goh, Huang, Kim, Gygi, & Sorkin, 2010), and even environmental 
temperature, which affects plasticity of the cell membrane enabling receptors internalization 
(Macdonald & Pike, 2008). 
There are two major endocytic mechanisms: clathrin-mediated (CME) and non-clathrin 
endocytosis (NCE) (Sigismund et al., 2005). In CME, receptors are being internalized via assemblies 
of clathrin coated pit proteins that form buds off the plasma membrane. NCE operates by forming 
membrane vesicles independent of clathrin. It has been suggested that CME is present at all ligand 
concentrations, whereas, NCE is triggered at higher EGF doses above a certain threshold (Sigismund 




of NCE. The two types of internalization are believed to direct receptors to different fates: CME 
preferentially guides the receptors to recycling, whereas NCE to degradation (Sigismund et al., 2008) 
The analysis of ErbB downregulation is challenging due to the fact that there are many 
dynamic processes entangled together, namely, receptors internalization, recycling, production and 
degradation. ErbB internalization and degradation help to maintain cellular homeostasis by controlling 
the number of receptors available on the cell surface. In the absence of ligand stimulation, the cell 
surface receptors levels can be kept relatively constant by a low level of basal internalization, 
degradation, recycling, and production of new EGFR. 
Cell context, namely gene expression of other receptors, can influence EGFR internalization. 
Specifically, the ErbB2 receptors can form dimers with EGFR, however, such heterodimers were 
shown to internalize slower than EGFR homodimers due to an internalization-defective ErbB2 
intracellular domain (Hendriks, 2003). 
Internalized receptors can still continue signaling to their downstream targets. Thus, 
endocytosis has been suggested to have a bidirectional relationship with signaling (Kholodenko, 
Hancock, & Kolch, 2010) – it helps to terminate signaling and, at the same time, it brings signaling 
closer to the remote downstream targets. 
In addition, endocytosis plays a role in temporary desensitization of cells to EGF. In the 
course of ligand stimulations, when receptors have been internalized from the cell surface, and prior 
to their recycling or production of newly synthesized receptors to the cell surface, the ErbB-mediated 
responses are substantially decreased (Kleiman et al., 2011). 
 
Section 2.5.2: EGFR dephosphorylation by phosphatases 
 
RTK phosphatases have been shown to play an important role in ErbB signaling (Tiganis, 
2002). Dimerized receptors are rapidly shuffling between phosphorylated and un-phosphorylated form 
due to the action of phosphatases, independently of the cellular localization of EGFR receptors 
(Kleiman et al., 2011; Shankaran et al., 2012). The half-life of the phospho-EGFR signal at inhibition 
with a small molecule kinase inhibitor is very rapid and was shown to be on the order of 10 - 40 




ErbB phosphatases are difficult to study experimentally due to their ability to act on multiple 
targets, as well as due to the fact that multiple different phosphatases, often yet unidentified, are 
present at different expression levels throughout the cell (Soulsby & Bennett, 2009). Recent 
experimental approaches focused on applying phosphatase inhibitors to assess the role of 
phosphatase activity in cell signaling. However, pan-phosphatase inhibitors, such as pervanadate, 
can inhibit other than the intended phosphatases and thus can generate various unanticipated effects 
on cell signaling (Huyer et al., 1997). 
Phosphatases can play an important role in maintaining cellular homeostasis by suppressing 
basal phosphorylation on EGFR (Reynolds et al., 2003). In the absence of external stimuli, ErbB can 
still auto-phosphorylate and transmit signaling downstream. ErbB overexpression can lead to ligand-
independent constitutive activation of EGFR observed in multiple cancers (Zhou & Agazie, 2012). 
Phosphatases are believed to prevent activation of signaling cascades downstream of EGFR by 
suppressing basal activation of receptors, which can arise due to receptor overexpression or in the 
context of noisy fluctuations in extracellular stimuli (Östman & Böhmer, 2001).  
Interestingly, studying RTK phosphatases can be challenging due to complex regulation of 
their activity in cell signaling: activated EGFR can phosphorylate and activate their phosphatases or 
induce gene expression of new phosphatases (Tiganis, 2002) 
Section 2.6: Receptor recovery dynamics  
Recovery of cell surface receptors is important for cell physiology as it determines cell 
sensitivity to repeated ligand stimulations. After responding to initial stimuli, cells might enter into a 
refractory state, duration of which is affected by the speed of receptor recovery. Extended refractory 
state might help cells complete processing initiated response and prevent new redundant response if 
stimulus is repeated.  
Dynamics of receptor recovery can depend on multiple factors. When receptors are removed 
via degradation or sequestration, the recovery of functional cell surface receptors can require more 
time to return existing receptors to the cell surface or to synthesize new receptors. The rate of 
production of new receptors might depend on the metabolic state of cells, which in turn can be 




complete recovery of cell surface receptors, if available ligand leads to receptor activation and 
downregulation (Reddy et al., 1998). Such characteristics of receptor recovery can be relevant to 
many different types of receptor sensory systems. For example, it has been shown that to recover cell 
surface Erythropoietin receptors, Epo ligand has to be depleted from the cell surface (Becker et al., 
2010). However, recovering cell surface receptors might not restore cell sensitivity to Epo if at the cell 
surface receptors undergo a rapid reversible inhibitory post-translational modification. This case is 
exemplified by inactivating methylation of CheY receptors in bacterial chemotaxis. 
To the best of our knowledge, there are no experimental studies of cell sensitivity to 
restimulation with EGF through EGFR that would encompass measurements of both the responses of 
downstream targets of EGFR, such as pERK, recovery of EGFR to the cell surface and EGF 
depletion from the media. For example, some studies assessed recovery of cells sensitivity to 
repeated ligand stimulation over extended periods of time by measuring phosphorylation on receptors 
or on pERK ( Kuppuswamy & Pike, 1991; Pennock & Wang, 2003), however exact receptors mass as 
well as EGF depletion were not measured in these studies.  
Various estimates of the time of cell surface EGFR recovery are presented in the literature, 
yet all of them agree that EGFR recovery is a slow process, which might take on the order of seven or 
more hours (Hirai M, Gamou S, Minoshima S, 1988). The reported time of EGFR recovery would also 
depend on the cell context and the dose of initial EGF treatment. For example, in response to six 
hours of incubation with 1ng/ml of EGF, a nearly physiological EGF dose, in HER-14 cells the levels 
of EGFR on the cell surface decreased by 20%, and were restored to their initial number only 24 
hours afterwards (van de Poll, van Rotterdam, Gadellaa, Jacobs-Oomen, & van Zoelen, 2005). 
Another study reports that four to six hours are required to recover expression of functional cell 
surface receptors through de novo EGFR synthesis (Vijver, Kumar, & Mendelsohn, 1991). 
In this work, EGFR receptor recovery dynamics plays a role in retaining the memory of the 
dose of a persistent stimulation with EGF. At repeated stimulation, cell responses depend on the 
number of functional EGFR present on the cell surface ,as well as, on the dose of EGF in the new 
stimulus. In addition, changes in various intracellular molecular components downstream of EGFR 




indicate that the downstream kinase cascade signaling module between Ras and ERK itself does not 
provide any memory of past stimulations (Toettcher et al., 2013). Thus, it is likely that recovery of cell 
sensitivity to EGF by restoring the number of EGFR on the cell surface is a key process behind cell 
memory of EGF at the level of downstream intracellular kinases. 
Section 2.7: Effects of ErbB expression levels on signaling outcomes 
Although the relationship between EGFR receptor activation and mitogenic cell responses is 
not very clear (van de Poll et al., 2005), it has been suggested that levels of ErbB expression can play 
an important role in causing aberrant signaling (Hendriks, Opresko, Wiley, & Lauffenburger, 2003). 
The exact role of EGFR expression in signaling activation and cell fate remains puzzling: cells 
expressing low EGFR levels can generate much stronger responses to EGF than cells with 
intermediary levels of receptors; whereas for some cells overexpressing EGFR EGF can be growth 
inhibitory and induce apoptosis (van de Poll et al., 2005). Among other factors, ErbB gene 
amplifications as well as mutations in ErbB receptors might control the number of ErbB receptors on 
the cell surface through overexpression or through, for example, impaired downregulation (Sigismund 
et al., 2013). These studies suggest that levels of expression of cell surface receptors are important 
to cell signaling. Moreover, the biochemical properties of various receptor species (e.g., homodimers 
or heterodimers), such as ligand binding affinities, rates of dimerization, and internalization, can 
shape signaling dynamics. 
Recent studies have explored the relationship between expression of cell surface receptors 
and signaling outcome. For example, Macdonald & Pike, 2008 suggested that variations in EGFR 
expression within a physiological range can affect signaling response by determining the distribution 
of receptors between monomers and dimers before EGF treatment. Given that the two species have 
differential affinities to EGF ligand, shifting the number of receptors can alter the proportion of 
monomer to dimer species and thus affect signaling outcomes.  
HER2 (ErbB2) overexpression has been detected in many cancers (Baselga & Swain, 2009). 
Hendricks et al (Hendriks et al., 2003) studied how HER2 amplification affects cell signaling via 
changing receptors trafficking. Their work suggests that internalization-defective ErbB2 receptors can 




surface and potentially prolonging cell signaling. HER2 overexpression has been reported to convert 
transient pERK responses to EGF into sustained pERK activation (Birtwistle et al., 2007). 
Interestingly, in development, cell surface EGFR can regulate spatial range of diffusible 
morphogens, by depleting morphogens from the extracellular space (Goentoro et al., 2006). As a 
result, cells with various levels of EGFR expression when exposed to gradient of the ligand, can 
produce different signaling responses. 
However, other studies suggested that reduced levels of EGFR might be important to avoid 
EGF-induced growth inhibition in certain cell lines (Hirai M, Gamou S, Minoshima S, 1988). In 
particular, the authors reported that A431 cells, which express on the order of 10  EGFR per cells, 
were inhibited by periodical high dose EGF (100ng/ml) treatments. The authors proposed that not 
only EGFR gene amplification loss, but also efficient downregulation of EGFR receptors was 
important in evasion of EGF-induced cell growth inhibition. 
Constitutively high levels of EGFR expression on the cell surface might allow cells to detect 
high doses of EGF (Becker et al., 2010). However, overexpression of EGFR might not necessarily 
lead to high cell sensitivity to EGF, if EGF is being efficiently depleted from the cell surroundings, as 
efficient EGF depletion might reduce EGF mitogenic potential (van de Poll et al., 2005).  
Although the exact predictive and diagnostic value of EGFR expression is not well 
understood yet, a positive correlation between pEGFR and EGFR has been reported (Olsen et al., 
2012). Surprisingly, one study found that in some cancer tissues, levels of EGF, pEGFR and EGFR 
are downregulated compared to the normal control mammary tissue (Olsen et al., 2012). It might be 
the case that difference in dynamics in pEGFR responses caused by upregulated levels of EGFR, 
and not the upregulated levels of pEGFR per se, could be of more predictive clinical power. Overall, 
understanding the abnormalities in dynamics of cell signaling through EGFR might help to consolidate 
studies with conflicting findings regarding the role of EGFR overexpression in cancer.  
Section 2.8: Signaling cascades downstream of the EGFR receptors  
Activation of the EGFR receptors ultimately leads to activation of their downstream targets, 
such as, phospho-ERK and phospho-Akt, which play an important role in determining cell fate. AKT, 




metabolism, suppresses apoptosis, and promotes cell size growth (Hemmings & Restuccia, 2012). 
Mutations in pathways leading to activation of AKT have been found in many cancers (Sulis & 
Parsons, 2003). ERK stands for extracellular signal-regulated kinase, also referred to as mitogen 
activated protein kinase (MAPK). The MAPK pathway is among the most well studied mammalian 
kinase signaling cascades. 
The balance between activation and deactivation of pERK and pAKT determines signaling 
duration and magnitude – features that influence cell fate decisions. Attenuation of signaling on the 
downstream targets of EGFR can be realized through signal decay on pEGFR itself, action of 
phosphatases on various components of the signaling cascade, translocation of the targets into a 
different cell compartment, and activity of negative feedback loops. Degradation of the downstream 
targets might also contribute to signaling attenuation. However, no significant degradation of the 
kinases downstream of EGFR has been reported in the course of several hours of EGF stimulation. In 
addition, upon activation, pERK is known to translocate into the nucleus where it can be a subject to 
regulation by various other phosphatases (Cohen-Saidon, Cohen, Sigal, Liron, & Alon, 2009). 
Negative feedback loops from ERK and AKT are cell-context and stimulus dependent features of 
signaling networks, and thus will not be considered in this work. Experimental studies with the use of 
kinase inhibitors of upstream activators of pERK, such as phospho-MEK, show that pERK is a subject 
to rapid dephosphorylation by phosphatases (Hornberg et al., 2005; Kleiman et al., 2011). Hence, in 
this work we consider signal decay at the receptors level and regulation by phosphatases as primary 
mechanisms of signal removal on pERK and pAKT. 
Section 2.8.1: Phosphatases in the signaling cascade downstream of 
ErbB 
  
Influencing cell decisions through regulation of phosphorylation responses to growth factors, 
phosphatases can play an important role in suppressing aberrant signaling and in malignant 
transformations of cells (Arroyo & Hahn, 2005). 
Since complete pERK activation relies on phosphorylation of both serine/tyrosine and 
threonine residues, dephosphorylation of either of these residues would lead to ERK inactivation 




dephosphporylate ERK (Keyse, 2008). pERK can phosphorylate, and thus activate some of its 
phosphatases; in addition, pERK can induce transcriptional activation of its DUSP (Bermudez et al., 
2011). Same phosphatases can regulate multiple kinases in the MAPK cascade across different 
cellular compartments (Junttila, Li, & Westermarck, 2008). 
Phospho-AKT can be regulated by protein phosphatase 2A (PP2A) in a stimulus and cell 
context dependent manner (Andrabi, Gjoerup, Kean, Roberts, & Schaffhausen, 2007). PP2A can also 
act on other downstream signaling targets of phospho-EGFR (Sontag, 2001). In signaling cascade 
upstream of pAKT, a different class of phosphatases can regulate pAKT activation: PTEN – lipid 
phosphatase of PIP3 is an important tumor suppressor gene upstream of AKT (Sulis & Parsons, 
2003). 
 
Section 2.8.2: Signal amplification and ultrasensitivity in the MAPK 
cascade  
 
A remarkable feature of ERK signaling is its ability to respond to growth factors in a steep as 
well as in a gradual dose-response manner, depending on stimulus and cell-context. Ultrasensitivity 
allows to generate detectable mitogenic signals on pERK even at a low number of activated pEGFR 
(van de Poll et al., 2005). In this case, signal on pEGFR is amplified through the MAPK cascade and 
thus produces detectable responses on pERK. Steep ERK dose responses have been reported from 
studies in frog oocytes (Goldbeterl & Koshland, 1984). Ultrasenstive, step-like dose response has 
been suggested to facilitate all-or-none cell fate decisions, such as cell division. However, in 
mammalian cells pERK has been reported to have gradual dose responses (Chen et al., 2009).  
Multiple molecular mechanisms enabling ultrasensitivity have been suggested, such as 
saturation of enzymes, cooperativity in enzyme activation, two-step phosphorylation and others 
(Goldbeterl & Koshland, 1984). In this work, we implement ERK activation as a two-step 
phosphorylation process. In addition, our model allows ultrasensitivity to arise due to saturation of 
kinases and phosphatases. As a result, flexibility in parameter assignments allows reproducing both 




Section 2.8.3: Cross-talk between ERK and AKT and negative feedback 
loops 
 
The existence of cross-talk between pERK and pAKT signaling cascades has been 
previously reported, yet much remains unclear about the details of these interactions (C.-C. Wang, 
Cirit, & Haugh, 2009). Elucidating cross-talks is challenging as it can be cell-context and stimulus 
specific. Moreover, observing cross-talk effects can depend on doses of ligand stimulation, doses of 
inhibitors applied, and timing of the responses (Moelling, Schad, Bosse, Zimmermann, & 
Schweneker, 2002). Signaling cascades leading to ERK and AKT activation were reported to have 
cross-talks at various components, and in different cell lines. For example, studies found that AKT 
can inhibit ERK through Raf (Avraham & Yarden, 2011) in a cell-context dependent manner (Rommel 
et al., 1999). In addition, components upstream of pERK and pAKT can overlap in a cross-talk. For 
example, PI3K-dependent MEK activation has been reported (Cirit, Wang, & Haugh, 2010). 
Moreover, studies suggest that pERK activation is sensitive to PI3K regulation mostly at early stages 
of signaling, prior to pERK reaching its peak signal (Birtwistle et al., 2007). 
pERK can realize a negative feedback loop through activation of its own phosphatases by 
either phosphorylation or their transcriptional upregulation, as is the case of DUSP activation. In 
addition, ERK has been reported to negatively regulate various other signaling components upstream 
in the signaling cascade, such as, for example, Sos (D. Chen, Waters, Holt, & Pessin, 1996), and Raf 
(Sturm et al., 2010). Furthermore, ERK can regulate various positive and negative feedback loops in 
the MAPK cascade through inactivation of RKIP, a Raf kinase suppressor (Shin et al., 2009).  
We experimentally tested the presence of negative feedback loops between EGF-activated 
pERK and pAKT in MCF-10A and SKBR3 cells at several different EGF doses and two doses of 
inhibitors of activation of either pERK or pAKT. The experiments did not reveal the presence of 
negative feedback loops between pERK and pAKT in SKBR3 cell line. However, they suggested a 
possibility of a negative feedback loop from pERK and pAKT in MCF-10A cells. With MEK and PI3K 
inhibitors experiments we used in our system it is not feasible to assess the effect of a negative 
feedback loop from pERK to itself. One reason for this is that MEK inhibitors prevent pERK 




appropriate approach to detect a negative feedback loop from pERK to itself would be to use 
inhibitors of kinase activity of pERK. However, it is not clear if such inhibitors would not perturb 
signaling cascade in various unexpected ways. Since establishing precise regulation of downstream 
targets by negative feedback loops in the EGFR receptors signaling cascades is not the primary 
focus of this thesis, we omit implementing any negative feedback loops in our model. Such 
simplification is acceptable, as our model can still capture reasonably well our experimental data.  
Section 2.8.4: Effects of pERK and pAKT signaling responses on cell 
fate decisions  
 
Activation of ERK and AKT is crucial for cell division, motility, and cell cycle progression 
(Shaul & Seger, 2007; Kim & Choi, 2010; Hemmings & Restuccia, 2012). ERK can be activated by 
different stimuli and can elicit a wide range of cell responses depending on the cellular context. 
Dynamics of signaling responses of pERK and pAKT is crucial as it can encode distinct cell decisions. 
Yet, it is still not well understood how information about various extracellular stimuli translates into 
corresponding signaling dynamics on pERK, pAKT, and other targets, and how it encodes specific 
cell functions. In general, it has been suggested that cells might use two approaches, combinatorial 
and dynamical, to transduce information through cell signaling. In the combinatorial approach, distinct 
stimuli that activate the same signaling target can also activate combination of other targets specific 
to the stimuli. Hence, the combination of these stimulus-specific targets then determines distinct cell 
responses (Toettcher et al., 2013). 
Another way cells can encode signaling information is through the distinct dynamics of 
signaling targets. Distinct stimuli can elicit activation of same internal targets, yet   the   target’s  
responses would have different temporal profiles, which would be differently interpreted by the 
downstream cell machinery into distinct cell functions.  
It is likely that cells use both types of information encoding. However, in practice, it is 
problematic to distinguish between the two mechanisms employed by cells, because network 
perturbations of specific targets in signaling cascades can often alter dynamics of the signaling.  
Even though pERK is an important and well-studied cell signaling target, much remains 




translates it into a specific cell response. Many features of ERK signaling responses, such as 
duration, magnitude and subcellular compartmentalization are believed to be essential for cell 
decisions (Ebisuya, Kondoh, & Nishida, 2005). Yet, exactly how differences in ERK activities govern 
cell responses remains a mystery. It was suggested that the main mechanism by which ERK 
regulates cell fate is through changes in gene expressions. pERK translocates into the nucleus where 
it activates transcription factors and initiates gene expression (Cohen-Saidon et al., 2009). In addition, 
ERK can regulate cell function through activation of cytoplasmic targets as well, further propagating 
the signaling (Ebisuya et al., 2005). 
How do various features of ERK activities affect gene expression? In one way, cellular 
localization of active ERK preferentially to the cytoplasm, and not to the nucleus, can limit ERK-
dependent gene transcription. Duration and magnitude of ERK responses are essential in 
differentiation and cell-cycle regulation (Sasagawa, Ozaki, Fujita, & Kuroda, 2005b). Overall, it has 
been suggested that distinct ERK activity profiles affect stabilization of immediate-early gene products 
and other proteins, and this way can lead to different changes in gene expression, ultimately, 
resulting in different cell fates. 
What regulators shape distinct profiles of ERK responses? First of all, the identity and 
amount of the stimulants affect signaling cascades leading to ERK activation (Chen et al., 2009). 
Next, phosphatases can control amplitude and duration of ERK responses (Heinrich, Neel, & 
Rapoport, 2002; Hornberg et al., 2005). ERK phosphatases can be already expressed in cells at the 
time of signaling; alternatively they can be activated by ERK itself through phosphorylation; finally, 
ERK activation can induce gene expression of its own phosphatases, as is the case with the Dual 
Specificity Phosphatases (Keyse, 2008). Amplitude and duration of ERK responses can also be 
affected by downregulation of the upstream activating machinery, such as internalization and 
degradation of receptors initiating signaling cascades. In addition, various negative feedback 
regulators, such as inhibitory post-translational modifications of phospho ERK or the upstream 
components, such as EGFR or Sos (D. Chen et al., 1996), can lead to signaling attenuation and thus 




What determines the expression and role of the regulators of ERK responses? The 
abundances, functions and mechanisms of controls of ERK regulators are stimulus, cell-type and 
cellular context dependent; see Figure  (Ebisuya et al., 2005). Such diversity and complexity in 
regulation can explain, for example, why ERK activation by different ligands in the same cell can lead 
to different cell response (Sasagawa et al., 2005b), as well as how stimulation with the same ligand 
can produce drastically different responses in cells of different types (Meloche & Pouysségur, 2007;  
Ebisuya et al., 2005). 
In summary, distinct qualitative and quantitative features in ERK activity, through gene 
expression, might be translated into specific cell responses. However, quantitative properties of the 
relationship of ERK activation and cell fate are still poorly understood. 
Overall, there is still no consensus as to what profiles of EGF stimulations are required to 
elicit mitogenic response. First, this relationship is complicated and might be cell-context dependent. 
Second, different studies vary on the experimental setup they use and cells they work with. It has 
been suggested that initiation of DNA synthesis in quiescent cells might require at least 8 hours of 
continuous presence of growth factors (Riddle, Pardee, & Rossow, 1979). Other studies suggested 
that two short pulses of EGF stimulation are sufficient to transition quiescent cells into G1 phase, 
followed by entry into S-phase (Pennock & Wang, 2003). Hence, it is possible that to detect 
subsequent ligand stimulations and activate pERK, cells might need to have functional receptors on 
their cell surface 8 hours after the initial growth factor stimulation to eventually transition into S-phase 
(van de Poll et al., 2005). 
Recently, effects of ERK activation dynamics onto cell responses were studied through 
quantitatively relating ERK signaling to the activation of its downstream targets, such as c-fos (Albeck 
et al., 2013). Transcription factor c-fos controls gene expression relevant to cell differentiation and 
survival, and has been implicated in many cancers (Milde-Langosch, 2005). c-fos has been shown to 
mediate entry into the S phase by responding to sustained, and not transient, activation of ERK (L. O. 
Murphy, Smith, Chen, Fingar, & Blenis, 2002). Such ERK-dynamics dependence of c-fos is likely due 
to the fact that sustained ERK activity is required for stabilization of c-fos. Although activation of c-fos 




still incomplete due to time-separation between processes of activation and the observed response. It 
might take hours to observe cell responses after pERK stimulation. Frequency of pERK stochastic 
pulses depends on levels of EGF stimulation and it was suggested that integral of ERK activation 
over a 2-3 day period results in stabilization and accumulation of downstream transcription factors 
leading to cell cycle progression (Albeck et al., 2013). Dose responses linking ERK phosphorylation 
to activities of c-fos   and   several   other   ERK’s   downstream   reporters   allow   to   establish   quantitative  
relationship between ERK activity and proxy of cell response. pERK activation at about 10% of its 
maximal value can have effect on cell proliferation. Hence, to inhibit cell proliferation through ERK 
one might need to inhibit ERK activity below the 10% threshold (Albeck et al., 2013). Although, this is 
estimate is quantitative, and not qualitative, it still leaves a wide range of uncertainty – what is an 
effect on cell proliferation if pERK is inhibited by 50%? It might be useful to have more nuanced 
quantitative understanding of this relationship between ERK and cell fate, especially, in light of recent 
tactics in drug development, when partial inhibition of tumor growth or induction of differentiation of 
tumor cells, and not the complete destruction of tumor, can be a mechanism of action of therapies 
(Stein et al, 2014).    
Emerging experimental optogenetic techniques allow us to directly alter ERK activation 
dynamics in single cells and observe resulting changes in cell decisions (Toettcher et al., 2013). Such 
methodology permits to study information processing features of isolated modules in signaling 
pathways -- for example, Ras/ERK cascade -- and how the dynamics of their responses is deciphered 
by downstream cell machinery. The advantage of this technique is that it allows direct regulation of 
targets of interest, bypassing a layer of regulation between extracellular signal and the target of 
interest. In addition, optogenetic activation allows a better control of timing of reactions and activation 
(e.g. activation and cell response are not obscured by extended timing between the two, usually 
present in studies reliant on gene-expression in response to ligand treatment). On the other hand, 
direct optogenetic activation of the target might disregard the broader context of cellular signaling: for 
example, stimulus acting via receptor-mediated signal transduction, might lead to activation of not 




although the optogenetic method allows better quantitative understanding of isolated components of 
signaling cascades, it might omit the broader, systemic regulation features of the signaling cascades. 
How do cells interpret quantitative changes in ERK dynamics? Here we have already 
mentioned how differences in duration in ERK signaling can produce different cell responses via 
stabilization of c-fos. However, not much is understood about effect of magnitude of ERK responses 
on cell fate. Does relative or absolute change in pERK in response to stimulation is important for cell 
decision? It has been hypothesized that effect of fold-changes in pERK on cell decisions might 
depend on the range of pERK activation; specifically, a two-fold change in pERK might result in a 
five-fold change in cell response if pERK levels are far below saturating; whereas, a two-fold change 
in pERK might be unnoticeable at cell response level, if pERK is approaching saturation (Albeck et 
al., 2013). In addition, fold-changes have been suggested to be important to cell fate in nuclear 
phospho ERK response to EGF treatment (Cohen et al., 2008). However, mechanisms that cells 
might use to encode and decipher pERK relative changes are not well established; incoherent feed 
forward loop at transcription regulation has been proposed as a potential mechanism, yet it was not 
confirmed experimentally (Goentoro, Shoval, Kirschner, & Alon, 2009). In this work we will focus on 
cell mechanism that allows cells to generate same pERK responses to step-increases in EGF stimuli 





Figure 2.2: Schematic representation of regulatory mechanisms of ERK activation and cellular 
responses. Adapted from (Ebisuya et al., 2005) 
 
Section 2.9: Perfect adaptation in cell signaling systems 
Previously we discussed how adaptation can allow biological systems to decrease their 
responses to chronic stimulation, while retaining sensitivity to relative changes in stimuli across a 




organisms and biological systems, due to survival advantages it provides to organisms and cells in 
changing environments.  
A classic example of adaptation at molecular level is perfect adaptation in bacterial 
chemotaxis. Perfect adaptation allows bacteria to move towards the source in a nutrient gradient, 
independently of the absolute concentration of nutrient at the source. Bacteria can either run or 
tumble. Tumbling allows bacteria search directions with higher nutrient content, whereas runs allow 
bacteria continue in the preferred, nutrient-rich direction. Sensing nutrients regulates bacterial 
proteins responsible for motility; perfect adaptation on the responses of these proteins allows bacteria 
to decrease its motility and stay in high-concentration nutrient region, yet capable to respond to 
further increases in nutrient levels (Alon et al., 1999).  
Recently, perfect adaptation in nuclear phospho ERK has been reported across distribution of 
single cells in response to EGF stimuli (Cohen-Saidon et al., 2009). However, no mechanism behind 
the perfect adaptation on nuclear pERK is proposed. 
In general, mechanistically, adaptation requires a delayed feedback loop, and in addition it 
may employ shorter-timescale mechanisms such as covalent protein modifications (Koshland, 
Goldbeter, & Stock, 1982). For example, adaptation in bacteria chemotaxis is realized through 
reversible methylation of CheY receptors responsible for bacteria motile function. Nutrient-induced 
phosphorylation of CheY activates the receptors and leads to bacteria runs. However, over time, 
CheY is being methylated, which reduces the motility. Demethylation of CheY restores the ability of 
bacteria to respond to further relative increases in stimuli levels. Such mechanism of realizing perfect 
adaptation is classified as integral feedback control. Other topologies capable of achieving perfect 
adaptation include incoherent feed-forward loop and have been recently explored in detail (Ma, 
Trusina, El-Samad, Lim, & Tang, 2009). 
To observe perfect adaptation in sensory systems experimentally, signaling responses would 
be required to return to a pre-stimulation level independently of the dose of the applied chronic 
stimulation. However, it might be impracticable to experimentally detect precise adaptation in 
responses due to measurement detection errors. In addition, it is often infeasible and unnecessary for 




exact values. Hence, it is reasonable to consider responses which return to the pre-stimulus level 
within a certain threshold, for example, within 5-10% (Goentoro et al., 2009). 
Moreover, since maintaining the perfect adaptation state might require energy expenditures 
from cells, there might be cases when perfect adaptation is not necessary, and approximate 
adaptation instead is a more suitable option (Koshland et al., 1982). For example, in tissues, hormone 
levels might decrease over time due to diffusion, washing away from cell surface by blood, or due to 
depletion through internalization of ligand-bound cell surface receptors. Fading of the extracellular 
stimulus would aid in attenuating the signaling, and thus help cells to return to pre-stimulus level even 
if cells do not possess machinery for perfect adaptation. For example, Epo receptors function by 
depleting Epo from their media through internalization of ligand-bound receptors (Becker et al., 2010). 
As of today, there are only few studies on adaptation in signaling systems, especially EGFR 
related signaling. A recent study explored perfect adaptation on Ras in response to activation of G 
protein coupled receptors. They find that adaptation in Ras pathway is realized through quantitative 
changes in upstream components and not through negative feedback loops (Takeda et al., 2012). 
It is not clear what are all possible cellular mechanisms behind perfect adaptation, what are 
the implications of adaptation to cell physiology and function. In this work we consider adaptation of 
phospho signals in EGFR signaling cascade and will explore differences in adaptation properties in 
cancer versus normal mammary epithelial cell lines. One hypothesis is that it is not the ability to adapt 
perfectly, per se, but the time scale of adaptation, which might be important to cell fate decision. 
Mutations in signaling cascade might delay adaptation, prolonging signaling, which might lead to 
aberrant cell growth and cancer.  
What would prefect adaptation in cell signaling through EGFR mean to cell physiology? Is 
this property lost in cancer cells? Is it still present in cancer cells the dynamics of pEGFR, pERK, 
pAKT responses is altered? What role does perfect adaptation in EGFR signaling play in deciphering 
consecutive EGF extracellular signals? What mechanisms do cells use in perfect adaptation to EGF 
at the levels of pEGFR and at the level of its targets? We will attempt to address these questions in 





Section 2.10:  Weber’s  Law  in  living  systems 
Beyond   ordinary   human   senses,   the   first   evidence   of   Weber’s   Law   in   biological   systems  
emerged in the end of 19th century  from studies of bacterial chemotaxis (Mesibov, Ordal, & Adler, 
1973). In this section, we will collect other known examples  of  Weber’s  Law  at  cellular  and  molecular  
levels as well as provide a rationale for why relative sensing in signals might be advantageous. It is 
possible that necessity to adapt to changing environments and to perform numerous complex 
functions, led living organisms to develop effective information processing strategies at cell, tissue 
and organism levels. Hence, it is not surprising if the organisms at these various levels converged to 
have a similar property of relative sensing. 
Cells in tissue might benefit from mechanisms (such as relative sensing) aiding effective cell 
group responses. For example, it has been suggested that collective cell responses can be 
advantageous from the point of view of information processing (Cheong, Rhee, Wang, Nemenman, & 
Levchenko, 2011): responses in a number of cells could help mitigate molecular noise. However, 
such information processing gains might be limited by the number of cells exposed to the same 
stimulus. Hence, the information processing strategy in cells might be further enhanced, for instance, 
through the integration of memory of the past signals in cell responses. Cell responses relative to the 
pre-stimulus state might be more robust to noise originated from cell-to-cell variability in gene 
expression or from uneven distribution of stimulus among the cells, characteristic to cell populations 
in tissues.  
Second, implementing relative sensing mechanisms allows cells to function in many different 
contexts. Various tissues in the organism can be exposed to the chronic stimulation with the same 
ligand, but of different doses. Hence, relative sensing might allow cells to use same mechanisms to 
perform same functions across tissues, independently of the stimuli doses characteristic to different 
tissues. 
Third, relative sensing can help cells maintain sensitivity to repeated signals. For instance, if 
a cell, while processing information from incoming signal, is receiving a next signal, of the same 
nature, but at a higher level, relative sensing can allow cells to adjust their sensitivity and generate 




Relative sensing is present across different simpler species and can help the organisms 
facilitate various physiological behaviors. A classic example of relative sensing in inputs in biology is 
bacterial chemotaxis in nutrient gradients. It has been reported that E.coli is able to navigate towards 
regions with the highest concentration of nutrient independently of the absolute level of nutrient at the 
source (Lazova & Ahmed, 2011). Furthermore, yeast has been suggested to implement relative 
sensing in glucose and galactose levels (Savir, Escalante-chong, & Springer, 2005). It is conceivable, 
that more precise stimuli sensing can help yeast optimize its growth strategies depending on the 
abundance of its preferred growth nutrient. Drosophila olfactory searches were suggested to be 
scale-invariant in odorant levels (Martelli, Carlson, & Emonet, 2013), and thus resemble bacteria 
chemotaxis nutrient searchers. The relative sensing in drosophila olfactory searches in mediated 
through olfactory receptors.  
Recently, several examples of relative signaling in mammalian cells were reported. Although 
these mechanisms might be essential for cell functioning in tissues, their effects on broader cell 
physiology remain to be elucidated. TNF-induced signaling has been suggested to determine 
downstream transcription in single cells via fold-changes, not absolute levels, in the activity of the 
transcription factor NF-kB (Lee, Walker, Savery, Frank, & Gaudet, 2014). Geontoro and colleagues 
(Goentoro & Kirschner, 2009) observed apparent correlation between Wnt initiated fold changes in b-
catenin levels and transcription of response genes, as well as the phenotypes they produce in 
drosophila development. As has been previously mentioned, nuclear phosphor-ERK levels might 
respond to EGF in fold-changes (Cohen-Saidon et al., 2009). 
Interestingly, the systems in the above examples most likely implement relative sensing 
through different underlying mechanisms. In the case of bacterial chemotaxis, relative sensing is 
known to result from integral feedback control via inhibiting reversible methylation of cell surface 
receptors; whereas for NF-kB, b-catenin and nuclear phosphor ERK examples, the fold-change 
detection is thought to be realized by transcription factors machinery. This outcome suggests that 
distinct biological mechanisms, such as methylation, a post-translational modification, as well as 
transcription regulation, can be responsible for the relative sensing of inputs. This again reinforces the 




systems. Furthermore, this observation leads to question what other mechanisms of post-translational 
modifications can retain memory of stimuli and implement relative sensing in inputs. 
In the following subsections we will consider in detail several recent works on relative sensing 
across different organisms and different signaling systems. 
Section 2.10.1:  Example  of  Weber’s  Law  at  the organism level: scale-invariant 
nutrient searches in bacterial chemotaxis  
 
First  evidences  of  Weber’s  Law  in  bacteria  emerged  as  early  as  1988  (Mesibov et al., 1973). 
Bacteria were placed in solutions with meat extract. It has been noted that a fivefold increase in 
concentration of meat extract over the initial background concentration was needed to produce a 
detectable movement of bacteria. This effect was observed independently of the initial background 
concentration of the extract across two orders of magnitude of this concentration. Such phenomenon 
is referred to as just noticeable difference and is described by the original  Weber’s  Law  (see Section 
2.10). 
Next, bacteria have been shown to perform scale-invariant searches in nutrient gradients 
(Mesibov et al., 1973). In particular, bacterial responses to nutrients were quantified by the number of 
cells that over some time migrated to the sources of the nutrient. It was found that bacteria responses 
were independent of the basal nutrient levels across several orders of magnitude, for the constant 
ratio of concentration at the source to the basal level. 
Subsequent studies focused on exploring molecular mechanisms behind scale-invariance in 
bacterial chemotaxis. In general, bacterial nutrient search relies on tumbling, or steps in random 
directions, and movements in one given direction (Keymer, Endres, Skoge, Meir, & Wingreen, 2006; 
Vladimirov & Sourjik, 2009). Tumbling is controlled by kinase activity of certain receptors, which upon 
binding of ligand decreases their methylation and reduce their kinase activity, thus keeping bacteria 
from tumbling and instead allowing it to move in one direction, along the gradient of the attractant (Tu, 
Shimizu, & Berg, 2008; Hart et al., 2013). This property allows bacteria to move towards the source of 
the nutrient, independently of the absolute level of nutrient at the source. Such scale-invariant could 




Series of theoretical studies (Alon et al., 1999; Tu et al., 2008) suggested mechanisms 
behind relative sensing in bacteria and proposed that topology enables bacteria to produce fold 
change detection responses in nutrient sensing (Shoval et al., 2010). 
Fold-change detection in E.coli chemotaxis recently has been experimentally verified both at 
the molecular level and at the organism behavior level (Lazova & Ahmed, 2011). The activities of key 
intracellular proteins regulating E.coli motility were measured in response to treatments with various 
doses of nutrient. To quantify the resulting displacement of the bacterial population in nutrient 
gradient with various background levels the authors report chemotactic migration coefficient that 
approximates average population-averaged spatial coordinate of bacteria. The authors identify 
regions   of   doses   of   stimuli   in   which   both   the   reporter’s   responses   and   bacterial displacement are 
constant over at least one order of magnitude and with a schematic model explain the key regulatory 
features of bacteria chemotaxis system that allow scale-invariant searches.  
Interestingly, mechanisms for both relative and absolute sensing in stimuli might be present 
in bacteria. For example, two-component systems with an absolute-response mechanism have been 
reported in bacteria (Batchelor, Silhavy, & Goulian, 2004; Shinar, Milo, & Alon, 2007). A classic 
example when an absolute amount of stimulus matters is a case of organismal embryo development 
(Rogers & Schier, 2011). 
 
Section 2.10.2: Example  of  Weber’s  Law  at  the organism level: relative sensing 
of odorant levels in the drosophila olfactory system 
 
 Odorant discrimination and responses in insects presents an interesting example of encoding 
various cell functions through different response dynamics of the same signaling target. Recent work 
explored dynamics of olfactory neuron responses to different odorants (Martelli et al., 2013). 
Responses generated in such system usually last on the order of seconds. The authors find that 
shapes of such responses are stimulus-dependent. Further, they find that for certain odorants, 
although the magnitude of the responses to repeated stimuli changes, response dynamics is 
independent of background intensity over several orders of magnitude of ligand dose. Since in natural 




systems to detect stimuli changes relative to the background level. Moreover, in the odorant regions 
where response dynamics is background-independent, several neurons can detect changes in 
odorant levels and produce response with reliable dynamics, which could then be interpreted as the 
same cellular function. The authors suggest that such feature can allow insects to perform olfactory-
driven navigation independent of signal intensity and background, reminiscent to bacteria chemotaxis 
movement in nutrient-gradient space.  
This example further demonstrates ubiquity of relative sensing in biological molecular 
systems. 
 
Section 2.10.3: Fold-change responses in nuclear phospho-ERK and an 
incoherent feed forward loop as a proposed mechanism behind it 
 
Recent studies focused on fold-change detection in cell signaling cascades as a mechanism 
for robustness in cell-to-cell variation in gene expression, and not from the point of view of cells in 
populations responding to noisy levels of extracellular stimuli. 
The possibility of phospho-ERK fold-change responses in sensing EGF has been recently 
investigated (Cohen-Saidon et al., 2009). Activated by EGF stimulations, phospho-ERK2 is known to 
translocate into the nucleus where it initiates transcriptional responses. The authors developed a 
clonal cell line with ERK2-YFP fusion protein and monitored single cells response to a constant EGF 
treatment. They found that despite the significant (up to four-fold) variability in pre-stimulus nuclear 
levels of ERK2 between individual cells, upon EGF treatment, ratio of peak to basal levels of ERK2-
YFP was approximately the same across the cells. In addition, in 80% of the cells ERK2-YFP 
returned within 10% of the original, pre-stimulus level, thus exhibiting exact adaptation to the basal 
level. 
However, the study was conducted using only a single dose of EGF, 10ng/ml. The dose is 
considered to be high physiological, at which phospho-ERK response has been shown to reach 
saturation in several other systems ( Chen et al., 2009). It is plausible to assume that the basal level 
of ERK phosphorylation in a single cell in the absence of the EGF stimulus constitutes a constant 




phosphorylated ERK is a constant fraction of the total expressed ERK in that cell compartment. 
These threshold values are likely to be preserved across single cells variance. It is not surprising 
then, that at saturating EGF dose, phospho-ERK responses across single cells reach the maximal 
thresholds of activation, thus showing the same ratio of the peak of the response to the initial basal 
phospho-ERK levels. In addition, the authors did not present any specific molecular mechanism 
which would be able to decipher pERK fold-changes downstream in the nucleus, although, as a 
possible candidate, they suggested an incoherent feed forward loop (IFFL) topology in transcription 
machinery. 
Another view on fold-change responses in single cells suggests that growth factor 
concentrations in tissues can control probability of various cell fate decisions based on basal levels of 
expression of signaling proteins in individual cells (Birtwistle et al., 2012). For example, total ERK 
expression variability affects phospho-ERK levels in cells responding to EGF. In certain contexts, to 
maintain tissue homeostasis some subpopulations of cells in the same tissue might need to generate 
different population-wide responses to the same stimuli. 
A theoretical study suggested a molecular mechanism able of fold-change detection at 
transcription level (Goentoro et al., 2009). Specifically, the authors investigated how an incoherent 
feed-forward loop (IFFL) network motif can realize fold-change detection. The authors claim the IFFL 
topology to be an “almost  minimal   circuit”   to   accomplish   fold-change comparison in transcriptional 
networks. The authors consider several possible transcriptional regulation motifs in three-node 
topologies (X- activator, Y- repressor, Z – target or output). They conclude that to exhibit fold-change 
detection, IFFL motif does not require parameter fine-tuning, but relies only on some constraints in 
parameter ratios. The authors also demonstrate limiting cases in which other network motifs, such as 
“sniffer”,  can  also  exhibit   fold-change detection. In addition, the authors suggest that some, but not 
all, networks with perfect adaptation might achieve fold-change detection. 
However, in the main paper the authors refer to the fold-change detection property as one in 
which signals with same fold-changes over initial different background levels, can elicit the same 
response not only in magnitude but also in the temporal adaptation profile. Whereas, in the detailed 




model, the authors require that the responses to two identical fold-changes in signal match their 
peaks within  10%.  The  latter  being  exactly  the  requirement  for  Weber’s  Law. 
Besides the possible benefits of providing robustness to cell-to-cell variation, the fold-change 
detection might be advantageous in discriminating meaningful stimuli changes over noise. More 
specifically, if noise strength is proportional to the standard deviation of the mean signal level, then, 
the higher the basal signal, the higher is its noise threshold level, and hence, mechanisms relying on 
fold-increases rather than absolute changes might be more suitable to function in such noisy 
conditions. 
 
Section 2.10.4: Fold-change responses in b-catenin signaling in response to 
Wnt stimulation 
 
 Another evidence of the possibility of encoding and reading cell information in relative, not 
absolute amounts was reported by Goentoro and colleagues (Goentoro & Kirschner, 2009). They 
investigated quantitative features of signaling through the Wnt pathway important in development. 
Wnt-induced signaling leads to accumulation of b-catenin in the cells which then leads to 
transcriptional activation of its downstream targets. This study suggests that ratio-sensing 
mechanisms might be present at the level of gene transcription. 
The authors find that Wnt-induced fold-changes of b-catenin, rather than the changes in its 
absolute levels, are robust to variations in cell parameters and guide transcription of its downstream 
targets. A theoretical analysis of the Wnt-signaling model with b-catenin accumulation suggests that 
the absolute levels of b-catenin are sensitive to parameter perturbations, whereas fold-changes are 
robust. The fold-changes in responses are measured by a ratio between steady state in b-catenin 
response in cells stimulated with a certain Wnt dose compared to steady state levels in b-catenin in 
absence of Wnt.  
The authors validate their predictions first, via series of experiments in mammalian cell lines: 
using inhibitors and overexpression constructs they show that absolute levels of b-catenin are 
sensitive to cell parameter perturbations; however fold-changes in b-catenin levels remain robust. 




On the model of Xenopus embryos they show that the fold-changes in b-catenin level correlate with 
the developmental phenotype. Further, they also demonstrate existence of the transcriptional 
machinery possibly decoding relative changes in b-catenin levels. 
Interestingly, this study investigated fold-change responses by considering the long-term 
steady state b-catenin levels, not taking into account the dynamics of immediate b-catenin response 
to Wnt, motivating it by the fact that to observe effects on phenotypes can take days. Finally, the 
authors emphasize that in order for the biological network to provide robustness in Wnt-induced fold-
change in b-catenin it is important for network parameters to be fine-tuned, a point which we explore 
in Section 4.7 and Section 5.1. 
 
Section 2.10.5: NFkB signaling in response to TNF stimulation 
 
Lee et al (Lee et al., 2014) found that the TNF treatment controlled transcription of early 
genes in single cells via fold changes of nuclear NF-kB. The authors observe that the nuclear NF-kB 
levels vary between untreated single cells. They develop reporters and cell constructs enabling them 
to measure simultaneously in a single cell the levels of NF-kB translocated into the nucleus in 
response to a given TNF dose, and the transcription changes of a certain target gene initiated by this 
translocation, thus linking the NF-kB fold changes to the induced transcriptional response. The 
authors used several different TNF doses (0, 0.1, 1, 10ng/ml) and combined results in one set and 
found a correlation between different TNF doses and the induced fold-changes in single-cell NF-kB 
levels and the accompanying transcription responses.  
The authors find that a model of transcription-level regulation by NF-kB levels with incoherent 
feed forward loop structure is able to recapitulate well the experimental data and predict existence of 
fold-change response detection. This study, however, did not investigate if the fold-changes in TNF 
levels were detected by the cells. Hence, similar to the previous example of nuclear phospho-ERK 






Section 2.11: Previous quantitative studies of the emergent properties of 
receptors signaling systems through a combined computational and 
experimental approach  
Combined computational and experimental approaches have been previously applied to 
study various receptor cell signaling systems (Becker et al., 2010; Tu et al., 2008). Such works often 
focus on gaining mechanistic insight on signaling networks through the consideration of signaling 
dynamics, or by understanding information processing of a signaling network. However, not many 
studies explored different emerging physiological properties of receptors sensory systems that are 
relevant to physiological context of the specific receptor system and that go beyond the cellular 
context. To the best of our knowledge, our work, for the first time relates EGFR cell signaling 
dynamics in response to EGF to a feature of cell memory essential for cells in their physiological 
environment.  
As an example, a recent quantitative study of Erythropoietin receptor (EpoR) signaling was 
able to explain a peculiar property of Epo receptors enabling cells to sense Epo ligand concentrations 
across several orders of magnitude (Becker et al., 2010). EpoR receptors stimulate growth and 
survival of red blood cells in response to Epo. The authors combined experimental data and 
computational modeling to study signaling dynamics of EpoR and through it were able to derive 
broader properties of EpoR signaling cascade relevant to its ability to process wide range of Epo 
concentrations. In particular, it was found that by rapid ligand-independent replenishment of EpoR to 
cell surface, cells efficiently internalize and degrade the Epo ligand from the cell environment, while 
recycling EpoR to the cell surface, and thus the cells are able to sense broad range of Epo 
concentrations. The study thus links the biochemical properties of ligand and receptor interactions, to 
signaling dynamics and finally to the physiological effect on the cells. As implications, such study can 
also suggest desirable properties for design of potential stimulants of red blood cell proliferation 
optimized for their bioavailability and outcome on cell function.  
Interestingly, the study (Becker et al., 2010) draws comparisons between the EpoR system 
and other receptor sensory systems, such as, EGFR and interleukin 3 (IL3) signaling. The authors 




EpoR, IL3 receptors rapidly deplete ligand from cell surface. However, the key operational 
mechanism of these receptors relies on production of new receptors, not the ligand-induced 
mobilization of already synthesized receptors as in the EpoR case. As a distinctive property of EGFR 
signaling rapid EGF-induced internalization of the receptors is featured; whereas for the EpoR the 
rate of ligand-induced internalization is comparable to that of the basal internalization. It is interesting 
to study these distinct receptor signaling systems with a combined approach of experiments and 
mechanistic modeling, and be able to explain the emerging properties of these system relevant to the 
physiological context in which receptors function.  
In addition, investigating the same cellular phenomenon, for example, the ability to sense a 
broad range of ligands or to remember doses of past stimulations, in different receptor systems can 
provide insight into different molecular mechanisms that can be used to realize same cellular function. 
In particular, it could be interesting to explore what other molecular mechanisms can implement cell 
memory of previous ligand doses, and how various properties of such memory affect cell functioning. 
Another recent work presented theoretical analysis of information processing properties of 
receptor signaling systems emerging from their various biochemical features (Shankaran et al., 
2007). The authors consider general properties of receptor internalization dynamics across several 
receptor sensory systems. In particular, they study how features of receptors ligand interaction and 
endocytosis influence function of the signaling system. The authors construct a unified mathematical 
model of receptors cell signaling and ligand transport, and instantiate each particular receptor 
signaling system with a specified set of kinetic parameters. They classify receptors systems into three 
types: those controlled mostly by efficiency of ligand capturing, second type is reliant on 
internalization of ligand from cell surface, and third type – utilizes both strategies. The authors 
suggest that the EGFR system is dual-controlled. In addition, they postulate that ligand-induced 
receptor internalization can help improve precision of signaling receptors.  
Given multiple commonalities between the receptors sensory systems it will be interesting to 
investigate   what   general   properties   of   signaling   cascade   would   allow   Weber’s   Law   in   in   their  
responses to fold-changes in ligand concentrations and to explore what various mechanisms of 




Chapter Three: Methods 
 
 Chapter Three describes in detail the computational part of the thesis - the dynamical ODE 
model of EGFR signaling and the probabilistic methodology to sample the model parameters space 
and generate predictions of EGFR signaling behavior. 
Section 3.1: Mechanistic Dynamic ODE Model 
Section 3.1.1: Previous models of the EGFR signaling cascades  
 
The EGFR signaling cascades have been modeled extensively for several decades now 
(Wiley, Shvartsman, & Lauffenburger, 2003; Kholodenko, Demin, Moehren, & Hoek, 1999; Chen et 
al., 2009; Schoeberl, Eichler-Jonsson, Gilles, & Müller, 2002; Shankaran et al., 2012; Kleiman et al., 
2011). Various aspects of signaling have been addressed, for example, kinetics of ligand binding, 
dimerization of receptors, their activation and regulation by phosphatases, transport, interaction with 
scaffold proteins and activation of downstream signaling cascades. Often, for simplicity, studies 
focusing on immediate-early signaling (Kholodenko et al., 1999) omit implementation of receptor 
synthesis. Other models assumed an abridged view of ligand binding (Lazzara & Lauffenburger, 
2009). In our model we focus on the most relevant features of EGFR signaling, while keeping the 
model as parsimonious as possible. Our model relates activation of EGFR to downstream responses 
of pERK and pAKT, yet also implements in detail EGF binding kinetics and receptors activation and 
downregulation. In general, mechanisms of signal attenuation present in the model are 
dephosphorylation of pEGFR, pERK, pAKT by their corresponding phosphatases and degradation of 
EGFR receptors. In addition, the model allows to attenuate signaling via EGF depletion from the 
media through receptor-dependent internalization of the ligand. 
Section 3.1.2: Mechanistic Dynamic ODE Model of ErbB Signaling 
 
Since in the MCF-10A and other cancer cells we work with, the abundances of signaling 
proteins in the cascade are on the order of at least one thousand molecules per cell, we do not 
consider stochastic modeling, but develop a dynamic ordinary differential equations (ODE) model. 
Our model relies on mass action kinetics. We use mass action kinetics, and not the Michaelis-Menten 




Chen, Niepel, & Sorger, 2010). Reactions are encoded as simple unimolecular or bimolecular 
processes with parameters representing protein concentrations and kinetic rate constants of their 
interactions and of the first-order reactions (see Figure 2.1). Model equations and species 
descriptions are provided in the Section A.1.  
Model scope encompasses both, detailed receptor-layer interactions (ligand binding, receptor 
dimerization, etc.) as well as simplified reactions leading to activation of downstream targets. At the 
receptor layer, we model EGF binding and unbinding, receptors dimerization, phosphorylation, 
receptors internalization, recycling, degradation, ligand-independent synthesis, and 
dephosphorylation by RTK phosphatases. 
EGF is allowed to bind to and unbind from receptor monomers, unoccupied receptor dimers, 
and one- EGF molecule occupied receptor dimers, with distinct kinetic rate constants of binding and 
unbinding depending on the receptors species. Such encoding allows literature-suggested negative 
co-operativity in EGF binding to one-EGF-occupied dimers (Macdonald & Pike, 2008). 
EGF-bound receptor monomer can reversibly dimerize with either unbound or bound EGF 
monomer. The two reactions are implemented with different binding rate constants to allow differential 
affinity between the dimers of two types. Dimerization between two unbound monomers is not 
implemented since its equilibrium constant is known to be about 2.5 orders of magnitude lower that 
the dimerization between receptors with at least one EGF bound (Macdonald & Pike, 2008). 
After receptors form dimers they undergo phosphorylation. We assume that ATP is 
overabundant in the cells, so phosphorylation of dimers is implemented as a first order reaction. Both, 
one EGF-bound dimer and two EGF-bound dimers are allowed to undergo phosphorylation.  
To keep the model simple, we assume that each monomer has only one virtual phosphorylation site, 
we do not distinguish between different phosphorylation sites on the receptor, and hence, the 
monomer can only be in one of the two states – it can be either phosphorylated or unphosphorylated. 
Phosphorylated dimers are being rapidly removed from the cell surface by receptors 
internalization, also called endocytosis. Our model contains two cellular compartments – the plasma 
membrane and the cytoplasmic compartment, and the endosomal compartment. Endocytosis is 




endosomal receptor species. Signaling from endosomal phosphorylated receptors is allowed. In 
endosomes, receptors can be recycled back to the plasma membrane, or be degraded, or be 
dephosphorylated by endosomal phosphatase.  
The endosomal RTK phosphatase is implemented as a separate species, distinct from the 
cytoplasmic RTK phosphatase. Both phosphatases act on phosphorylated dimers and are encoded 
as first-order reactions. Such implementation is supported by the findings that different phosphatases 
are overabundant throughout the cell and might have different catalytic properties. Hence, a first-
order rate constant of dephosphorylation represents a unified dephosphorylation action of 
phosphatases in each of the two implemented compartments. 
In addition to internalization and recycling of phosphorylated dimers, our model implements 
basal, ligand-independent internalization, degradation and recycling of inactive receptors. For the 
ErbB receptors, basal internalization is known to be an order of magnitude slower than the EGF-
induced internalization (Becker et al., 2010). In addition, our model implements ligand-independent 
production of EGFR to the cell surface. The receptors production constant effectively encompasses 
both, receptors synthesis and their delivery to the cell surface. 
Downstream of the EGFR receptors the model implements signaling to two targets, ERK and 
AKT. The kinase signaling cascade between EGFR and ERK is simplified, grouping details of 
receptors interactions with scaffold proteins and multiple intermediate kinases into one effective 
signaling component. Since measuring abundances and dynamics of signaling responses at scaffold 
and adaptor proteins is outside the scope of this thesis, the interactions with scaffold and adaptor 
proteins are encapsulated in effective rate constants of reactions between receptors and downstream 
kinases.  
Similarly, signaling cascade leading to AKT activation is reduced to one effective intermediary 
component. Such simplifications still allow to fit well the experimental data with a substantially 
reduced   number   of   model’s   parameters.   However,   we implement ERK activation via double 
phosphorylation of ERK in our model. Deactivation of both ERK and AKT is implemented via 




To keep most essential features of the model and prevent the model from growing in the 
number of reactions, we assume several simplifying assumptions, supported in literature. First, 
phosphorylated dimers are not allowed to bind and unbind EGF, as we assume that phosphorylation 
and dephosphorylation, and dimerization and undimerization processes are relatively faster than the 
diffusion-limited EGF binding and unbinding. We assume that receptors phosphatase removes two 
phospho groups in one step (as opposed to two steps), as otherwise, dimers with one phosphorylated 
receptor would be rapidly re-phosphorylated. 
The EGFR signaling model has been implemented in Jacobian, a reaction-engineering 
program from NumericaTech (Cambridge,MA). Jacobian implements numerical integration methods 
optimized to sparse systems, such as the EGFR signaling model. The model implementing EGFR 
and ERK dynamics consists of 54 reactions, encompassing 26 species and 15 rate constants listed in 
Section A.1. 
Section 3.2: Bayesian sampling of model parameter space: Markov Chain 
Monte Carlo 
Our mechanistic dynamic ODE model contains multiple parameters which are infeasible to 
measure experimentally in vivo. Literature derived estimates of parameter values may come from 
very different experimental biological systems, might have been obtained from assays performed 
outside of the living cells. In addition, given the large number of parameters (up to 29 non-zero initial 
conditions), it is not feasible to collect such experimental data set of signaling responses to constrain 
the model. Hence, the resulting models we develop are still vastly underdetermined.  
Since the main goal of the developed models is to be able to reproduce the experimentally 
observed data, as well as to generate novel predictions, parameter unidentifiability presents a 
significant problem. Specifically, given that multiple different sets of parameter values might all fit the 
observed data equally well, yet, differ significantly in their prediction of unseen behavior, traditional 
single-point parameter estimate approaches are not applicable in light of parameter unidentifiability.  
Hence, we develop and apply a principled probabilistic framework to address the problem of 




probabilistically   sample  models’   parameters   space   regions  which  are  most   likely   to   have  produced  
system behavior consistent with the experimentally measured data.  
MCMC approach is used to sample a probability distribution that is difficult to sample directly 
(Gilks, Richardson, and Spiegelhalter, 1996). MCMC chain will perform a random walk over the 
parameter space, at each point evaluating how well the model with a given parameter assignment fits 
the observed data (see description of likelihood calculation in Section 3.2.2 and Section 3.2.3). Steps 
that improve the fit are always accepted, whereas, steps that decrease the likelihood of the fit can 
also be accepted, but with the probability of acceptance decreasing  as  the  fit’s  likelihood  decreases.  
Such transition rule allows to sample regions of high likelihood, as well as to move from one highly 
probable region to another through regions with lower likelihood. 
Let           be the true underlying probability distribution over parameter space, y, that we want 
to sample. The true stationary distribution )( y we are interested in sampling from represents the 
probability of parameters space given the observed experimental data X : 
)|()( XyPy   
Since estimation of        would require its evaluation over the multi-dimensional parameter 
space of the model, it is infeasible to compute it deterministically, which is why we use an MCMC 
framework to estimate it. To sample from           MCMC works with a proposal distribution, Q(x). If the 
Markov Chain transition rules adhere to the detailed balance property, described below, MCMC will 
generate a statistically-dependent sequence of states from the target distribution          by sampling 
the proposal distribution Q(x).  
The detailed balance condition requires that the transition function A(x,y) of the Markov Chain 
is such that the probability of being in point x and transitioning to point y at any given time is the same 
and thus satisfies the following:  
)(),()(),( yxyAxyxA    
The detailed balance property together with the conditions of aperiodicity and irreducibility guarantee 
that independently of the form of the proposal distribution, the MCMC chains will sample the 









Metropolis-Hastings algorithm provides a convenient way to construct the proposal 
distribution Q(x) with detailed balance property. The algorithm starts with an initial state 𝑥  and 
generates subsequent samples according to a transition function, A(x,y): 
 
(*) 
𝑄(𝑥, 𝑦) represents the probability to propose a step from point 𝑥  to point 𝑦 . In our work we use 
Gaussian proposal probabilities centered at the current point 𝑥 and with variance   specific to the 
particular parameter dimension. Choosing Gaussian proposal distribution favors generation of points 
closer to the current point 𝑥. In addition, Gaussian proposal function provides symmetry in transition 























To estimate the transition probability given by the expression (*) we do not need to actually 







of its value at a 






























Where )(xP  and )( yP  are the prior probabilities on parameter values x and y , and 
)|( yXP  and )|( xXP  are the likelihoods of the experimental data at these points in the parameter 
space. Likelihood score of the data in a given parameter point estimates how well the fit at that point 
in parameter space approximates experimentally observed behavior. )|( yXP  is usually estimated 





































where the product is taken over all experimental data points iX  fitted in the simulations, with their 
associated experimental errors i  , and iS being corresponding solutions produced by model 
simulations.  
The MCMC chains can have an additional parameter, referred to as temperature, T , which 
essentially can flatten out the likelihood function landscape by scaling down the difference between 





















If 1T , then the ratio of the likelihoods between the proposed and the current step is 
decreased, compared to the case if 1T  and therefore the step has a higher probability of being 
accepted. The MCMC simulations ran with  1T are referred to as heated. 
To run MCMC chains over parameter space, one first needs to establish the prior probability 
distributions over the possible ranges of parameter values. We define the prior distributions of 
parameters based on generally accepted literature-derived estimates and extend that range by one or 
two orders of magnitude around the literature-derived values. In this way, we do not impose any 
specific point constraints on parameter values, but only limit their ranges to biologically relevant 
regions. The posterior distributions of parameter values we derive are not imposed artificially, but we 
derive them based on their likelihood to fit the experimental data. Next, the obtained posterior 
parameter distributions allow us to generate probabilistic predictions of unobserved model behaviors 
and postulate new hypotheses about the studied system.  
 
Section 3.2.1: Parameter scan for the simplified and the detailed models 
  
We apply the same probabilistic framework to simulate both the detailed mechanistic ODE 
models of the signaling network as well as the simplified analytical models derived for theoretical 




fit the models to the experimental data, whereas, for the simplified models, we fit the model only to 
reproduce certain features of the signaling responses observed in the experimental data. For 
example, the list of features might include perfect adaptation, sensitivity to consequent EGF 
stimulations, non-zero amplitude above a certain threshold over the basal level, signal decay within a 
specific time frame. Hence, the application of the framework for the different types of models requires 
using different likelihood functions.  
Section 3.2.2: Likelihood function in the detailed model 
 
We apply our probabilistic framework to fit the detailed ODE model of EGFR signaling to the 
experimental time-course of phosphorylated targets and the total EGFR in response to treatment with 
constant doses of EGF over three hours.  
MCMC chains explore the multi-dimensional parameter space by random walk guided by a 
set of Metropolis-Hastings transition rules. In this section we describe the likelihood function used to 
calculate the transition probabilities at each step of the MCMC chain. Each point in the parameter 
space is evaluated by a likelihood function describing how well the model fits the observed data given 
this parameters assignment. 
Let ),,,( 21 nXXXX  be a set of experimentally measured data points representing 
responses of a given target (e.g. pEGFR or pERK), to a given experimental condition (such as 
treatment with a certain EGF dose). To compute log likelihood score of each individual experimental 
data point iX  we assume the following generative model for our experimental data. Consider 
model’s   fit   produced   at   a   given   parameter assignment o . The fit, represented as )(t
o , is a 
simulated time-course response of a target at a treatment with a given dose of EGF ligand with 
parameter values assignments o . We then suppose that the fit represents a true biological behavior 
of the system in response to treatment with that dose of ligand, and that each experimental point, iX
, we observe has been generated randomly from normal distribution with mean oi

  and standard 
deviation i . The mean oi





time point corresponding to the time of measurement of the point iX , and the standard deviation i  
is the error of that experimentally measured data point (Figure 3.1). 
We compute the log-likelihood  score  of  model’s  fit  to each individual experimental data point. 
Each data point has a standard error associated with it. In case the model is fitted to a single cell 
distribution, the error represents the actual standard deviation of single cell responses, and the data 
point itself is the mean of that distribution; if the model is fitted to the ensemble averages data, the 
error represents the error in the mean, whereas the data point itself captures the average of the 
independent replicates of the experiment (see Section 4.1 for detailed description). 
The probability of an individual experimental data point iX given the parameter assignment 



















Assuming independence of individual experimental data points, we can compute the probability of the 









































Figure 3.1: Computing likelihood of the experimental data given a model fit 
In this derivation we assumed the normality of distributions from which the experimental 
points were generated. Such approach is applicable when, for example, experimental points iX
represent an average ensemble behavior of the cells, and i are the corresponding errors in the 
mean. If, however, we chose to fit the model to a distribution of single cell responses, which in their 
shapes might deviate from the normal distribution, we could compute the likelihood function of the 
data assuming other than normal probability function. For example, the gamma distribution could be 
appropriate for representing skewed distributions (Figure 5.7). In other cases, the likelihood could be 
computed based on the directly derived probability density function of the single cell distribution at 
each experimentally measured condition. 
We assume that individual targets, pERK, pAKT, pEGFR and tEGFR are independent of 
each other; therefore, to compute the overall log-likelihood of the data we can sum up together all 
their individual log-likelihood scores. However, in reality, the assumption of the targets independence 
may not necessarily hold, as, for example, both pERK and pAKT activation depend on pEGFR signal.  
To compute the overall log-likelihood score for each target, we sum up the individual log-




For example, if in a certain simulation we choose to fit the model to pEGFR responses at high, 
medium and low EGF doses, at every point in the parameter space we will separately simulate model 
responses to the three given EGF doses, separately compute the log-likelihood of each response and 
report the sum of the three log-likelihoods. Such summation of the log-likelihoods relies on the 
assumption   that   target’s   responses   to   different   EGF   doses   are   independent   between   themselves,  
which may not necessarily be true, as given some observed responses to several doses may affect 
the probability distribution of responses at a different dose. 
To compute the log-likelhood score of a time-course  of  a  target’s  response  to  a  given  dose  of  
EGF, we sum up the log-likelihood scores of individual time points fitted in the data, relying on the 
assumption of their independence from each other. However, in reality, phosphorylated responses at 
a given time point are probably dependent, and even determined by, phosphorylation responses at 
preceding time-points.  
To address a concern that the experimental data points for different conditions might not be 
strictly independent, we consider the following argument. The experimental data in this work is 
obtained from separate individual wells treated with a specified condition and measured at a specified 
time. Each experimental measurement has a compounded error associated with it consisting of a 
measurement device error and a human-based error, which cannot be controlled absolutely, but can 
be limited with careful experimental practices. Still, if the measurement device error has a predictable 
distribution and is expected to be the same in measurements of different experimental data, the error 
from the experimental handling is not guaranteed to be the same on different days. Therefore, even 
though, the underlying biological quantities, such as phosphorylation signal at consecutive time points 
might represent dependent quantities, their measured values are treated as independent estimates 
due to the impossibility to reliably quantify the human-based error. 
Using a large number of experimental data points in computation of the likelihood of the 
entire data set can over-constrain the sampling of the underlying parameter space. For example, a 
change in parameter values only slightly affecting the solution of the model could have a significant 
added-up change in the likelihood of the data, and therefore, unlikely to be accepted, resulting in a 




parameter space. We partially address such concern by applying established heuristic approaches, 
such as adaptive-step size MCMC chains and increasing the temperature at which the chains are run 
(Section 3.2). 
 
Section 3.2.3: Likelihood function in the simplified model 
 
In the simplified model described in Section 4.7 we do not fit the experimental data itself, but 
impose constraints on certain features of model responses, such as requiring adaptation of model 
responses to a pre-stimulus level within a given time-frame, or requiring the peak responses to be 
monotonic in EGF doses, and others. Depending on the goal of simulations and the imposed 
conditions, likelihood functions can very. 
In the simplest case, we require that system’s  responses to stimulation with a constant non-
zero dose of EGF over several hours are non-trivial and decay. Specifically, we require that the 
maximum response rises above a certain threshold over its pre-stimulus level and that the response 
at the end of the observation is lower than the maximal response. For example, Figure 3.2 shows 
hypothetical responses of the simplified model to the step input 𝑢 → 𝑢  produced at two different 
parameter values assignments. The dark blue fit has 𝑦 > 𝑦   and 𝑦 < 𝑦  – producing a non-
trivial, decaying signal response, and thus, the parameter assignment which produced such fit will be 
accepted. Although the light blue fit produces an increase in the response to the step input (𝑦 >





Figure 3.2: Diagram of two possible fits produced by the simplified analytical model. 
Additional constraints on model responses to be included in the computation of the log-
likelihood function are the monotonicity in the peak of the responses. For example, if we consider 
responses to two step inputs 𝑢 → 𝑢  and 𝑢 → 𝑢 , where 𝑢 < 𝑢  , we could require that 𝑦 <
𝑦 . 
In another type of simulations we impose perfect adaptation on model responses. At each 
point in parameter space system responses to three doses 𝑢 ,   𝑢   , 𝑢  are simulated. The doses are 
fixed for all simulations and are such that 𝑢 < 𝑢 < 𝑢    , are equally distanced in the log space, i.e. 
=  , and cover at least one order of magnitude = 10. Such requirement on the input doses 
insures  that  the  fitted  effect  (for  example,  perfect  adaptation  or  Weber’s  Law)  holds  over  a  significant  
range in input doses and is not just a trivial artefact due to similarity of the initial inputs.  
To impose perfect adaptation, first, we require that responses to all 𝑢  significantly decay from 
their corresponding peaks at the end of ligand treatment (empirically derived threshold of 
𝑦 <0.2* 𝑦 ). In addition, we minimize the distance between the responses at the end of 
simulations by minimizing the coefficient of variations (CV) of the responses with a squared error 
function. However, the similarity of the responses to three different doses at the end of ligand 
treatment does not guarantee that the responses have reached steady state and are thus indeed 
adapted to their perfect adaptation levels. Hence, in addition, we numerically solve the system for 




(three hours) the response at each dose is within 10% of the corresponding to that dose steady-state 
response value. 
In Section 4.7.4 we  describe  parameter  distributions  obtained  from  fitting  Weber’s  Law  in  the  
simplified  model.   To   impose  Weber’s   Law   constraint   in   the   simplified  model,   at   a   given   parameter  
assignment 𝑝  we simulate model responses to the three step inputs 𝑢 → 𝛼𝑢 , 𝑢 → 𝛼𝑢 , 𝑢 →
𝛼𝑢 with same fold change, 𝛼 , and different initial background levels of stimulus 𝑢 , 𝑢 , 𝑢 ,   as 
described for fitting perfect adaptation in previous paragraphs. We simulate system responses pre-
adapted to stimulations with 𝑢 , 𝑢 , 𝑢   and impose that the produced responses are non-trivial, adapt 
within the time of simulation, and have similar amplitudes, despite an order of magnitude difference in 
the basal input levels 𝑢 , 𝑢 , 𝑢 . We quantify the similarity of the three maximal amplitudes by their 
coefficient of variations, thus, not constraining the model to produce outputs of any specific absolute 
levels, but allowing them to vary (Figure 3.3). The smaller the obtained CV, the more similar the 
peaks are to each other. An empirically derived CV threshold of 0.1 suggests that the responses 
exhibit   approximate  Weber’s  Law   (Goentoro et al., 2009). In addition, comparing the amplitudes of 
the responses to step inputs with CV as a metric provides a distance metric applicable to assess the 
degree of  Weber’s  Law  across  a variable number of responses. For  example,  Weber’s  Law  could  be  
imposed more strictly on an interval of EGF doses by minimizing the CV of responses from more then 
just three points from that interval. 
All points in the parameter space which do not satisfy the conditions for perfect adaptation, 
non-triviality of responses, and monotonicity of the peak responses at the initial treatment with 
𝑢 , 𝑢 , 𝑢  , are rejected. If the preliminary conditions are satisfied in a given point, the likelihood score 
of the peak amplitudes is computed and decision to accept or reject the proposed step is made.  
Requirement  that  all  model’s   responses at the three different doses decay to within 10% of 
the pre-stimulus level does not require that the responses decay within the same time, thus, allowing 
a flexibility in their rates of decay. Restraining the responses to all three doses to decay with the 
same dynamics, in addition to requiring that the responses have same amplitude and perfect 
adaptation, would generate fits with a so-called property of fold-change detection, which entails 







Figure 3.3: Imposing Weber's Law on system responses to three step inputs with the same fold increase, 
𝜶 and different initial background levels of stimulus 𝒖𝟏, 𝒖𝟐, 𝒖𝟑. (A) Input time-courses. (B). Example of a fit 
with low coefficient of variation in amplitudes of the responses which also satisfies conditions for 
perfect adaptation and non-triviality of the responses. (C). Computing the likelihood score of the fit 
 
Section 3.2.4: Prior distributions on parameter values 
 
Our model parameters consist of the non-zero kinetic rate constants of reactions and the 
non-zero initial conditions of protein concentrations. At the beginning of the simulations prior to ligand 
addition, it is assumed that all receptors and downstream targets are inactive and therefore, 
abundances of the phosphorylated species have zero initial conditions and are not simulated as 
model’s   parameters.   We   use   literature-based estimates of parameter values to derive the prior 
probability distributions on the parameters.   In  particular,  we  do  not  constrain  model’s  parameters  to  
the specific literature estimates, instead, we use those estimates as a basis for the range of possible 
values the model parameter can assume. We allow the range to be at least one or two orders of 
magnitudes around the literature estimates to accommodate various different literature estimates if 
they are available and to allow for parameter flexibility. We impose log-uniform prior distributions over 
the derived ranges. Parameters description and their prior distributions are listed in Section A.1. 
Literature estimates of ErbB expression in mammalian cell lines are usually given within an 
order of magnitude precision. Experimental errors and variability in handling and media conditions to 
which cells have been exposed prior to receptor abundance measurements can result in fluctuations 

















cell lines express on the order of 105 ErbB1, whereas SKBR3 – 105, and MCF-7 -104 receptors per 
cell. We use ELISA assays (Lequin, 2005) to quantify average per cell abundance of EGFR in a 
population of cells in a given well. Our experimental measurements suggested that MCF-10A 
expresses about 300,000-600,000, whereas SKBR3 had about 250,000, and MCF-7 about 51,000 
receptors per cell. To account for the fact that receptor abundances are measured with precision of 
up to an order of magnitude, in our model we let the priors on ErbB concentrations vary within one 
order of magnitude of the experimentally measured values. 
It is experimentally infeasible to directly quantify fractions of total number of EGFR receptors 
present throughout different cellular compartments. To the best of our knowledge, not many studies 
have addressed this question with direct experimental measurements of total EGFR. Hence, in our 
simulations, we assign all receptors to be on the cell surface in the inactive state, rather than 
simulating various possibilities of distribution of the receptors among cell compartments. Such 
approach does not present a problem, since for every fit shortly after simulating ligand addition 
receptors are being redistributed from empty cell surface receptors into other receptor species. 
Since we reduce the details of signaling cascades between EGFR and its downstream 
targets into effective rate constants, we do not need to simulate abundances of various intermediate 
proteins, such as, for example, scaffold proteins. We simulate total initial abundances of ERK and 
AKT.  Our previous experimental measurements indicated that there are approximately 700,000 ERK 
molecules per cell, and approximately 600,000 AKT molecules per cell in the mammalian cell lines 
MCF-10A we are working with. In the model, we allow 104-106.5 variability for both total ERK and total 
AKT abundances. 
Although many literature estimates of enzymatic rate constants are available, most of these 
rates are derived based on in silico assays, and outside of the in vivo context, or based on 
computational simulations, and hence, might differ substantially from the actual values in vivo (Chen 
et al., 2010). Hence, as our priors for rate constants we take literature-derived estimates and allow up 
to two orders of variation above and below the literature values to account for the differences in the 
biological backgrounds from which the estimates were derived from and the experimental errors in 




still retaining the information about relative differences between various model parameters. For 
example, the rate of degradation of phosphorylated EGFR is believed to be approximately an order of 
magnitude slower than the rate of receptors autophosphorylation (Chen et al., 2009), which is 
reflected accordingly in the shifted ranges of the prior values of these parameters in our simulations. 
Kinetic rate constants of the reactions related to ERK activation have been studied extensively within 
the context of understanding dynamics of ERK signaling; the literature-reported estimates of such 
rate constants are incorporated into the priors of ERK- related parameters in our model (Fujioka et al., 
2006; Aoki, Yamada, Kunida, Yasuda, & Matsuda, 2011). 
We assume the prior distributions are uniform over the log range of parameter values, to 
avoid biasing the priors towards any particular experimental estimates derived from the literature. 
Alternatively, we could impose log-normal priors over the parameter space, or fix the parameter 
values to very specific point estimates if such precise measurements were available. 
Section 3.2.5: Simulated Annealing to find the starting points for the MCMC 
chains 
 
To optimize the overall running time of the MCMC chains, we perform simulated annealing 
(SA) searches to find starting points for the chains. SA allows efficiently exploring the model 
parameter space and finding the points with good likelihood scores. Hence, starting the MCMC 
chains from the SA-found points allows reducing the simulation time necessary for the MCMC chains 
to mix. The prior probabilities on parameter values, the likelihood function of the experimental data, 
and the transition rule for SA chains are the same as for the MCMC chains we run. For each sampled 
condition, we run sixty different simulated annealing chains. Each SA chain starts from a randomly 
generated point in the parameter space. Each chain is first run at a high temperature (in our case 
T=10) for 100-200 steps per parameter, followed by a long run at cooler temperature, T=1, for 1000-
2000 steps per parameter. The cooling schedule was derived empirically, based on the properties of 
our system. With such cooling schedule, SA chains usually find reasonable fits to the data. Each 
chain reports its best-likelihood point in the parameter space and the points across all chains are 
ranked. Top 5 to 10 points with best likelihoods are selected as starting points of the MCMC chains 




Starting multiple SA chains from randomly generated over-dispersed starting points allows a 
reasonable coverage of the overall parameter space. Running multiple chains with heating and 
cooling ensures the chains do not get stuck and explore various regions in the parameter space. 
Steps in the SA chains and in the MCMC simulations are made in one parameter at a time, in 
a fixed order of parameters. In all chains, the steps are performed in log-space of parameter values to 
ensure an efficient coverage across parameter space. At every step, the magnitude of the proposed 
step size is first generated from a normal distribution with the same variance for all parameters. If the 
proposed position is outside of the prior range for that parameter, the step is rejected and the chain 
moves to the next parameter. Otherwise, the likelihood of the data is evaluated at the proposed point 
and accepted or rejected according to the chain transition rules.  
 
Section 3.2.6: Running MCMC chains 
 
We start several independent MCMC chains from each of the top 5 to 10 point found by SA. 
The starting points may vary in their likelihood scores up to one or two orders of magnitude. We run 
multiple MCMC chains in parallel until approximately 2,000-5,000 steps per parameter have been 
simulated. The first 500-1000 steps per parameter are discarded as a burnoff during which the chains 
are  “forgetting”   their  starting  points  and  mixing   in  the  parameter  space.  We  then  thin  each chain by 
reporting only every Nth step, where N is the number of parameters simulated. To reduce 
autocorrelations within the chain, we report running average on the reduced chains. If the 
autocorrelation is still significant, we further thin the chains by increasing N, until autocorrelation is 
reduced but chains still contain sufficient number of points. 
The acceptance rate of each chain is monitored for each individual parameter, and not for the 
overall chain, and is aimed to be within 20-30%. The chains are started with the same step size for all 
parameters. Initially, for each parameter, the acceptance rate is recorded and step size is adjusted in 
order to maintain the acceptance rate at its target level. The acceptance rate is calculated every 20 
attempted steps, and the step-size is increased by 25% if the acceptance rate is too high, or 
decreased by 25%, if it is too low. If the acceptance rate is within the set limit, step size is kept 




there is a lower limit on the step size for all parameters –it is set to 0.075 to prevent chains from being 
stuck in limited areas in parameter space. Initially, every parameter is allowed to have up to six step 
size adjustments, to find a step size suitable for each parameter. After the six attempted step size 
adjustments the step size is being kept constant for the rest of the simulations. The segment of each 
chain in  which  parameters’  step  size  adjustment  is  performed  is  being discarded as part of a burnoff. 
Customizing the step size for each individual parameter based on its acceptance rate takes into 
account features of direction specific to each parameter space and helps to improve mixing of the 
MCMC chains and to speed up their convergence. 
 
Section 3.2.7: Metrics of Convergence of MCMC chains 
 
We derive the posterior distributions of parameters based on samples obtained from running 
multiple MCMC chains. However, to ensure we obtain the true estimates of the parameter 
distributions we first need to make sure that the parallel MCMC chains have converged. In other 
words, we need to make sure that overall the chains have visited and sampled same regions in 
parameter spaces. Methods to assess convergence of MCMC chains mostly rely on heuristics 
(Brooks & Gelman, 2010). Given the parallel MCMC chains adhere to the same transition rule and 
use the same likelihood function, although they are started from points dispersed in the parameter 
space and are run independently of each other, after sufficient number of steps the chains are 
guaranteed to converge to the true underlying distribution due to maintaining the detailed balance 
requirement in the MCMC chains. In practice, we cannot run the MCMC chains indefinitely; hence, 
monitoring the convergence allows to assess if the chains have not converged yet and need to be run 
for longer time. If after multiple steps, the convergence of the MCMC chains is not changing 
significantly and the chains have sufficiently converged, we stop running the MCMC chains. 
We monitor the MCMC chains convergence for one parameter at a time. First, for all chains 
we discard their burnoff regions. We then visually inspect the traces of multiple MCMC chains for 
every given parameter by plotting them on a graph with iteration step on the X axis and value of each 
chain at that particular step on the Y axis. We can thus identify the chains that are stuck in certain 




a general trend for chains to converge, suggesting for how many more steps the chains need to be 
run for to achieve a better convergence score. In case that the chains appear to be well-mixed in 
certain parameters but stuck in others, we redistribute the attempted steps in each chain to be done 
in the stuck parameters, thus, possibly speeding up the mixing of the chains in such stuck 
parameters. 
In addition to the visual inspection of chain trajectories we apply a frequently used Gelman-
Rubin heuristic criterion to monitor the convergence of the MCMC chains (Brooks & Gelman, 2010). 
Briefly, the method considers within-chain and between-chain variances and computes the ratio of an 
over- and under-estimates of the variance of the true underlying distribution. When the obtained ratio 
is relatively small, the between-chain variance is small compared to the within-chain variances, thus 
suggesting that the chains are approaching convergence. Detailed description of the Gelman-Rubin 
criterion formula is given in Section A.3. 
 
Section 3.2.8: Derivation of the posterior distributions of parameter values 
 
Given the observed experimental data fitted in the model, X, from the converged MCMC 
chains we obtain the probability distributions of parameters θ  using Bayesian approach. Overall, such 
distributions are more realistic than the literature estimates, since they are based on the real 
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Therefore, up to a constant, the posterior probability distribution over parameter values is a product of 
the prior probability distribution of that parameter and the likelihood of the experimental data in that 
point in parameter space.  




, properties of the 
transition rules of the Metropolis-Hastings MCMC chains allow to sample the )|( XP   by simplifying 
the computation of the transition probabilities from point in parameter space i to j  by expressing 
them as ratio of likelihoods and priors of the corresponding points: 
 
   
 
In practice, to obtain the posterior parameter distributions we combine the simulated points in 
the parameter space from all converged MCMC chains. For each parameter we compute a 
normalized histogram over the entire range of parameter values, which was initially specified in the 
prior of that parameter. The obtained histogram can then be interpolated into a continuous probability 
density function. In our analysis we can choose to work with either the original normalized histogram 
or with the interpolated, continuous distribution.  
However, since the MCMC chains might not necessarily converge in all dimensions of the 
parameter space, to generate the posterior distributions we combine points from the MCMC chains 
taking into account the average likelihoods of the chains from which the points were obtained. Such 
approach relies on assumptions that the MCMC chains which do not converge perhaps sampled two 
distinct high-likelihood regions in parameter space, yet were unable to mix between the two different 
regions. We then combine the samples from each of the region according to the average chains 
likelihood score, which would allow rating the regions between themselves relative to their average 
likelihoods. To obtain the corrected MCMC sample we perform the following steps:  










































2) Normalize the likelihood of each point by the sum of the likelihoods of all points in the 
combined set of points, thus obtaining the probability distribution over the sampled points 
3) Generate N random points from the collection of all the points according to the probability 
density function obtained in (2).  
4) Report the probability distributions obtained from (3). 
Reweighting the posterior distributions according to the likelihoods of the chains thus allows to correct 
for the possibility that the MCMC chains have not converged perfectly, and to obtain a better 
approximation of the true underlying posterior distribution of model parameter values. 
Section 3.2.9: Derivation of the predictive distributions of the EGFR signaling 
model behaviors 
 
Our method allows to conduct predictive inference on our model behaviors. Given the 
observed data, X, we want to obtain a probability density function of a new, previously unobserved 
data point, x. We marginalize the probability distribution of the unobserved data point given the fitted 
experimental data over the parameter space. We then derive that the probability of the unobserved 
behavior, up to a constant, is proportional to a product of the prior of the parameters, the likelihood of 
the fitted experimental data given parameter assignment and the conditional probability of the 














Based on the above expression, we can generate the predicted distribution of the 
unobserved system behavior, x, from model responses simulated across the points in the parameter 
space, according to their posterior distributions obtained from fitting the model to the given 
experimental data X (Section 3.2.8). To actually obtain the predicted distributions of values of x, in our 
simulations we fit the model to a given set of experimental data X, and at each step in the parameter 
space we record the simulated model response to the experimental condition corresponding to x, 
which we want to predict. For example, if we fit the model to early phosphorylation responses and aim 
to predict model response three hour of constant EGF stimulation, then at each given point in the 
parameter space we simulate model response up to three hours, use the specified early responses to 
evaluate the goodness of the predicted fit (i.e. compute the likelihood of the data), and record the 
response at the three hour time point as   a   prediction.   In   case   we   predict   model’s   response   to   a  
perturbation other than the treatment with a constant dose EGF to which we actually fit the model, at 
each step we simulate model responses to such perturbation after we have simulated the necessary 
constant EGF dose condition. Therefore, the simulated MCMC chain would not only produce 
parameter values assignments at each step, but also, the values of the response being predicted. 
In addition to predicting system’s   responses at various times of ligand treatment, or to 
inhibitor perturbations, we can also generate predictions of any other variables in the system, 
including ones which were not measured experimentally or not fitted in the simulations. For instance, 
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intermediary signaling components, such as, for example, the activated or total MEK, or time-courses 
of inactive receptor dimers, and others (see Section 4.2 for examples). 
The MCMC chains generate predicted distributions of values of experimental points to which 
the model is actually being fitted. Although, the model likelihood is computed directly based on the fit 
in these points, the predicted distributions shows some deviation from the experimental point, rather 
than being exactly at the imposed experimental value. This observation can be explained by the fact 
that we fit multiple experimental data points simultaneously, computing the likelihood score based on 
the fit to all points: while some fits may have similar overall likelihoods, they may vary between the 
likelihood  scores   to   the   fits  at  certain  points.   In  addition,   the   fact   that   the  model’s  multidimensional  
parameter space is vastly underdetermined could also contribute to the variability in the predicted 
values of the fitted points. 
 
Section 3.3: Statistical method to compare parameter distributions and to 
identify parameters sensitive to specific experimental data points 
 
Traditional approaches to assess model parameters sensitivity often rely on analyses ran at 
several points in model parameter space by varying one parameter at a time at those points and 
examining the induced change in system responses ( Kohberger, 1978; Gutenkunst et al., 2007). We 
develop a novel statistical method to investigate global parameter sensitivities to specific features of 
model responses. Our probabilistic framework allows to globally assess model parameter sensitivity 
to specific experimental data points across the multidimensional parameter space. 
More precisely, by fitting the model to the experimental data set with and without the points 
for a given condition of interest, we can identify parameters which have changed their distributions to 
accommodate fitting the additional experimental data points. The rationale behind this approach is 
that fitting additional data should impose more constraints on parameter space which is then reflected 
in changes in parameter distributions. It is important to note that additionally fitting points which do not 
necessarily provide new information about system behavior compared to the main set of experimental 




method is applicable to cases when additional data adds substantial qualitative constrain on system 
responses. 
We run the MCMC simulations and fit the model to a set of the experimentally measured data 
points ),,,( 21 nXXXX  . Next, we add the 1nX  point and rerun the MCMC chains. From each 
of the two types of simulations we obtain probabilistic distributions of parameter values and identify 
the ones which significantly shifted in their distributions to fit the 1nX  point. 
To compare parameter distributions obtained from fitting different conditions, we use a metric 
based on the Kullback-Leibler divergence measure (Kullback, 1987) and several other techniques. 
Comparing parameter distributions requires that the MCMC chains ran for each of the two compared 
conditions have converged. The metrics can then be applied to the two distributions obtained by 
combining individual chains for the same condition together. In case the chains in one condition have 
not converged, the combined distribution might appear multiple-peaked and heterogeneous, possibly 
substantially varying from the corresponding distribution from the second condition, in which the 
chains have converged. We apply a chosen comparison metric to each pair of the distributions for the 
same parameter, and then rank all parameters by their difference and, if applicable, their significance, 
corrected for multiple hypothesis testing. 
The Kullback-Leibler divergence and Kolmogorov-Smirnoff tests allow to compare the actual 
distributions between themselves, and not just comparing their statistics. The Kullback-Leibler 
divergence is an asymmetrical measure which can be used to quantify the difference between two 
probability distributions Q and R. In its essence, the measure divides the range of values of the two 
distributions into small intervals; at each interval it then computes the difference between the two 
distributions and sums them up over the entire range. The higher the Kullback-Leibler divergence of R 
relative to Q, means that Q is more distinct from R. To obtain a symmetric distance measure from the 
Kullback-Leibler divergences we take a sum of the two distances from R to Q and from Q to R.  
The Kullback-Leibler based metric does not take into account the relative order of columns of 
the histogram being compared. However, some important information on parameter distributions 




distributions we derive might be dependent on binning applied to compute them. Therefore, we also 
apply the two-sample Kolmogorov-Smirnov test (Corder & Foreman, 2014) to compare parameter 
distributions taking into account the relative order of the columns of the compared distributions. The 
two-sample Kolmogorov-Smirnov test is a non-parametric test to compare the cumulative distribution 
functions of the two distributions. The advantage of the Kolmogorov-Smirnov test is that it is sensitive 
to differences in both location and shape of the cumulative distribution functions of the two compared 
samples. When Kolmogorov-Smirnov test is applied to a list of parameters, the returned p-values are 
corrected for the number of tests performed. The Kolmogorov-Smirnov test is a non-parametric test 
which does not operate on the averages or the standard deviations of the distributions that are being 
compared. 
To identify parameter distributions which are distinct between the two fitted conditions, in 
addition to the distribution-based metrics, namely, the Kullback-Leibler divergence and the 
Kolmogorov-Smirnov test, we use several other measures which rely on comparing statistics of the 
distributions. This statistic also allows in a more intuitive way to identify parameter distributions which 
changed between the two conditions. First, we visually inspect parameter distributions from the two 
types of conditions. We can rank the parameters by absolute differences in the means of their 
distributions in the two conditions, thus identifying parameters with most shifted distributions between 
the two conditions. We can also rank parameters by the ratio between their variance of distribution 
from a condition with the additional fitted experimental data to the variance of distribution with less 
data fitted: if a given parameter distribution is constrained by the additional experimental data, it may 
be reflected in the smaller variance of the parameter distribution. 
Although, comparing parameter distributions solely by their statistics is a more intuitive way to 
understand and interpret the differences in model parameter space, such methods may disregard 
important information offered by the distribution-based comparison methods we mentioned above. 
For example, in case the two distributions are symmetrical, their averages would be the same, 





By comparing parameter distributions between two conditions with several types of statistical 
techniques one can not only gain an insight as to what parameters are important for a given 
experimental data, but also, an understanding of how the additional constraints can affect the 
underlying model parameter space. For example, we can find parameters for which a given 
experimental point shifts their distributions while preserving the shape of the distribution; alternatively, 
we can find parameters variance of which is significantly constrained by the additional data. 
Therefore, applying several distribution-comparison techniques we can identify various qualitative 
aspects of the structure-function relationship between model parameter space and its responses (see 
Figure 4.12 for examples of comparing parameter distributions). 
Importantly, analyzing changes in parameter distributions resulting from imposing additional 
data constraints and simulating all parameters could also allow to identify global trends in the 
parameter space which could have been missed in the traditional single-point parameter sensitivity 
analyses..  
The statistical method presented here allows to find parameters important to certain 
experimental data and is sufficiently versatile. The method can be applied in multiple different ways. 
For example, we can identify parameters responsible for phosphorylation signal decay by comparing 
parameter distributions obtained from fitting only initial signaling response to ones obtained by fitting 
initial and the long term response capturing phosphorylation signal decay (see Section 4.4). 
Alternatively, we can use our approach to compare parameter distributions in conditions which 
contain the same set of experimental data, yet in one condition certain points of interest would have 
more weights contributing to the overall likelihood function. For example, we can identify parameters 
most sensitive specifically to the early dynamics or only to the peak of the phosphorylation response, 
by running the second condition with increased weight on those specific points of interest. Moreover, 
our statistical approach could be useful in case the model is fitted to a combination of experimental 
data of different types. For instance, fitting receptors degradation data (measured by the total EGFR 
abundances time-courses) in addition to fitting the phosphorylation time-courses could suggest 
parameters important to fitting signal decay with a specified level of receptors degradation (see 




points one could impose various other, not necessarily experimentally detected, features and 





Chapter Four: Results 
 
 In this section we present the main results of this study. First, we describe in detail the 
processing of the phosphorylation and receptor abundance time-courses experimental data used to fit 
the model. We then report various types of experimental data to which the model is fitted and the 
resulting changes in parameter distributions imposed by each type of data, thus exploring 
relationships between the model’s   parameter   space   and   the observed behavior of the system. All 
experimental measurements described in this section have been performed and collected by our 
collaborator, Dr. Mario Niepel at the Laboratory of Prof. Peter Sorger at the Department of Systems 
Biology, Harvard Medical School. 
Section 4.1: Processing of the experimental data fitted in the model: methods 
for scaling, normalization, and combining the data 
 
Section 4.1.1: Cell lines 
 
Experimental data for this work has been collected in mammalian cell lines. Specifically, 
MCF-10A, MCF-7, and SKBR3 cell lines derived from human mammary epithelium were selected for 
their high levels of ErbB expression and/or their responsiveness to EGF. MCF-10A cell line was 
derived from normal, non-cancerous mammary tissue. The MCF-10A cell line is considered to be a 
reasonable representation of normal mammary tissue, without any known mutations in the ErbB-
related signaling cascades. However, since the MCF-10A cell line is an immortalized cell line, it still 
differs from the original normal epithelium cells from which it was derived. MCF-10A cells express 
EGFR on the order of 105 receptors per cell. We also work with two breast cancer cell lines, SKBR3 
and MCF-7. SKBR3 cells express a significant amount of EGFR, estimated to be on the order of 105 
receptors per cell, and overexpresses ErbB2 receptors, on the order of 106 receptors per cell. MCF-7 
is known to express ErbB receptors, but the EGFR levels are very low, on the order of 104 receptors 
per cell.  
Cells are seeded into the 96-well plates, each plate with 8 rows and 12 columns. 
Measurements from the wells at the edges of each of the 96-well plate are discarded due to possible 




well is determined by the type of the cells incubated in each well and is based on cell volume and 
confluence levels specific for each cell type derived from our empirical observations. MCF-10A cells 
are seeded at approximately 10,000 cells per well, SKBR3 at 20,000, and MCF-7 cells at 10,000 cells 
per well.  
In the experiment’s run on a single day, the number of cells in each well can differ between 
2,000 and 20,000 cells per well. The difference in cell number is due to various factors, such as, 
deviations in number of cells pipetted during their seeding into the wells, uneven rates of cell loss due 
to staining with antibodies, and others. The distribution of the cell counts from the wells in a same day 
experiment usually has a coefficient of variation within 0.08-0.18. However, the average cell count 
across all wells for a given day can differ more drastically between the days. 
The cells are incubated in the standard media for 24 hours, followed by media washout. The 
media washout is performed to eliminate any possible autocrine secreted ligands. Next, the cells are 
incubated in the starvation media for another 24 hours, followed by the second washout of the media. 
Such cell handling protocol has been suggested by empirical work with these cell lines and is thought 
to better synchronize the cells and induce them into a quiescent state. Following this experimental 
protocol the MCF-10A cells are at about 70% confluence.  
Often, studies of cell signaling use ligand treatment profiles unnatural to the physiological 
conditions of the cells. For example, in certain studies bolus stimulations with very high doses of 
ligand are instantaneously added into the cell media (Becker et al., 2010). Although biologically not 
very likely, such stimulations can still lead to a useful insight about the functioning of the system by 
elucidating its behavior at maximal activation. In this work, however, we treat cells with various EGF 
doses, ranging from low physiological to high un-physiological doses, and maintain the EGF dose 
relatively unchanged over several hours. Such ligand stimulation profile evokes features similar to 
chronic ligand stimulation which cells might encounter in vivo. 
Section 4.1.2: Microscopy Imaging 
 
After the cells have been incubated in wells for 24 hours, starved for another 24 hours, had 
their media washed out, one hour after the final washout, cells are being subjected to experimental or 




specified amount of time. ELISA immuno-histochemistry (IHC) fluorescence techniques used in this 
work to collect data need careful processing of the read-outs (Lequin, 2005; Weemen & Schuurs, 
1971). IHC is used to quantify abundance of a target, such as the phosphorylated form of a protein, 
present in cells. The emitted fluorescence intensity from each well is captured by a microscopy 
device, quantified by an image analysis algorithm and reported in arbitrary units of fluorescence. At 
the time of the measurements, primary antibodies for the measured target, pEGFR, pERK, pAKT, 
total EGFR, or no primary antibodies for controls, are being added, followed by the addition of 
secondary antibodies. Primary antibodies bind to the target, whereas, secondary antibodies bind to 
the bound primary antibodies and emit fluorescence. To minimize possible perturbation effects due to 
experimental handling, - all wells on each plate are being measured at the same time point. Each row 
on the plate measures a single target; so plates can have rows with different targets measured. 
Different doses of ligand treatment are administered by columns, usually, with the control no EGF 
treatments being in the first one or two leftmost wells, with increasing EGF doses in the wells to the 
right from the controls. In each experiment run on a given day, we aim to have at least two repeats of 
same the experimental condition. 
After the staining with primary and secondary antibodies, wells are imaged with an automated 
microscopic device. The images are then processed by an image analysis software package to 
quantify data from the experimental results. The algorithm detects individual cells in the image of 
each well, computes average fluorescence in the area corresponding to each cell, and for each well a 
distribution of values of single cell fluorescence is reported (see Section 4.1.4). To distinguish 
different cells, cell nuclei are stained with Hoechst dyes and are then detected based on the emitted 
Hoechst blue fluorescence.  
The image analysis algorithm uses empirically derived thresholds for nuclei detection levels, 
to count only viable cells and avoid counting cell debris. Upon nuclei detection, the cell area is 
computed by expanding cell boundaries from the nuclei until bounds of neighboring cells are reached. 
The total fluorescence from this cell area is then measured and normalized by the detected cell area. 
Thus, the average fluorescence per cell area is reported to account for variations in cell sizes. In 




bound region, the cytoplasm or the nucleus; however, in this work we use only the total cell 
fluorescence averages due to their higher reliability. The coordinates of the box area detected of each 
cell are also reported by the algorithm. The quantified fluorescence readout is reported in arbitrary 
fluorescence units (A.U.).  
The image analysis algorithm also implements a quality control check to avoid counting 
fluorescence from overlapping cells multiple times. However, occasionally, due to possible optical 
anomalies of the microscopy or error in cell boundary detection due to nuclei staining, average 
fluorescence from a region with multiple neighboring cells might be reported as read-out for one cell. 
This generates very high values of fluorescence read-outs in the single cell distributions. Thus, 
discarding the top 3% of highest outlying read-outs in the distribution corrects for this effect. Overall, 
single cell distributions after such corrections have smaller variances and appear consistent from day 
to day. 
 






Figure 4.2: Microscopy imaging of MCF-10A cells treated with high dose EGF and total EGFR detecting 
antibodies. 
Section 4.1.3: Background fluorescence offset subtraction in microscopy 
imaging 
 
Despite technological advances in biology it is still challenging to quantify dynamic time-
courses of protein abundances in mammalian cells (Teeffelen, Shaevitz, & Gitai, 2012). 
Measurements of in vivo fluorescence in the cells can be obscured by various levels of noise and 
artifact. There are still no reliable methods to convert fluorescence reported in arbitrary units into 
actual numbers of detected target molecules, although some techniques have been developed for 
bacterial cells (Rosenfeld, Perkins, Alon, Elowitz, & Swain, 2006). In our work we first pre-process 
reported fluorescence imaging data by correcting it for background fluorescence offset. Next, in our 
simulations we fit a parameter that corresponds to the fluorescence scaling factor and converts the 
experimental data into the number of molecules simulated in the model. 
Each single cell fluorescence readout encompasses fluorescence actually emitted by the 
detected target, and also fluorescence emitted by non-specific binding of primary and secondary 
antibodies and device-related fluorescence background. To correct for the fluorescence offset not 
related to the detected target, background fluorescence needs to be quantified and subtracted from 
each single cell measurement. Many studies report fluorescence data with fluorescence background 




automatic background subtraction can be unreliable, and hence, more carefully developed techniques 
should be used instead. 
We apply a customized background fluorescence subtraction algorithm. First, we measure 
the time=0 fluorescence in wells with the cell population treated only with secondary antibodies, 
omitting any primary antibodies and EGF. Since there are no primary antibodies in such wells, the 
fluorescence readout should reflect only the compounded fluorescence due to the use of the 
microscopic device and the fluorescence offset due to secondary antibodies off-target binding. We 
refer  to  the  measured  quantity  as  “no  primary”  control  or  “background  fluorescence  offset”.  Since  the  
primary antibodies are specific to each target, pEGFR, pERK, pAKT or tEGFR, but the detecting 
secondary antibodies are the same for all targets, the background fluorescence offset is the same for 
measurements of all targets across the experiments run in the same cell line on the same day. We 
observe that the background fluorescence can vary from day to day, and might depend on the 
condition of the measuring device (e.g. the last date when the device was serviced). 
Even in absence of ligand, some small fraction of target protein can be phosphorylated, a 
phenomenon referred to as basal phosphorylation. We need to quantify the abundance of 
phosphorylated target induced specifically due to ligand treatment, thus excluding any fluorescence 
due to background offset or due to basal phosphorylation. Therefore, for each measured condition we 
also have a 0 EGF control that entails basal phosphorylation of the target at each given time point in 
the absence of EGF treatment as well as off-target binding of the primary antibodies, and the 
background offset. This no EGF control is then used to normalize and scale read-outs from the non-
zero EGF wells (see Section 4.1.4). 
We find that, in MCF-10A, the no primary and the 0 EGF controls are very similar on a given 
day, with the 0 EGF controls being only slightly (about 5%) higher than the no primary controls. This 
suggests that in MCF-10A the fluorescence due to the basally phosphorylated target is low compared 
to the background fluorescence offset. Hence, in case no primary control is missing in MCF-10A data, 
it is justifiable to use the 0 EGF controls instead to account for both device-related fluorescence offset 




For total EGFR measurements, the no EGF control readout of total EGFR at the time=0 
represents fluorescence due to total number of EGFR detected in the cells, off-target binding of 
primary and secondary antibodies, as well as the device-related fluorescence background. After we 
subtract the background fluorescence offset from the no EGF measurement of total EGFR at time 0, 
in the remaining fluorescence we cannot quantify relative contributions to the total fluorescence due 
to off-target binding of primary antibodies versus fluorescence due to the actual measurements of 
total EGFR. We can assume that the fluorescence due to off-target binding of primary antibodies to 
tEGFR is negligible in the fluorescence remaining after no primary control subtraction, and thus the 
remaining fluorescence corresponds mostly to the total EGFR abundance.  
However, to get a more precise assessment of total EGFR in the cells, a more appropriate 
control to correct for off-target binding of primary antibodies for tEGFR would be a no EGF 
measurements of tEGFR in MCF-10A cells expressing no EGFR. If all other treatment and handling 
conditions are the same, the MCF-10A cells expressing no EGFR should be identical to the normal 
MCF-10A levels of off-target binding of primary, secondary antibodies and the same device-related 
fluorescence offset. However, generating such MCF-10A cells with knock-out EGFR is outside the 
scope of this study, and so, as an alternative, one might use the control no EGF tEGFR measurement 
from cells expressing very low levels of EGFR, for example, the MCF-7 cell line. In this case, the no 
EGF readout would encompass device-related offset, and fluorescence due to off-target binding of 
primary and secondary antibodies, and low levels of fluorescence due to detected EGFR. Such 
control measured in MCF-7 due to differences in gene expression between MCF-7 and MCF-10A, 
might have different levels of off-target binding of primary and secondary antibodies. However, in our 
case tEGFR readouts from MCF-7 cell lines are very similar to the no primary control measurements 
in MCF-10A, and thus might serve as an approximate control for tEGFR measurements in MCF-10A. 
To compute the actual value of the fluorescence background control we use all 
measurements from single cell distributions from wells containing only cells treated with secondary 
antibodies added (no primary antibodies) and no EGF added at time=0 and all measured on the same 
day. We combine all single cell distributions from such wells, and report the average of the resulting 




background offset is then subtracted from each single cell value in the entire dataset for that cell line 
on the specific day. 
Section 4.1.4: Single cell distributions data  
 
We collect single cell measurements of pEGFR, pERK, pAKT and tEGFR response to EGF 
treatments and their no EGF controls in MCF-10A cells. Data reported from each well is the 
distribution of single cell responses of a given target at a given time point after treatment with specific 
EGF dose or the no EGF treatment control. We observe that the obtained single cell distributions are 
mostly bell-shaped. 
To correct single cell distributions for day-specific instrumental offset, from each value in 
each single cell distribution we subtract background fluorescence, estimated as described in Section 
4.1.3. To reiterate, the background fluorescence offset captures the effect of device-related 
fluorescence and fluorescence due to off-target binding of secondary antibodies, and is the same for 
all measured targets on a given day. After the background offset subtraction, to each single cell 
distribution we apply scaling and normalization protocols according to the type of the measurement in 
that distribution - phosphorylation or total EGFR. We present detailed descriptions of each of these 
protocols throughout Section 4.1. 
 The no EGF controls for a given phosphorylation target, after background offset subtraction, 
produce an estimate of the compounded fluorescence due to off-target binding of the primary 
antibodies and the basal phosphorylation of the target. The no EGF control wells measuring a given 
target and run on the same day have no perturbation applied (i.e. no EGF treatment), and thus are 
expected to have lower variation between single cell responses distributions across the wells. We find 
that for most days, the no EGF distributions within same day have similar bell shapes and similar 
variances, although they can have somewhat different means. Even the two no EGF controls on the 
same row can have slightly different means, most likely due to variations in experimental handling, 
such as different number of cells in  wells. 
We check the quality of the no EGF control distributions prior to using no EGF control single 
cell distributions to normalize the data. Specifically, we overlay the z-transformed no EGF control 




or variance significantly different from the majority of the distributions. Rows, in which no EGF 
controls distributions are abnormal, might be discarded from the data set, as this abnormality 
indicates that possible errors in handling the wells most likely occurred during treatment or imaging 
steps. In addition, identifying abnormal control distributions can help to detect possible 
inconsistencies in cell handling and to improve the experimental techniques thus yielding a better 
quality data. 
Next, for each individual single cell distribution from a non-zero EGF treatment well, we 
combine the corresponding to it no EGF control single cell distributions and use the average and the 
standard deviation of the combined distribution to z-transform the single cell distributions for each 
individual non-zero EGF treatment. Therefore, by subtracting the average of the corresponding no 
EGF control distribution from the non-zero EGF responses, we obtain fluorescence value corrected 
for off-target binding of primary antibodies and the background phosphorylation, and hence, 
corresponding specifically to only the target response to the applied EGF treatment. Such 
transformation allows us to account for row-to-row variations between the wells and to obtain single 
cell distribution in target phosphorylation specifically elicited due to EGF treatment. To summarize, 
the obtained single cell distributions of phosphorylation responses are first corrected for the 
background fluorescence offset, and then z-transformed to their corresponding no EGF control 
distributions.  
For total EGFR measurements, unlike for the phosphorylation measurements, we cannot 
separate fluorescence due to actual abundances of total EGFR from the fluorescence due to off-
target binding of the primary antibodies. However we can assume the latter one is negligible 
compared to the former one. For a given day, we combine all single cell distributions measuring 
tEGFR at time=0, no EGF added and after the background offset has been subtracted from them. We 
then set the average of this distribution to represent fluorescence corresponding to 100% of total 
initial abundance of EGFR in the cells on that day. We then use this value to scale each single cell 
measurement of tEGFR on that particular day. To normalize the obtained tEGFR single cell 
distributions to the variance of the combined 0 EGF, time=0 single cell distribution of tEGFR, we 




tEGFR distribution. Hence, we obtain tEGFR measurements expressed as fractions of initial tEGFR 
abundance on that day, and standardized to correct for the well-to-well variations.   
We then can examine the properties of single cell distributions across multiple replicates all 
performed on the same day. The observed variability in the replicates done on the same day is most 
likely due to experimental handling and instrumental errors, as the underlying biological fluctuations in 
each repeat should be minimal.  
Section 4.1.5: Combining the normalized experimental data obtained on 
different days 
 
The goal of the experimental part of our work is to obtain a representative average behavior 
of the EGFR signaling system, which is independent of instrumental handling. Whereas multiple 
repeats of the same experiment conducted on one day allow to account for instrumental errors, 
repeating the same experiment on different days allows to capture true biological variability in the 
system behavior. To filter out instrumental errors from true biological behavior of the system, we need 
to be able to integrate and analyze together multiple independent replicates of the same condition 
measured on one day, as well as to combine them with replicates measured on different days. For 
this we assemble an experimental data set derived from multiple replicates of experiments conducted 
on different days, with every replicate containing several repeats of the same-day measurements of 
the condition. In this section we describe our methods to process repeats from different days to 
correct for their day-specific variations and render the data comparable between the days. 
Analysis of single cell distributions for a given condition and a given target across different 
days allows to uncover the true biological variability separated from instrumental noise. We find that 
single cell distributions for most responses are consistently bell-shaped across the days. The means 
of the distributions might vary from day to day, even after correction for the background fluorescence, 
most likely due to accidental cell-count variations in the wells across the experiments (see Section 
4.5). To be able to directly compare single cell distributions for the same condition, measuring the 
same target on different days, we need to scale each distribution for the day-to-day variability. We 




single cell distribution obtained from a well measuring a specific target at a specific condition, which is 
defined by EGF dose applied and time when the response is measured. 
After correcting the data for background fluorescence on different days, reported 
fluorescence responses to the same conditions for a given target, in principle, should be directly 
comparable across the days. However, we observe that the scales of fluorescence readouts for the 
same phosphorylation target can vary significantly between the days. For example, we find that 
whereas for pEGFR and for pAKT, the values of their corresponding maximal signals usually are 
similar between the days, for pERK the maximal fluorescence readout can vary several folds on 
different days. One possible explanation is that primary or secondary antibodies used to detect the 
same target on different days can have some batch-specific variations, and thus emit somewhat 
different fluorescence signal in response to equal amount of the detected target. Hence, we perform 
an additional step of scaling the entire data for a given phosphorylation target on a given day and 
target-specific scaling factor described in detail in Section 4.1.7.  
For tEGFR measurements since our within-the-day normalization procedure converts tEGFR 
data in arbitrary fluorescence units (A.U.) into the fractions of total initial EGFR present, no further 
scaling is needed to render the data comparable between different days. 
Section 4.1.6: Working with the averages versus the single cell distributions 
data  
 
After the responses for each target are normalized and scaled in each individual day-specific 
repeat, the responses for the same condition can be directly compared and combined together to be 
fitted in the model. This data set represents the behavior of the biological system separated from the 
instrumental noise and accounting for the day-to-day variation. In this section we present two 
approaches to combine the processed data for the use in model fitting: the ensemble averages 
approach and the combined single cell distributions approach.  
There are two fundamentally different approaches to combine the experimental 
measurements from our experimental system. One approach combines responses from single cell 
distributions; second approach deals with averages from the individual single cell distributions. In the 




different days, are all combined together in one distribution. If the resulting distribution is bell-shaped, 
its average and standard deviation can be used to fit the model. Alternatively, if the resulting 
combined distribution substantially varies from the normal distribution, one might attempt to fit the 
model to the combined distribution itself, and thus to better capture the biological information about 
the single cell population encoded in such distribution. Fitting the model to the combined single cell 
distribution would then allow us to simulate a distribution of individual single cell responses in cell 
populations. For example, such approach can be useful to study variability in single cell responses in 
a given cell population. 
Some studies may aim to understand a collective cell response, or the average most 
probable response of cells in cell population. Such approach may be applicable, for example, in 
studies of cells behavior in tissue context, in which case, it would be more appropriate to fit the model 
to the averages of ensemble responses rather than to the combined single cell distribution. Hence, 
the context and goals of the study would determine which of the two data interpretation and 
combining approaches should be used.  
In practice, fitting the data processed by either of the two presented approached may require 
slightly different MCMC sampling techniques. For example, ensemble averages data can have 
smaller variances, thus significantly constraining the model parameter space, and hence restricting 
MCMC chains movements across it. On the contrary, single cell distribution data is likely to have 
higher variances and thus could help MCMC chains move faster across the   model’s   parameter 
space, sampling it more efficiently.  
In this work we present the results of fitting the model to the combined ensemble averages of 
the individual distributions of responses. In Section 5.4 we describe how the model can be fitted to 
the combined single cell distributions of responses. We can analyze and compare parameter 
distributions obtained from each of the two approaches using similar methods. 
Section 4.1.7: Normalizing and scaling phosphorylation data: the averages of 
single cell distributions  
 
We measure pEGFR, pERK, pAKT responses to continuous treatment with different doses of 




different days. In this section we first present a method of scaling and combining the averages of the 
single cell distributions, and then describe a method of working directly with the single cell 
distributions. For both of the cases the first step of data processing is the same: for each target on a 
given day the measurements from each well are subjected to quality check based on the variances of 
their distributions, background fluorescence subtraction and z-transformed to the corresponding no-
EGF control distribution within a given day for a given target.  
Then, we take the averages of the single cell distributions from each replicate of same 
condition for a given target on a given day. To control for the day-specific effects, we need to rescale 
all same-day replicates to a day-specific scaling factor. For instance, the data can be scaled by an 
average fluorescence of the dose response of this data at the time when the signal reaches its peak; 
or the fluorescence at the saturating response of this target on a given day. Alternatively, more 
nuanced quantile-based techniques can be applied, although, it is not clear if such elaborate 
techniques, that may also require corrections for differences in distributions of single cell responses, 
would produce qualitatively very different data. 
In some cases, for each individual target we often observe that the averages of single cell 
distributions in responses to several highest doses are very similar, reaching the maximum average 
of single cell distributions observed on that day. This peak represents the saturation response of the 
target on a given day. Since the correspondence between the absolute levels of phosphorylated 
proteins and the arbitrary unit of fluorescence of the measurements can change from day to day, 
relating fluorescence scales on different days by comparing the saturating fluorescent values may be 
more robust to instrumental errors. In a way, fluorescence readouts of a saturating response 
represent a more distinctive and specific biological feature (marker) of the cell population, which 
should be easier to capture in a day-to-day variability rather than the more variable between the days 
average of dose response at the time when maximum is reached.  
However, if the observed responses to higher EGF do not appear to reach saturation, we 
cannot rely on the scaling by the maximal value. Instead, we can scale the data using average value 
of a dose response at time when maximum response is detected. Specifically, we can consider dose 




reached. This approach could be more noise-proof as it relies on an average value from multiple 
measured repeats, as opposed to just one measurement of the maximal point.  
Finally, the entire data for a given target is divided by the scaling factor of our choice – an 
average of the dose response or the saturating response. Then, we report the average and the 
standard deviation of the set of all reported means for single cell distributions for the same target and 
the same condition, combined across multiple days. Hence, the resulting data then represents 
ensemble averages of cell populations. 
Next, we describe a method to combine single cell distributions across the replicates from 
different days. We use the same day and target-specific scaling factor as derived for the ensemble 
averaging to correct individual data points in single cell distributions. We then combine together all 
single cell distributions of a given target and condition measured across the days. The average and 
the standard deviation of the obtained combined distribution is then reported for each condition. If the 
obtained distribution appears normal, the model can be fitted to the points represented by such 
average and standard deviation. Alternatively, the model can be fitted to the entire single cell 
distribution corresponding to a specific target and time point. 
Since our data processing algorithm involves division by values which themselves have 
associated with them errors, we apply the error propagation formula to correctly compute the 
standard deviation in the reported data points.  
Section 4.1.8: Normalizing and scaling the total EGFR data: ensemble 
averages vs single cell distributions  
 
Traditionally, changes in EGFR abundances over time are measured through quantifying the 
ability of cells to bind radio-labeled EGFR ligand (van de Poll et al., 2005). Such measurements do 
not directly measure receptor mass, but infer it indirectly through fraction of unbound ligand, 
remaining in the media of cells incubated with some dose of ligand over time. Hence, such 
techniques can incorporate errors due to various factors, for example, often neglected heterogeneity 
in ligand-binding properties of receptor monomers and dimers. Directly measuring the total EGFR 
abundances in cells over time with ELISA assays (Lequin, 2005; Weemen & Schuurs, 1971) has 




processing the tEGFR readouts: until recently there were no homogenous and reliable algorithm to 
correct for the background fluorescence offset and the off-target binding effects in measuring total 
EGFR abundance. 
We use ELISA to experimentally measure changes in the total EGFR abundance in response 
to continuous treatment with different EGF doses over three hours of EGF treatment. We develop and 
apply a proper, in our view, background fluorescence subtraction algorithm for the tEGFR 
measurements.  
Our experimental measurements of the total EGFR expression include levels of functional 
receptors present on the cell surface, as well as in other intracellular compartments. Specifically, our 
tEGFR measurements can include newly synthesized receptors en-route to the cell surface, or, 
receptors just internalized through endocytosis, or receptors in lysosomes targeted for degradation. 
We assume that most of the measured EGFR are actively participating in signaling, and that there are 
no reservoirs of receptors inaccessible to signaling. Some of our experimental observations suggest 
that in the absence of ligand stimulation, most of EGFR receptors reside near the cell surface: the 
levels of plasma-membrane-localized EGFR receptors are very similar to the total EGFR levels 
measured in MCF-10A cells. Therefore, we can assume that the tEGFR fluorescence measurement 
reported in the no EGF time=0 readout, after correction for the background fluorescence corresponds 
to the total number of receptors actively participating in cell signaling.  
Converting the tEGFR fluorescence readouts into the absolute number of EGFR receptors 
present in the cells is experimentally demanding for several reasons. First, the scale of fluorescence, 
determining how many receptors are detected in a unit of reported fluorescence, can change from 
day to day. Second, the abundance of EGFR expressed in cells can not only vary between the days, 
but also, can vary within the same day in cells in different wells. Hence, to avoid necessity to quantify 
the absolute number of EGFR on every day the experiment run, on each day, we convert the 
fluorescence measurements of tEGFR into fractions of the initial tEGFR abundances. We then 
combine such fraction data between different repeats and days. We thus fit our model to the tEGFR 




Our previous ELISA measurements show that MCF-10A cells express between 3x 105 and 
6x105 EGFR molecules per cell. We expect that the average EGFR expression in cell populations 
with no EGF stimulation at time=0 in different wells on a given day to be similar. Plating cell 
population of several thousand cells in each well, in theory, should cancel out most of the variability 
due to stochastic fluctuations in cell populations, such as possible differences in cell cycle stages and 
gene expression.  
However, the average EGFR expression in cell populations is expected to vary from day to 
day, reflecting slight variations in experimental handling of cells which can occur between different 
days. For examples, variations in cell densities in the wells plated on different days, the age of the 
media in which the cells are pre-incubated, and other conditions may contribute to the variation in the 
average EGFR expression in the cells on different days. Interestingly, incidental exposure of a batch 
of cells to residual doses of EGF can also affect the number of EGFR receptors expressed on the cell 
surface.  
To summarize, after the background fluorescence subtraction and normalization, we 
represent changes in EGFR levels over time in fractions of initial amount of receptors present in the 
cells. Such approach then allows us to combine the total EGFR time-courses measured on different 
days and bypass the burden of experimentally measuring the average number of EGFR molecules in 
cells on each day the experiment is run. Repeating the same experiment on different days and 
combining the tEGFR data processed to represent the fraction of initial tEGFR allows to address 
biological variability in EGFR expression in cells between various days.  
In our model simulations we incorporate the measured abundances of EGFR receptors in 
MCF-10A cells as a prior constrain on the range of values of parameter, which represents initial 
condition abundance of EGFR receptors in a cell. Then we probabilistically sample the values of the 
initial abundance of EGFR by fitting the phosphorylation and the tEGFR data. We thus obtain 
posterior distribution of the initial EGFR abundance which is derived based on the fitted experimental 
data. 
Since we rely on assumptions that at the beginning of the experiment cells are in a quiescent 




EGFR levels implies that the rate of EGFR production is balanced by the rate of the basal 
internalization, degradation, and recycling of receptors. For each given day, the tEGFR data is then 
scaled by the average of the combined single cell distribution of tEGFR at no EGF and at time 0, so 
that at initial time point the number of receptors corresponds to 100% of total EGFR actively 
participating in cell signaling. 
We then divide the rest of the tEGFR data measured on that day by this value. After the data 
from each individual day have been processed and represented as fractions of total EGFR receptors, 
repeats from different days can be combined together. For each condition we report the average and 
the standard deviation of all the averages of single cell distributions from multiple wells. 
To combine single cell distributions of tEGFR measurements, first, we use the day-specific 
scaling factor derived as in the above procedure of scaling and normalization of the averages to 
divide each individual point in the single cell distributions of tEGFR on that day. The single cell 
distributions from each condition then represent the fraction of total EGFR. In addition, within each 
day, we divide all points in the single cell distributions by the variance of the distribution obtained from 
combining the corresponding controls of no EGF time=0 tEGFR distributions. For each condition, we 
then combine together all single cell distributions across repeats from the same day as well as from 
different days. If the resulting distribution appears normal, the model can be fitted to the reported 
averages and standard deviation for each of the resulting distributions for a specified condition; 
alternatively, the model can be fitted to the very distribution at each condition.  
Standard errors of the reported data are corrected by taking into account the division by 
scaling factors, which themselves have standard errors associated with them.  
Section 4.2: Various types of experimental data constrain the model parameter 
space: exploring relationship between the structure of the model parameter 
space and system behaviors  
 
To explore the structure-to-function relationship between the model’s  parameter space and 
model’s   responses to EGF stimulation we fit the model to different types of experimental data 
measured specifically in our biological system - MCF-10A cells. It has been previously suggested that 




collect various complementary types of experimental data, rather than to collect multiple repeats of 
the same type of measurements (Apgar, Toettcher, Endy, White, & Tidor, 2008). In our approach, we 
first conduct experiments measuring the phosphorylation and the EGFR receptor abundance time-
courses in response to treatments with various constant doses of EGF. We collect several 
independent replicates of the same experiment conducted on different days to ensure that the 
obtained data is reproducible and that it captures the true biological variability in the studied system 
(see Section 4.1). In addition, we conduct several other experiments of different types to further 
dissect the ErbB signaling system from multiple angles. In particular, we measure the EGFR signaling 
responses to constant-dose EGF stimulations with addition of other perturbations, such as, for 
example, EGF washout from the media, or addition of various kinase inhibitors. Fitting the model to 
such additional data allows to further constrain the model’s  parameters   space  and   thus   leads to a 
better understanding of the underlying molecular mechanisms realized in the ErbB signaling system. 
Kinetic modeling of signaling responses to different EGF doses has been previously applied 
to understand the MAPK signaling cascade (Schoeberl et al., 2002). However, previous approaches 
relied on deriving their conclusions based on simulating various perturbations to the system, such as, 
for example, altering protein overexpression or rates of interactions, in a limited number of parameter 
assignments. Our approach allows to account for broad variations in the underlying model’s  
parameter space and to derive a mechanistic insight about EGF signaling based on the distributions 
of parameters, rather than based on single point estimates of the parameter values.  
This section describes our analysis on identifying model parameters which are sensitive to 
various additional types of experimental data. The experiments measure pEGFR, pERK, pAKT, and 
total EGFR in response to perturbations either by saturating doses of kinase inhibitors, or by ligand 
washout from the media of EGF pre-treated MCF-10A cells. Obtaining such complementary to the 
main phosphorylation responses data leads to a better understanding of the mechanisms shaping the 
ErbB signaling dynamics that are most likely to be actually realized in this biological system. Our 
model shows that same system behavior (i.e. phosphorylation signal decay) can be fitted through 
different combinations of available mechanisms (i.e. degradation of receptors or action of 




individual mechanisms to shaping system dynamics. The main principle in the analysis presented 
below is that constraining model responses to additional experimental data should lead to changes in 
the model parameter space to accommodate the additional data points. Therefore, by comparing 
predicted distributions of parameters obtained from fitting the model to the fundamental experimental 
data set (the phosphorylation time-courses in response to constant-dose EGF treatment over several 
hours) to the distributions of parameters obtained from fitting the model to the same data set and 
additional data points, we should be able to identify parameters that have significantly shifted in their 
distributions to accommodate the extra data points, and thus are potentially important to the 
additional experimental conditions.  
By fitting our model to the comprehensive data set of the phosphorylation time-courses we 
derive posterior distributions of parameters. The obtained distributions reflect constraints imposed on 
the model parameter space by experimental data representing most essential aspect of the ErbB 
signaling system – phosphorylation responses. However, as we show throughout Section 4.2, in 
addition to the phosphorylation time-courses we fit our model to other types of experimental data. 
Thus, the posterior distributions of parameters obtained by fitting only phosphorylation data serve as 
the fundamental distributions of parameters, to which we then compare the distributions obtained 
from the simulations with addition of other types of experimental data. 
In the next sections, we describe how fitting the model to various additional experimental data 
affects posterior parameters distributions. More specifically, we first derive posterior parameter 
distributions to fit only the phosphorylation time-courses at different EGF doses (as in Section 4.3.1). 
We then refit the model to the phosphorylation time-courses and the additional experimental data and 
obtain a set of more constrained posterior parameter distributions. We apply statistical methods of 
comparing parameters distributions described in Section 3.3 and report parameters that were most 
shifted in their distribution by the additional experimental data. Note that the shift suggests the 




Section 4.2.1: The phosphorylation signaling time-courses of phospho-EGFR, 
phospho-ERK, and phospho-AKT in response to treatments with multiple 
constant EGF doses 
  Our main experimental data consists of the phosphorylation time-courses of pEGFR and its 
downstream targets, pERK and pAKT, in response to stimulations with constant EGF doses up to 
three hours (Figure 4.3). The data shown was obtained by combining and normalizing independent 
biological replicates of the experiments conducted on three different days (see Section 4.1). The time-
courses span up to three hours after EGF addition and the earlier more transient dynamics is being 
measured at more frequent time intervals.  
 
Figure 4.3: The experimental data: the three-hour phosphorylation and the total EGFR time-courses 
collected from MCF-10A cells treated with different EGF doses (0-100ng/ml).Each point represents a 
triplicate average and its corresponding standard error. Phosphorylation signal at time 0 is assumed to 
be 0 
The phosphorylation time-courses data captures various important features of the ErbB 
signaling dynamics. For example, we observe differences in the signal decay rates on pEGFR and on 
its downstream targets: pEGFR at highest EGF dose decays to its basal level within 1.5 hours, 
whereas pERK and pAKT decay slower. Lower doses of EGF elicit pEGFR responses of a more 
sustained dynamics, whereas higher EGF doses produce transient pEGFR responses with well-
defined pulse-like shapes. The dose-responses of pEGFR and pERK at early time (10mins) 
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demonstrate the effect of ultrasensitivity (Figure 4.4), a well-studied feature present in the MAPK 
cascade (Goldbeterl & Koshland, 1984). Ultrasensitivity describes a condition when signal at pEGFR 
is amplified by the kinase cascade leading to the downstream pERK responses, leading to pERK 
signal saturation even prior to the saturation at the pEGFR responses. Hence, the collected 
phosphorylation time-courses data at different EGF doses captures such key properties as the dose-
dependent signaling dynamics (transient or sustained), differential sensitivity to EGF doses of each 
target (threshold of pERK activation is at lower EGF doses then that of pEGFR), as well as the non-
trivial relationship between activation of pEGFR and its downstream targets (relative shifts in pEGFR 
and pERK dose responses).  
  
Figure 4.4: ERK ultrasensitivity: dose responses of pEGFR and pERK measured at 10 minutes after EGF 
treatment in MCF-10A cells. 
Figure 4.5 shows a model-produced fit to the experimental data, in which the model was fitted 
to the phosphorylation responses of pEGFR and pERK and to the time-courses of the total EGFR 
abundances up to three hours of stimulation with EGF doses ranging from 0 to 100ng/ml EGF. The 
produced fit agrees reasonably well with the experimental data. However, due to a relatively large 
number of fitted conditions (10 EGF doses), number of targets (three), and extended time of 
observation (3 hours) fitted in this simulation, some experimental data points are inevitably worse 
fitted then others (see tEGFR at highest doses). In addition, our assumptions used for the 
normalization and scaling of the experimental data could have led to data with certain intrinsic 
inconsistencies and thus contributed to the fact that some points are not being fitted well by the 
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model. For example, our assumptions regarding the amount of the background fluorescence offset 
subtraction in total EGFR measurements could result in under-estimating the fraction of EGFR 
receptors degraded by three hours of EGF stimulation (Section 4.1.3): by subtracting the lower 
background fluorescence values from the tEGFR experimental data, we produce normalized and 
scaled tEGFR measurements with lower fraction of receptors degraded by the end of three hours. 
 
Figure 4.5: Model fits to the experimental data (phospho-EGFR, phospho-ERK and tEGFR time-courses) 
found by simulated annealing. EGF fraction data were not fitted. Solid lines represent one fit to 
the data. Points represent the experimental data points with their corresponding standard 
errors.  
 
Section 4.2.2: The total EGFR degradation time-courses at multiple EGF doses 
The results presented in this subsection were obtained by fitting the extended ErbB signaling 
model previously published in (Chen et al., 2009). Due to the size (159 non-zero initial condition 
parameters) and complexity of the model in described this section, we fit the model only to the 
experimentally measured responses to high EGF dose (100ng/ml) for up to 1.5 hours of stimulation 
(Figure 4.6). Among the key distinctions of the extended model over the simplified model is the 
implementation of two types of EGFR internalization, namely, internalization through coated pit 
proteins (cPP) and non-cPP dependent internalization. In addition, the extended model implements 









































































































































































separately species of cytoplasmic and endosomal RTK phosphatases of EGFR and represents their 
activity as bi-molecular reactions with their own separate rates. Lastly, the extended model 
encompasses a generally accepted view that phosphorylated receptors are preferentially destined for 
degradation in endosomes, whereas unphosphorylated receptors can be recycled to the cell surface 
(Sigismund et al., 2005). 
To experimentally assess degradation of EGFR in our system, we quantify the changes in 
total abundances of EGFR receptors over several hours in response to stimulations with different 
constant doses of EGF. These experiments show that a higher EGF dose elicits more receptors 
degradation by 1.5 or 3 hours of EGF stimulation. In addition, the data shows that initially, at all EGF 
doses, the number of EGFR receptors does not change significantly, reflecting the established fact 
that prior to degradation receptors need to be internalized and shuttled into the lysosomes 
(Sigismund et al., 2005), a process requiring time on the order of minutes. As described in Section 
4.1, we fit receptors abundances data using fractions of the initial number of receptors remaining in 
the course of cells treated with different doses of EGF over time. Although we are working with 
fractions, rather than with the absolute number of receptors, we simulate initial abundances of EGFR 
in the cells as a parameter.  
Fitting receptors degradation data in addition to the phosphorylation time-courses imposes a 
constraint on model not only to fit phosphorylation signal decay, but also to fit this decay with a 
specified degree of receptors degradation. Therefore, we anticipate that such constraint could limit 
certain mechanisms and dynamic processes in the model, not necessarily directly related to 
degradation of active receptors.  
We observe that fitting our model exclusively to the phosphorylation time-courses produces 
fits with а  wide range of predicted fraction of receptors degraded in the long run of stimulation with 
EGF (Figure 4.6, fits in blue). We then plot the predicted distribution of fraction of EGFR remaining by 
1.5 hours of 100ng/ml EGF stimulation (Figure 4.7A, distribution in blue). The distribution suggests 
that fitting phosphorylation data can be realized with various degree of receptors degradation. 
However, in the majority of fits (60%) phosphorylation signal is fitted with degradation of almost all 




20% of the fits it is possible to fit phosphorylation signal with almost no degradation of EGFR 
receptors (>90% receptors remaining). Experimentally we have detected that in MCF-10A cells 
treated with 100ng/ml EGF by 1.5 hours approximately 55% of the initial number of EGFR receptors 
would remain undegraded in the system. Therefore, our model predicts a very different behavior from 
the one that is realized in the cells. We then re-simulate the model by imposing the experimentally 
observed EGFR degradation time-courses (Figure 4.6, fits in red). We see that the model can still fit 
well the imposed experimental phosphorylation data, although the predicted average time-courses 
with the imposed degradation time-courses show a slightly different amplitude of the pEGFR peak 
and early dynamics on all phosphorylation targets (5 minute time point) (Figure 4.6). Imposing the 
experimentally measured EGFR degradation time-courses results in significantly constrained 
distributions of the remaining tEGFR by 1.5 hours, with smaller variance (Figure 4.6, 1.5 hours time 
point and Figure 4.7A, dark red). 
 
Figure 4.6: Predicted fits to the phosphorylation and the total EGFR responses to 100ng/ml EGF in MCF-
10A cells. Model was fitted to the experimentally measured data points (green). Blue curves represent 
the averages and the standard deviations of the predicted probabilistic distributions from the fits to the 
phosphorylation data only; red curves represent the averages and the standard deviations of the 
predicted probabilistic distributions from the fits to the phosphorylation and degradation data.  
 























































































Figure 4.7: Probabilistic predictions: degradation of receptors and activity of EGFR phosphatase. (A) 
Predicted amount of remaining EGFR at 1.5 hours of stimulation with 100ng/ml EGF. Shown in blue are 
the distributions obtained from fitting the model only to the phosphorylation time-courses up to 1.5 
hours of 100ng/ml EGF treatment in MCF-10A cells; shown in red are the distributions obtained from 
fitting the model to the same phosphorylation time-courses and the corresponding total EGFR time-
course up to 1.5 hours of 100ng/ml EGF treatment in MCF-10A cells. (B) Predicted distributions of 
pEGFR t1/2 in MCF-10A cells treated with 100ng/ml EGF for 10 minutes followed by addition of saturating 
dose of pEGFR inhibitor gefitinib at 10mins.  
We consider early pEGFR responses (2.5-5 minutes) to 100ng/ml EGF stimulation – 
predictions that appear to change once EGFR degradation data is included in the fit. In fits to the 
phosphorylation data only, pEGFR appears to have reached its peak by 2.5 minutes and is decaying 
by 5 minutes (Figure 4.8), a trend suggested by shifted leftwards predicted distribution of pEGFR at 5 
minutes. The shift in the distributions from fitting the phosphorylation and the degradation data 
suggests that between 2.5 and 5 minutes, the pEGFR signal is predicted to mostly increase. 
Therefore, including the experimentally measured EGFR degradation data in the fits affects pEGFR 
activation dynamics by slowing it down. 
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Figure 4.8: Predicted distributions of the early pEGFR responses in MCF-10A cells treated with 100ng/ml 
EGF.Model was fitted only to the phosphorylation time-courses alone, or to the phosphorylation and the 
tEGFR time-courses measured in MCF-10A cells treated with 100ng/ml EGF. 
We then analyze the changes in the model parameter space that occurred to fit the EGFR 
degradation data. We consider the differences in the averages of predicted parameter distributions 
from each of the two fitted conditions: the first condition fitting phosphorylation signal only, and the 
second condition fitting the phosphorylation and the total EGFR time-courses (Table 1). We rank the 
parameters by the differences in the averages and find that most of parameters on the top of the list 
are related to EGFR internalization, dimerization, and phosphorylation. We include parameters 
related to activities of EGFR phosphatases and the rates of degradation of active receptors – 
reactions that directly affect tEGFR abundance by degrading phosphorylated receptors and 
determining what fraction of the total receptors is phosphorylated and thus subject to faster 
degradation. Fits with experimentally observed tEGFR degradation are predicted to have a more 
efficient rate of recycling of cPP proteins (k15), which facilitate internalization of receptors, and also 
have a faster rate of direct internalization of receptors (k6), possibly indicating enhanced removal of 
active receptors from the cell surface. However, changes in these parameters are also accompanied 
with a decreased rate of EGFR phosphorylation (kd123), and a faster kcat of endosomal RTK 
phosphatase (kd95), which together could suggest more efficient dephosphorylation of active 
receptors. Signal attenuation through receptors dephosphorylation rather than through their 
degradation thus could lead to preservation of receptors from degradation. Interestingly, we find that 
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parameters related to cytoplasmic RTK phosphatase (c5000 and k940) suggest a higher abundance 
of the phosphatase and a faster rate of its binding to activated cytoplasmic receptors. Since, in the 
model, phosphorylated surface receptors are internalized much faster than unphosphorylated ligand-
unbound receptors, having a more active cytoplasmic RTK phosphatase could lead to more rapid 
dephosphorylation of cytoplasmic receptors, which thus could help to attenuate signal, with a 
decreased receptors degradation. Therefore, the model predicts the importance of parameters of 
RTK phosphatases to fit the experimentally measured EGFR abundance time-courses, suggesting a 






Table 1: Top parameters related to EGFR signaling and degradation. The parameters are ranked by the 












    k15 -5.43 -4.37 1.07 
    k6 -5.14 -4.48 0.66 
    kd123 -0.26 -0.67 -0.41 
    kd2b -2.60 -2.21 0.39 
    kd95 1.08 1.45 0.37 
    kd2 -2.78 -2.43 0.35 
    k940 -4.65 -4.34 0.31 
    c5000 4.96 5.25 0.29 
    k2 -5.10 -5.39 -0.29 
    kd4 -2.32 -2.60 -0.27 
    kd5 -0.72 -0.94 -0.22 
    k60 -3.36 -3.15 0.21 
 
parameter name Description 
    k15 recycling of internalized cPP proteins to the cell surface 
    k6 direct internalization of active receptors 
    kd123 phosphorylation of EGFR 
    kd2b undimerization of EGF bound ErbB1-ErbB2 heterodimer 
    kd95 kcat of phosphoatase - stronger (in endosomes) 
    kd2 undimerization of EGFR homodimers 
    k940 binding of cytoplasmic RTK phosphatase to active EGFR dimers 
    c5000 concentration of cytoplasmic RTK phosphatase 
    k2 dimerization of two EGF bound EGFR monomers 
    kd4 unbinding of cPP from receptors 
    kd5 release of receptors into endosomes through cPP internalization 
    k60 rate of degradation of active receptors 
 
To further investigate the relationship between EGFR degradation and RTK phosphatase 
activities predicted by changes in model parameters space, we compare system’s responses 
assumed to be strongly affected by the corresponding parameters. For example, the amount of EGFR 
remaining in the system after 1.5 hours of stimulation with EGF can serve as a proxy for the values of 
parameters related to receptors degradation in the system: The more receptors remain undegraded, 




activities on system behavior (phosphorylation responses of pEGFR), we consider the following 
quantity. In model simulations described in this section, along with the predicted time-courses 
responses to constant EGF that are used to fit the model, we also generate predictions of a scenario 
in which after 10 minutes of 100ng/ml EGF treatment signaling phosphorylation of EGFR is inhibited, 
thus imitating addition of saturating doses of EGFR kinase inhibitor gefitinib. The approximate metric 
of pEGFR RTK phosphatase activity is then estimated from such responses by measuring a half-life 
of pEGFR signal immediately after kinase inhibition. A lower pEGFR signal half-life (t1/2) could 
suggest a faster activity of EGFR phosphatase. In most fits, the predicted pEGFR signal half-life is 
sufficiently fast, on average 5.2+/-4.1 minutes, thus such rapid signal decay is unlikely to be attributed 
exclusively to the more time-consuming process of receptors degradation. Hence, most probably 
such rapid signal decay is realized through RTK phosphatases. The predicted distributions of pEGFR 
signal t1/2 show that imposing experimentally observed tEGFR degradation speeds up pEGFR signal 
decay at inhibitor treatment, as manifested through shifts in predicted distributions to the left (average 
predicted pEGFR signal t1/2 shifted to 2.8+/-2.2 minutes). This suggests somewhat faster activity of 
the phosphatases (Figure 4.7 B). Since, the experimentally imposed degradation of EGFR was 
significantly lower than the predicted degradation in the majority of the fits, we hypothesize that RTK 
phosphatase activity is anti-correlated with the strength of receptors degradation. 
To further check if the negative correlation is observed in the predictions of the model fitted 
only to the phosphorylation data, we consider two subsets of fits from these simulations: in one 
subset, phosphorylation responses decay is predicted to be fitted with most receptors degraded 
(Figure 4.7A blue distribution, left-most peak), and in the second subset, phosphorylation is fitted with 
insignificant receptors degradation (Figure 4.7 blue distribution, right-most peak). We then compare 
the predicted distributions of pEGFR half-lives at inhibitor treatment between the two subsets, which 
thus could allow to compare the average strengths of the RTK phosphatases in these two subsets 
(Figure 4.8). We find that in the fits with strong EGFR degradation, the pEGFR half-life was predicted 
to be on average 4.49+/- 3.43 mins, whereas in the subpopulation of fits with weak EGFR 
degradation the pEGFR half-life was predicted to be shorter, on average 1.85+/-0.83 mins. In the fits 




receptors remaining by 1.5 hours of EGF treatment) the pEGFR half-life was predicted to be even 
shorter, on average 1.15+/-0.16 minutes. The correlation coefficient between the amount of receptors 
remaining and the pEGFR half-life at gefitinib was found to be -0.3106 (p-value <10-4). It follows that, 
in the model, faster phosphatase activity could indeed be correlated with lower receptors degradation 
(Figure 4.9). 
 
Figure 4.9: Predicted half-life of pEGFR signal at gefinitib inhibition in fits with different strength of EGFR 
degradation. 
We demonstrated how experimental measurements of EGFR degradation could be used to 
infer constraints on the parameters related to other mechanisms of pEGFR signal attenuation, 
namely, receptors dephosphorylation by RTK phosphatases. Quantifying relative contributions of 
these two mechanisms to the attenuation of phosphorylation on EGFR, to the best of our knowledge, 
has not been previously addressed. It might be interesting to explore what possible combinations of 
different molecular mechanisms can realize the same cell function (e.g. phosphorylation signal decay) 
and predict their relative likelihoods to occur in vivo. For example, the choice of mechanisms to decay 
phosphorylation signal can depend on cellular context (e.g. levels of expression of RTK 
phosphatases) or on various features (e.g. duration or dose of ligand treatment) of the environmental 
perturbation to which the cell is exposed. Our approach could allow simulating multiple cellular 
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conditions of interest (i.e. various dose profiles of ligand treatment or perturbations) and gaining an 
insight  about  model  mechanisms  through  the  properties  of  model’s  parameter  space. 
Section 4.2.3: Estimation of EGFR phosphatase activity through the rate of 
phospho-EGFR signal decay in response to treatment with EGFR kinase 
inhibitor Gefitinib 
  
Kinase inhibitors have been previously used to study dynamics of phosphorylation 
responses. Experimental use of kinase inhibitors has allowed to establish that the observed 
phosphorylation response is determined by the dynamical balancing of two opposing processes of 
phosphorylation and dephosphorylation in signaling cascades (Kleiman et al., 2011). Gefitinib is an 
ATP-competitive inhibitor of tyrosine kinase domains of ErbB. Applying saturating doses of gefitinib to 
EGF-treated cells promptly inhibits EGFR phosphorylation and results in a rapid drop in 
phosphorylation signal, on the order of seconds to minutes. Such drastic signal decay cannot be 
attributed to a slower-scale process of receptor internalization and degradation, and thus is most 
likely caused by action of RTK phosphatases (Kleiman et al., 2011). 
We use experimental data collected in MCF-10A cells in response to EGF pulse gefitinib 
chase (pulse-chase) experiments reported in (Kleiman, 2010). MCF-10A cells are first stimulated with 
100ng/ml EGF for 2 or 10 minutes, followed by addition of saturating dose of gefitinib. 
Phopshorylation of EGFR is then measured over time every 10 seconds after gefitinib addition. In 
addition, pERK and pAKT signals are measured as well (see Section 4.2.4). 
In the model, we simulate the addition of inhibitor by completely stopping any phosphorylation 
of EGFR receptors at the time inhibitor is added. Such simplification, however, does not take into 
account possible time needed for the inhibitor to diffuse in the cells in the experiments. Fitting the 
model to the phosphorylation and the total EGFR time-courses as described in Section 4.2.2 we 
generate predicted distributions of the pEGFR half-life at gefitinib addition in cells treated with 
100ng/ml EGF for 10 minutes. For comparison, the experimentally measured pEGFR half-life in MCF-
10A cells is reported as ~ 43 sec in (Kleiman et al., 2011) (Figure 4.10). Although, the model predicts 
that the majority of fits have a much slower pEGFR half-life at gefitinib addition, the experimental 




a fast activity of RTK phosphatases in vivo, the model predicts that phosphorylation signal can be fit 
even with a much slower phosphatases, possibly due to compensatory degradation of EGFR as a 
second signal attenuation mechanism. 
 
Figure 4.10: Predicted half-life of pEGFR signal at gefitinib addition, 10 minutes after stimulation with 
100ng/ml EGF. Model was fitted to the phosphorylation and the tEGFR time-courses measured in MCF-
10A cells. Shown in red is an experimental estimate of the pEGFR half-life after 100ng/ml EGF and 
gefitinib applied in MCF-10A cells and reported in (Kleiman et al., 2011) 
 
We can use our model to explore the effect of gefitinib inhibition of pEGFR on its downstream 
target, pERK, and on the levels of EGFR abundance. Figure 4.11 shows predicted responses to the 
constant stimulation of 100ng/ml of EGF of pEGFR, pERK and total EGFR (bold lines), which were 
fitted to the experimental measurements, along with the predicted responses of these targets to 
gefitinib inhibition at 10 minutes after 100ng/ml EGF stimulation (shown in dashed lines). In the 
shown fit, the pEGFR half-life is very short, ~26 sec, and that of pERK is on the order of 3 minutes - 
values which reasonably well agree with the corresponding experimental estimates (pEGFR t1/2~43 
sec, pERK t1/2 ~4mins (Kleiman et al., 2011)). This fit predicts that immediately after gefitinib addition 
the total EGFR would remain constant, suggesting that after the disappearance of phosphorylated 
receptors, degradation of receptors stops. Interestingly, such observation could suggest possible 
therapeutic implications of gefitinib treatment – by inhibiting phosphorylation of receptors in the 
presence of high doses of EGF, gefitinib still preserves a number of EGFR receptors, therefore, 






















potentially maintaining cell sensitivity to consequent changes in EGF doses. For example, for a 
sufficiently high increase in EGF dose, gefitinib action could be overpowered, leading to activation 
and phosphorylation of receptors. Since our model implements gefitinib action in a general, non-
detailed, all-or-none manner, the model cannot be used for exploration of this effect. However, other 
studies have focused specifically on in-detail modeling of interactions of kinase inhibitors with 
receptors and their effects on signaling (Chen et al., 2009; Kleiman et al., 2011).   
 
Figure 4.11: Simulated time-courses of MCF-10A cells responses to 100ng/ml EGF with addition of 
pEGFR inhibitor gefitinib at 10 minutes. 
We proceed to use the predicted parameter distributions obtained from fitting the model to 
the phosphorylation and the total EGFR abundance at 100ng/ml EGF treatment for 1.5 hours to 
deduce information about parameter values in which the data can be fitted with similar to the 
experimentally measured in vivo strength of RTK phosphatases. Figure 4.12 shows predicted 
distributions of parameters related to EGFR activation and RTK phosphatase activity obtained from 
all found fits (in blue), and from a subset of fits with RTK phosphatase activity as measured 
experimentally (in red). We see that although not all parameters are predicted to differ in their 
distributions (for example, kd950, the rate of kcat of cytoplasmic RTK phosphatase) in the fits with 
fast RTK phosphatase activity, some parameters distributions seem to be shifted in a trend 
suggesting a more abundant RTK phosphatase (c5000) and a faster rate of its binding to active 
receptors (k940), which is consistent with the faster rate of pEGFR signal drop at gefitinib inhibition. 
Somewhat shifted distributions of parameters not directly related to RTK phosphatases, such as, for 
example, the rate of EGFR degradation (k60), internalization (k6, kd6) or dimerization (k2, kd2) of 
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receptors, suggest that not only dephosphorylation of receptors, but also other dynamic processes 
can affect the observed pEGFR behavior at gefitinib inhibition. Overall, the predicted distributions can 
be used to get an insight about values of parameter space in which the model is consistent with 
phosphorylation and total EGFR experimental data and fits this data with the experimentally observed 
strength of RTK phosphatase (Figure 4.12, in red).  
 
 
Figure 4.12: Predicted parameter distributions from model fitted to the phosphorylation and the total 
EGFR time-courses measured in MCF-10A cells. Shown in red are the parameter distributions from the 
subset of fits with the half-life of pEGFR at gefitinib being within the experimentally measured estimate 
of 10-40 seconds. For parameters description see Table 1. 
Section 4.2.4: Estimating ERK phosphatase activity through the rate of pERK 
decay at MEK inhibition 
 
In our model, pERK downregulation is realized through the action of pERK phosphatase, as 
well as through signal decay at the receptors level. To assess the rate of phospho-ERK 
dephosphorylation, we use an EGF pulse, MEK inhibitor chase (pulse-chase) experiment: EGF 
stimulation of cells is perturbed by the addition of inhibitors of MEK, the upstream kinase activating 
ERK (Figure 2.1). After the initial stimulation with 100ng/ml EGF for 10 minutes, cells are treated with 












































































a saturating dose of MEK kinase inhibitor PD0325901 and pERK response is measured frequently for 
one hour afterwards. The iMEK treatment induces rapid decrease in pERK signal with a half-life of 
pERK signal on the order of minutes. Since in the iMEK experiments pERK is decoupled from 
regulation by its upstream kinase, the observed rapid pERK decay should be attributed solely to the 
action of pERK phosphatases. First, it is unlikely that ERK is degraded during EGF stimulation. 
Therefore ERK degradation cannot contribute to the observed rapid pERK decay at iMEK treatment. 
In addition, series of experiments reported in literature (Kleiman, 2010) show that inhibition of 
phosphatases with small molecule inhibitors leads to rapid increase in phosphorylation of their targets 
and suggest that the phosphorylated targets are under constant downregulation by phosphatases. 
Hence, pERK signal decay observed in the pulse-chase experiments is most likely caused by the 
action of ERK phosphatases. 
We fit the model to the phosphorylation and the total EGFR time-courses and predict the 
distribution of the pERK half-life after iMEK addition after 100ng/ml EGF stimulation for 10 minutes 
(Figure 4.13). The obtained distribution varies across several orders of magnitude, suggesting that 
the model can fit pERK signal decay in response to persistent EGF stimulation relying on different 
degrees of strength of pERK phosphatase. The model predict the median pERK half-life at iMEK to 
be 0.98 mins; however, the experimental estimates of the pERK half-life in an EGF pulse-iMEK chase 
experiment in MCF-10A are somewhat lower, approximately 2.7+/- 0.3 minutes. The experimentally 
measured value has a non-zero probability in the predicted distribution (the area shown in red in 
Figure 4.12). It is possible that our model underestimates the half-life of pERK at iMEK due to our 
assumption that iMEK addition instantaneously prevents phosphorylation of ERK by pMEK. However, 
in reality, the iMEK molecules may need time to diffuse into the localization of their targets, therefore 
possibly slowing down the time to observe pERK signal decay. In addition, it is plausible that 
inhibitors of MEK are not specific and may have unintended off-target effects that could influence the 
MAPK signaling cascade not only at the level of MEK but possibly at other signaling components.  
Here we demonstrate how our approach can be used to investigate the relationship between 
model parameters space and model’s   responses   (e.g., pERK signal decay) through analyzing 




addition). To explore the relationship between regulation of phospho-ERK signal decay and model 
parameter space, we look at the correlations between values of the predicted pERK half-life at iMEK 
addition and individual parameter values. We find that the parameters highly correlated with the rate 
of pERK decay at iMEK are related to the action of pERK phosphatase. Specifically, effective rate of 
ERK phosphatase binding (represented by the product of the concentration of ERK phosphatase and 
the rate of its binding to phosphorylated ERK) is negatively correlated with the observed pERK half-
life at iMEK addition (Pearson Correlation coefficient = -0.97, p-value < 10-4); the rate of kcat of the 
ERK phosphatase also had a negative correlation (Pearson correlation coefficient =-0.32, p-value < 
10-4). Such findings are not surprising, as ERK phosphatase is the only direct negative regulator of 
pERK signal in our model. We also find that the rate of binding of MEK phosphatase to pMEK 
positively correlates with the pERK half-life at iMEK addition (Pearson correlation coefficient = 0.59, 
p-value < 10-4). This may suggest that the faster MEK phosphatase binds to its target, the slower the 
pERK decay at iMEK, and thus the slower the phosphatase of pERK can be. This points to a possible 
compensatory relationship between actions of phosphatases in the kinase signaling cascade. 
To better understand what molecular mechanisms were actually regulating pERK signal 
decay in MCF-10A cells, we examined the predicted fits with the pERK half-life at MEK inhibition 
being within the experimental estimate of 2.4-3 minutes. Figure 4.14 shows how constraining the 
model to the experimentally measured responses to iMEK perturbation allows to significantly limit the 
model parameter space. In particular, the possible range of values of the effective rate of ERK 
phosphatase can be narrowed down from about 4 to only 0.5 orders of magnitude based on the 
EGF/iMEK pulse chase experiment. Overall, this result suggests that to regulate phopho-ERK signal 
decay the system is more likely to use a pERK phosphatase of moderate activity. 
In addition, this example demonstrates how applying our model simulations and additional 
experimental data could elucidate the relationship between the system’s   mechanisms   (expressed  
through the model parameter space) and system’s   function (observed signaling responses). The 
parameter distributions predicted by fitting the model to a given set of experimental data can be used 
to generate specific hypotheses about the underlying mechanisms realized to produce the observed 




parameter space. However, imposing constraints from various perturbations experiments should 
constrain the model parameter space to a more narrow range of specific molecular mechanisms. 
Therefore, our approach may be useful in optimizing experimental design by suggesting most 
informative perturbations and conditions to elucidate various molecular mechanisms involved in cell 
signaling. This topic is an important area of research in system biology and has been previously 
explored in detail (Liepe, Filippi, Komorowski, & Stumpf, 2013).  
We now briefly describe several other examples of how our model predictions can be used to 
explore the relationship between the model parameter space and its functions. For instance, we can 
consider two subsets of predicted fits with opposing pERK half-life at iMEK perturbation: one set with 
pERK half-life under 1 minute, and the second set – on the order of half an hour. We can then 
compare parameter distributions different between the two subsets and find the most distinct 
parameters between the two observed pERK behaviors. Therefore, such comparison can provide an 
insight into the regulation of pERK with various underlying mechanisms, yet resulting in similar pERK 
behaviors. 
Another possible application of our approach can be used to differentiate between the two 
possible types of kinase activation and deactivation reactions. For example, activation of pERK relies 
on phosphorylation of two of pERK residues and is performed by the same enzyme, MEK. Such 
activation is processive if in one binding to its target, the enzyme performs the two phosphorylation 
steps; otherwise, if the enzyme unbinds and rebinds between the two steps, the reaction is referred to 
as distributive. Recent works suggested that the double-phosphorylation activation of ERK and its 
dephosphorylation in vivo are distributive processes. However, some studies reported that under 
certain molecular condition of the so-called molecular-crowding effect (Aoki et al., 2011) the double 
ERK phosphorylation reaction may become processive. pMEK activation also relies on two 
phosphorylation steps. 
We can fit our model to the experimental data and by examining the obtained parameter 
distributions and dynamics of individual intermediate variables not measured experimentally, we can 
generate predictions as to which two-step reactions are processive or distributive in the ErbB 




activation and deactivation in our model, we implement each of the activation/deactivation steps as 
separate reactions with distinct kinetic rate constants. We then can simulate these parameter values 
by fitting the model to the phosphorylation and total EGFR time-courses and impose the constraint of 
pERK half-life at MEK inhibition to be within the experimentally observed range. The model simulation 
then allows to sample various parameter combinations in which pERK signaling is fitted through the 
activation/deactivation processes of distributive or processive types. To distinguish whether in a given 
model fit the ERK activation is realized via processive or distributive phosphorylation, we examine 
dynamics of intermediate variables, namely singly phosphorylated ERK (Figure 4.15). The model 
suggests that processive activation of ERK is characterized by a sharp increase in the double-
phosphorylated ERK species and with low levels of the intermediate single-phosphorylated ERK, 
indicating that all ERK is being rapidly converted into double-phosphorylated ERK at the beginning of 
stimulation. Similarly, one can distinguish between processive or distributive dephosphorylation of 
ERK and MEK by analyzing dynamics of single- and double-phosphorylated ERK at later times, after 
the signal peak, when signal is decaying due to the action of ERK phosphatases and decreased 
activation from upstream kinase. Generating model fits with two different types of the two-step 
activation reactions and comparing their parameter distributions could then provide an insight into 





Figure 4.13: Predicted distribution of pERK t1/2 after addition of MEK inhibitor in MCF-10A cells treated 
with 100ng/ml EGF. Shown in red is the corresponding experimental estimate measured in MCF-10A 
cells. 
 
Figure 4.14: Correlation between the predicted half-life of phospho-ERK at MEK inhibition and the rate of 
ERK phosphatase parameters. 
 In addition to phosphorylation signal decay on pERK in response to perturbation with MEK 
kinase inhibitor, we also have experimental measurements of pERK signal decay caused by kinase 
inhibition of pEGFR with gefitinib. The data suggests that upon gefitinib addition at 10 minutes, pERK 
in MCF-10A cells decays with a half-life of approximately 3.5 minutes, and pAkt is dephosphorylated 
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slightly faster, with t1/2 ~ 1.2 minutes. Using half-lives of pERK in response to signal inhibitions at the 
upstream, pEGFR level, or the downstream, MEK level, can help to understand the information flow 
in signaling cascades. In particular, by fitting the model to the phosphorylation and the total EGFR 
time-courses and imposing constraints on the half-life of pERK signal after perturbation with either of 
the inhibitors, and then comparing the resulting changes in the model parameter space, one might 
assess information content of each of the perturbations. Furthermore, including experimental data 
from both of the perturbations to be fitted in the model can help better constrain signaling cascade 
parameters relevant to signal propagation between pEGFR and pERK. 
 
 
Figure 4.15: Examples of model-predicted time-courses of ERK species in the two types of phospho-ERK 
activation: processive and distributive. Time-courses of ERK, and intermediate species - single 
phosphorylated pERK and final product - double phosphorylated ERK. 
Section 4.2.5: Phosphorylation signal decay and EGFR abundance recovery in 
EGF washout experiments 
 
In this work we consider signaling responses to stimulations with constant doses of EGF over 
several hours. However, we also use the results of two types of perturbations - addition of kinase 
inhibitor (described in Sections 3.2.3 and 3.2.4) and EGF washout experiments presented in this 
section. In ligand washout experiments, cells are being treated with various constant doses of EGF 
for ten minutes, followed by replacement of the cells media with a ligand-free media. 














































Ligand removal from the cell surface is a physiologically plausible scenario, in which, for 
example, growth factors can be rapidly removed from the cell surface by blood, or alternatively, slowly 
diffuse away. Hence, it may be useful to understand what mechanisms are shaping cell responses in 
the conditions of ligand washout. Furthermore, it may be interesting to study how rapid changes in 
extracellular stimuli are propagated towards the downstream targets and if buffering or time-delay 
effects are present in the cascade.  
 
Figure 4.16: Ligand washout experimental data: phosphorylation and total EGFR time-courses measured 
in MCF-10A cells exposed to EGF for 10 minutes and subjected to EGF washout at time=10mins. 
Figure 4.16 shows the experimental measurements of the phosphorylation responses and the 
total EGFR time-courses in MCF-10A cells after they were treated with a range of EGF doses for 10 
minutes and subjected to EGF washout (at t=10 minutes in the graph). Phosphorylation signal and 
the total EGFR abundance are measured after EGF washout for up to three hours. These 
experiments show that phosphorylation signal drops after EGF is removed, with the rate of decay 
apparently dependent on the dose of EGF in the initial 10 minute treatment: at EGF doses between 4 
and 100ng/ml, the half-life of pEGFR is between 5 and 10 minutes (estimated as 6.75+/-1.75 
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minutes), whereas at lower doses (EGF < 0.8 ng/ml) the half-life of pEGFR appears to be between 10 
and 15 minutes (Figure 4.16). Phosphorylated ERK and AKT signals also appear to decay with 
relatively fast dynamics.  
Interestingly, pEGFR drops slower at EGF washout (t1/2~ 8 mins after 100ng/ml EGF) than at 
kinase inhibition (t1/2~ 43 sec minutes after 100ng/ml EGF), possibly due to the fact that at the time of 
washout EGF bound to cell surface receptors remains in the media and thus stimulates some 
remaining signaling. Moreover, in the kinase inhibition experiment, EGF is constantly present in the 
media, and gefitinib competes with ATP for binding to the receptors. Gefitinib bound to receptor 
temporarily inhibits its activation, until it unbinds. This demonstrates that although both the EGF 
washout and the pEGFR kinase inhibition lead to pEGFR signal decay, these two perturbations lead 
to phosphorylation signal decay through very different mechanisms. Hence, using experimental 
inhibition from both types of such perturbations should better constrain various parameters in our 
model and provide more precision about the mechanisms used in the model to fit signaling dynamics. 
The total EGFR time-courses data shows that even after EGF is washed out, receptors 
continue to degrade over some time – possibly reflecting the degradation of the remaining 
phosphorylation receptors in the system. However, by three hours after EGF washout, total EGFR 
receptors appear to recover to nearly their pre-stimulus levels at most EGF doses, and possibly at the 
100ng/ml as well, although at a slower rate. Since the experimental measurements count all total 
EGFR receptors, the observed recovery in the number of receptors is not likely due to mobilization or 
transport of previously inactive in signaling receptors, as those would have been detected in the total 
receptors abundance. Therefore, it is most probable that the observed recovery was due to de novo 
synthesis of receptors. In addition, this observation suggests that relatively short, on the order of 10 
minutes, pulses of EGF may be forgotten by cells within several hours after their removal, depending 
on the dose of the treatment. However, pulses of higher EGF doses might change the number of 
receptors on the cell surface for several hours after removal of the pulses.  
Additionally, we conduct an experiment in which MCF-10A cells are stimulated with 100ng/ml 
EGF for 10 minutes, followed by EGF washout, incubation for 60 minutes, and restimulation with 




fitting the model, it serves as an additional confirmation of the model predictions. The experiment 
showed that the amplitude of pEGFR responses at the second EGF addition is significantly lower 
than the amplitude of the initial response, even though the EGF doses in both stimulations are the 
same. Therefore, the cells have reduced their sensitivity to EGF, possibly due to the fact that one 
hour after EGF washout is not sufficient to restore the system’s sensitivity after a high dose EGF 
treatment. The time-courses of tEGFR measurements in the experiments where washout is applied 
10 minutes after 100ng/ml EGF (Figure 4.16) show that, even after ligand washout, tEGFR continues 
to decay, most likely due to the presence of phosphorylated receptors. Recovery in tEGFR is thus 
delayed. The data shows that by 1 hour after EGF washout in the 100ng/ml stimulated cells, tEGFR 
abundances decrease to their lowest values, and start to recover from that time. Moreover, since this 
is an estimate of the total EGFR in the cell, it is not clear what fraction of these receptors has returned 
to the cell surface, where it can bind ligands, as opposed to still being transported to the cell surface 
in some ligand-inaccessible intracellular compartments. 
 
 
Figure 4.17: Experimental confirming of decreased sensitivity to EGF in MCF-10A cells previously 
exposed to EGF .MCF-10A cells were treated with 100ng/ml EGF for 10 minutes. At t=0, 100ng/ml EGF is 
applied, at t=10 minutes, EGF is being washed out from the cell media, at t=70 mins 100ng/ml EGF is 
added to the media. Reported are the averages of triplicates and the standard errors. 
We fit the model to the phosphorylation data and the total EGFR time-courses in response to 
continuous stimulation with various EGF doses and predict the distribution of pEGFR half-lives at 
EGF washout after 10 minutes of 100ng/ml EGF. The model predicts an average pEGFR t1/2 of 13.5 
































+/- 0.3 minutes, whereas, the experimental estimate of the pEGFR half-life in the washout after 
100ng/ml is approximately 6.75+/-1.75 minutes, and is substantially faster. The model predicts that on 
average, tEGFR by three hours after EGF washout would recover to approximately 70% of its initial 
levels (Figure 4.18, dashed blue line).  
We then refit our model to the same phosphorylation and the total EGFR time-courses. In 
addition, we impose that the pEGFR t1/2 at EGF washout after 100ng/ml is within 6.75+/-1.75 minutes, 
according to the experimental data. The model predicts the fastest pEGFR signal drop at EGF 
washout at 100ng/ml (Figure 4.18, red dashed line) and pEGFR t1/2 on average to be 8+/-0.41 
minutes. In addition, tEGFR is predicted on average to recover to its initial levels by three hours after 
EGF washout 
 
Figure 4.18: Distributions of time-courses predicted by model fitted with or without the experimental 
estimate of the pEGFR half-life after 100ng/ml EGF followed by EGF washout in MCF-10A cells.Shown 
are the averages and the standard errors of the predicted distributions from model fits with (red) and 
without (blue) the pEGFR half-life at washout estimate included. 
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Table 2: Comparison of the averages of the predicted distributions of parameter values fitted to the 
phosphorylation and the tEGFR data versus the averages from the distributions obtained by additionally 
imposing the experimentally measured pEGFR half-life at washout. 
parameter name 
phospho and 
tEGFR data only, 
m1 (log10) 
phospho, tEGFR and 





   kd31 -2.80 -0.73 -2.07 
    kd2a -0.17 1.75 -1.92 
    kd1 -2.73 -1.22 -1.51 
    kd2 -1.69 -0.68 -1.01 
    k2a -7.32 -6.37 -0.95 
    k60 -3.18 -2.59 -0.59 
    predicted pEGFR 
t1/2 at 100ng/ml 
washout 
13.58 +/- 0.33 
mins   8 +/- 0.4 mins   
    
    
kd31 koff of EGF unbinding from two-EGF bound dimer 
 kd2a undimerization of two-EGF bound dimer 
 kd1 koff of EGF unbinding from monomer 
 kd2 undimerization of one-EGF bound dimer 
 k2a dimerization of EGF-bound dimers 
 k60 degradation of active receptors 
  
We then compare the distributions of parameters that have shifted to accommodate faster 
pEGFR decay at EGF washout. We find that the most shifted in distributions parameters are related 
to processes of EGF unbinding, receptors undimerization, and degradation of active receptors. 
Specifically, the rates of EGF unbinding from monomers and fully occupied dimers were faster by 1.5 
and 2 orders of magnitude, suggesting faster dissociation of EGF from receptors. In addition, rates of 
undimerization and active receptors degradation were also predicted to be faster. Therefore, using 
EGF washout data in our approach we can better constrain parameters important to EGFR ligand 
kinetics, undimerizaiton and receptors degradation. 
Note, that in this example we fitted our model to the phosphorylation and the tEGFR time-
courses and pEGFR t1/2 at washout only at a single, highest EGF dose. Potentially, we can fit our 




the highest EGF dose (Figure 4.19, Figure 4.20). This, however, would require an additional model 
simulation step at each dose at which we choose to fit the EGF washout measurement, which would 
substantially slow down the simulation times compared to model fitting with only one washout 
condition. We find that fits to the phosphorylation, the tEGFR and the washout data only at high EGF 
dose can still reproduce reasonably well the features of the washout data at other EGF doses (Figure 
4.19, Figure 4.20). In addition, simulating the washout experiments at the found model fits could allow 
a direct computation of pEGFR t1/2 at EGF washout at various pre-treatments with EGF doses, unlike 
the case with the experimental data, in which pEGFR t1/2 at washout can be determined only within 
the errors of time intervals at which the experimental pEGFR signal was measured after EGF 
washout (in our case this interval is 5 minutes). 
 
Figure 4.19: Example of model predicted pEGFR responses to stimulations with continuous dose EGF 
and to stimulations with 10 minutes constant dose EGF followed by EGF washout. 



















pEGFR, predicted responses at constant EGF stimulation and washout at 10 minutes
 
 
























Figure 4.20: Example of model predicted total EGFR responses to stimulations with continuous dose 
EGF and to stimulations with 10 minutes constant dose EGF followed by EGF washout. 
Section 4.3:Sampling results: predicted distributions of parameters values 
Section 4.3.1: Predicted distributions of parameter values 
 
We fit our model to the phosphorylation time-courses data measured between 0 and 1.5 
hours of treatment with EGF in MCF-10A cells (described previously in Section 4.2.1). We then run 
MCMC simulations and obtain probabilistic distributions of parameters that were most likely to have 
produced the observed data. The prior distributions imposed on the ranges of the parameter values 
were derived based on the literature estimates when available (see Section 3.2.4), and depend on the 
type of reaction that the parameter represents. To demonstrate our methodology with regards to 
various features of the parameter space of a large, complex signaling cascade model, in this section 
we use a previously developed extended EGFR signaling model (Chen et al., 2009) (see Section 
A.1.1) with 159 parameters. The model encompasses EGFR, ERK and AKT activation and has 
detailed implementation of EGFR receptors interactions with adaptors and scaffolding proteins.  
 We generate probabilistic predictions of the protein concentrations and of the kinetic rate 
constants of reactions (see Section A.1.1). Such probabilistic predictions could provide a valuable 
insight about likely ranges of in vivo protein abundances or rate constants of reactions in vivo, 
quantities which are still challenging to measure experimentally in the mammalian cells (Beck et al., 































2011). Our model simulations predict the levels of various phosphatases that affect cell signaling 
responses and can be important in downregulating the phosphorylation signal. The prior probability 
distribution on values of parameter for ERK phosphatase abundance was allowed to vary within three 
orders of magnitude, 103-106 molecules per cell; the predicted distribution is skewed towards 104-
3x104 molecules per cell (Figure 4.22). The predicted distribution of the abundance of PTEN (c279), 
phosphatase negatively regulating signaling upstream of AKT, has two peaks and is concentrated 
either between 3x104 and 3x105 molecules per cell (Figure 4.21). Being able to predict the levels of 
PTEN in cells may be biologically useful, as loss of PTEN has been implicated in cancer (Sulis & 
Parsons, 2003). 
 
Figure 4.21: Predicted distribution of ERK phosphatase abundance. The model was fitted to the MCF-10A 
phosphorylation data. 
 
Figure 4.22: Predicted distribution of PTEN phosphatase abundance . The model was fitted to the MCF-
10A phosphorylation data. 






































number of molecules (log10)  




We can also predict the distributions of initial abundances of various scaffold and adaptor 
proteins, which bind to the activated EGFR receptors in the cytoplasm and may alter signaling 
dynamics (Levchenko, Bruck, & Sternberg, 2000). Predicted distributions of initial levels of Sos(c30), 
Grb2(c22), and Gab1, a Grb2 associated protein 1, (c426), although spread within several orders of 
magnitudes, still are helpful by suggesting more probable regions of approximately 1-2 orders of 
magnitude for the abundances of these signaling components in cells in which the experimental data 
has been collected (Figure 4.23 A-C). 
Along with the abundances of scaffold and other proteins, we predict the distribution of initial 
levels of PIP2 (c444) (Figure 4.23 D), a phospholipid which serves as a substrate for other signaling 
proteins and is important for activation of the AKT branch (Manning & Cantley, 2007).  
             
            
Figure 4.23: Predicted distributions of the adaptor and scaffold proteins abundances: (A) Grb2 (c22); (B) 
Gab1 (c426); (C) Sos (c30); (D) PIP2 (c444). The model was fitted to the MCF-10A phosphorylation data. 
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The rate of degradation of active phosphorylated EGFR receptors is an important parameter 
controlling EGFR signaling (Sigismund et al., 2005). However, since the effects of EGFR receptors 
degradation are entangled with other dynamical processes of receptors trafficking, such as, for 
example, receptors recycling, it may be experimentally challenging to correctly establish the rate of 
receptors degradation. The obtained distribution (Figure 4.25) suggests that within a range of two 
orders of magnitudes of 10-5-10-3, the degradation rate constant most likely lies in the interval 10-3.5-
10-3 sec-1.  
         
Figure 4.24: Predicted distributions of the rate of EGFR phosphorylation 
Figure 4.25:  Predicted distribution of the rate of degradation of phosphorylated EGFR The predicted 
distribution of the rate of EGFR phosphorylation (kd123) although varies across four orders of 
magnitude, is concentrated around 10-1 sec-1 (Figure 4.24), which agrees with other estimates of the 
EGFR activation rate (Chen et al., 2009). 
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Figure 4.26: Predicted distributions of the rates of EGFR dimerization with EGFR and ErbB2: EGFR 
homodimerization (A) and undimerization (B), EGFR-ErbB2 dimerization (C) and undimerization (D). 
Our model can predict the distributions of rate constants of reactions of dimerization between different 
species of EGFR receptors (Figure 4.26). For example, in this run of an extended model, EGFR 
receptors are allowed to form homodimers with other EGFR or heterodimers with ErbB2 receptors. 
The corresponding rate constants of homodimerization (k2) and heterodimerization (k2b) are allowed 
to vary within one order of magnitude, and the relative shift in their ranges of values reflects a prior 
belief that EGFR can have varying affinities to different dimerization partners. The predicted 
parameter distributions suggest that the rate of undimerization of EGFR homodimers (kd2) is skewed 
towards lower possible allowed values, whereas, the rate of undimerizaiton of the heterodimers is 
skewed towards higher values, suggesting faster undimerization of the latter dimers and therefore 
their reduced stability relative to EGFR homodimers. Although such prediction can be challenging to 
verify experimentally, it might provide some understanding on how various assumptions about the 
biochemical properties of receptors, such as their dimerization preferences, can be encoded as the 
priors on the models parameters and whether such assumptions are supported by the underlying 
experimental data.  
The distributions for some parameters are predicted to be double-peaked, for example, k2 in 
Figure 4.26 A. It might suggest that there are two different modes in the multi-dimensional parameter 
space in which k2 is likely to be to fit the given experimental data; the correlation analysis between 
values of k2 and other parameters could possibly help to explain the double peaked distribution of k2. 
However, it is also plausible that the double-peaked distribution is a result of slow convergence of the 
MCMC chains in that parameter dimension, in which case, running longer MCMC chains in that 
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parameter could allow the chains to cross the barrier between the two regions of parameter space 
corresponding to each peak.  
Certain parameters are predicted to have flat distributions, suggesting that based on the fitted 
experimental data, the value of the parameter within a given prior range is not important to fit the 
given data. Several possible conclusions about such parameters could be made from their flat 
distributions. It may be the case that the imposed range of the prior probability is outside the region 
where the parameter can have an effect on model responses. For instance, the rate of internalization 
of inactive receptor (k6c) with very low imposed prior range of 10-8 to 10-7 is predicted to have a flat 
distribution in this range (Figure 4.27 A) and suggests this parameter has no significant effect on 
systems response to which the model is fitted. Such scenario is plausible, given that the experimental 
data we fit represent phosphorylation dynamics in response to EGF, a condition in which available 
EGFR receptors upon EGF ligand binding rapidly form dimers and get activated. Therefore, the rate 
of internalization of inactive receptor monomers, although could be important in determining system’s 
steady state in the absence of EGF, may not be relevant to fit the system phosphorylation responses 
to EGF treatment.  
To check if a parameter with a flat distribution is indeed not important in the model, one might 
rerun the simulations with a wider range of prior parameter values. Alternatively, one might choose to 
remove the process represented by this parameter from the model, thus simplifying and reducing the 
model, while not compromising its ability to fit the experimental data. 
For example, we find that the rate constants of EGF unbinding from EGFR monomer in the 
endosomes (kd10) has a relatively flat, thus, uninformative distribution across about three orders of 
magnitude, and hence, can be removed from the model (Figure 4.27 B). Biologically, it has been 
suggested that unlike other ligands, EGF does not dissociate from EGFR receptors in the 
endosomes, but is degraded with the receptors (Roepstorff et al., 2009), therefore, corroborating the 
fact that the process of EGF unbinding from monomers in the endosomes might not be relevant to 
fitting the phosphorylation data in this model. Similarly, we find that some rates of reactions 




aspects of interactions between receptors and adaptors could possibly be simplified in this model 
(Figure 4.27 C). 
         
 
Figure 4.27: Predicted distributions of various model parameters (A) rate constant of internalization of 
inactive receptors (k6c); (B) rate constant of EGF unbinding from EGFR monomers in endosomes (kd10); 
(C) rate constant of adaptors binding to phosphorylated EGFR (k25) 
Section 4.3.2: Identifying parameters sensitive to specific experimental 
condition 
 
In this section we describe examples of the application of our approach to study the 
relationship between parameter values and systems behaviors. In particular, by comparing parameter 
distributions obtained from fitting two different subsets of experimental data (one set being inclusive 
of the other set) we can identify parameters important to fitting specifically the experimental data 
different between the two subsets. For example, we can detect parameters responsible for 
phosphorylation signal decay by comparing the parameter distributions obtained from the fits to only 
early dynamics of the responses to fits to the entire time-courses, including early and late responses, 
which demonstrate the long-term signal decay. The constraints on the model responses imposed by 
additional experimental data should be reflected in the changes  in  model’s  parameter  space. 
In Section 4.2.1 we described the procedure of fitting the model to the phosphorylation time-
courses. In the analysis presented in this section, we first fit the model to the phosphorylation 
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signaling response of up to 30 minutes of stimulation with only high EGF, and plot the predicted 
distributions of pEGFR and pERK phosphorylation response at 1.5 hours of stimulation (Figure 4.28, 
experimental data shown in black).  
Model simulations show that fitting the model to early dynamics predicts a wide range of 
possible responses by 1.5 hours. This suggests that the fits with different parameters assignments 
can all equally well capture amplitude and dynamics of signaling responses at early times, but have 
different underlying rates of signal decay, and thus vary in their predictions of the 1.5 hour signaling 
responses. We find that although the obtained distributions predict a non-zero probability over the 
experimentally observed values of pEGFR (0.0182+/-0.016 A.U.) and pERK (0.273+/-0.017 A.U.) at 
1.5 hours, both distributions are predicting significantly higher average responses (Figure 4.28), 
suggesting that, according to the model, phosphorylation signal decay measured on pEGFR and 
pERK signals is not very likely based on the early dynamics of the responses. We then fit the model 
to the early phosphorylation responses and include the 1.5 hours responses as well. In this way, we 
impose that the signal on pEGFR and pERK decay by the 1.5 hours of stimulation with EGF(Figure 
34, Figure 4.32). We find that the model can fit signal decay dynamics observed in experimental data, 
and compared to the fits to only early dynamics (three points) predicts the distributions of 1.5 hours 





Figure 4.28: Predicted distributions of pERK and pEGFR responses in MCF-10A cells after 1.5 hours of 
stimulation with 100ng/ml EGF. The model was fitted to the experimental measurements of the 
corresponding responses in MCF-10A cells up to 30 minutes of simulation with 100ng/ml EGF. 
 
Figure 4.29: Predicted distribution of pEGFR response 1.5 hours after 100ng/ml EGF stimulation in model 
fit to the phosphorylation time-courses data measured in MCF10A cells. 








































Figure 4.30: Predicted distribution of pERK response 1.5 hours after 100ng/ml EGF stimulation in model 
fit to the phosphorylation time-courses data measured in MCF10A cells  
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Figure 4.31: Predicted average time-courses of pEGFR response obtained from the model fitted to the 





Figure 4.32: Predicted average time-courses of pERK response obtained from the model fitted to the 
early or to the entire phosphorylation responses in MCF10A cells. 
We then apply statistical methods described in Section 3.2.9 to compare parameter 
distributions and find parameters important to phosphorylation signal decay. We find that the top 
ranked parameters differing between fitting the two conditions (early responses only or the entire 
time-course) are mostly related to activity of phosphatases and internalization and degradation of 
EGFR receptors (Table 3, Table 4).  
  
Table 3: Top ranked parameters related to pEGFR signal decay at 1.5 hours of 
stimulation with 100ng/ml EGF in MCF-10A cells. 
 
parameter description sum of Kullback-
Leibler divergence 
scores 
k60 rate of degradation of EGFR -1.92 
kd123 rate of phosphorylation of EGFR -1.68 
c12 abundance of cPP protein (internalization 
of EGFR) 
-1.28 
c280 abundance of endosomal RTK 
phosphatase 
-1.25 
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Table 4: Top ranked parameters related to pERK signal decay at 1.5 hours of 
stimulation with 100ng/ml EGF in MCF-10A cells 
 
parameter description sum of Kullback-
Leibler divergence 
scores 
k56 rate of binding of ERK phosphatase -3.07 
kd55 kcat of ERK activation by pMEK -2.29 
kd57 kcat of ERK phosphatase -0.87 
c60 Abundance of ERK phosphatase -0.27 
  
 
  In addition to comparing parameter distributions by the Kullback-Leibler based metric, we compare 
the averages and the medians of the distributions of the same parameter in the two different 
conditions. We find that indeed, the Kullback-Leibler criterion may miss distinctions in distributions of 
some parameters known to be important to fitting phosphorylation signal decay on pEGFR. For 
example, kcat of endosomal RTK phosphatase was found to be not significantly different in the 
distributions by the Kullback-Leibler metric (kd95 sum of the Kullback Leibler scores =-0.52), however 
the differences in the medians suggested that this rate is by approximately one order of magnitude 
faster in the fits to the entire response dynamics which entails decay of the phosphorylation signal. 
Abundance of the endosomal RTK phosphatase is predicted to be approximately 1.5 order lower in 
the fits with phosphorylation signal decay (c280 sum of the Kullback Leibler scores =-1.25). Although 
endosomal phosphatase can remove phosphorylation signal, it can also prevent receptors from 
degradation, as phosphorylated receptors are usually degraded faster than the unphosphorylated 
ones. Therefore, the role of the activity of the endosomal RTK phosphoatase can be ambiguous in 
respect to phosphorylation signal decay. 
Since the rate constant of degradation of receptors was found to be important in 
accommodating phosphorylation signal decay, we considered system output variable which can serve 
to estimate the actual strength of degradation in the fit. Specifically, we consider predicted distribution 
of undegraded EGFR receptors at 1.5 hours of EGF stimulation (Figure 4.33). We assume that the 
number of receptors remaining undegraded in the long run after high EGF stimulation could reflect 
the rate of degradation of activated receptors – the higher it were, the more receptors would be 
degraded in the course of stimulation with EGF, thus less of the receptors remaining by 1.5 hours. 




with on average 90% of receptors remaining undegraded; however, in the fits with imposed 
phosphorylation signal decay, most receptors are predicted to be degraded by 1.5 hours, indeed, 
supporting the predicted importance of receptors degradation process in fitting signal decay. 
 
Figure 4.33: Predicted fraction of remaining, un-degraded EGFR receptors at 1.5 hours of stimulation 
with high dose EGF in MCF-10A cells. 
In general, it is a non-trivial undertaking to identify parameters responsible for a specific 
feature of experimental data, such as, phosphorylation signal decay, as it can be realized through an 
interplay of multiple mechanisms, namely, action of phosphatases, internalization, and degradation of 
receptors, as well as ligand depletion. Relative contributions of these processes to signal decay are 
not known and could be elucidated through studying the properties of parameter space of the model 
fitted to the experimental data. 
In the example presented here, we imposed signal decay on both pEGFR as well as pERK, 
and therefore, the detected parameters with significantly shifted distributions are relevant to fitting 
dynamics of both pEGFR and pERK together. However, if we were interested in identifying 
parameters responsible specifically for signal decay on either one the two targets, we could 
resimulate our model by including late response of only one target of interest, either pEGFR or pERK, 
and repeat the analysis. 
Section 4.3.3: Identifying correlations between parameters  
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The generated probabilistic parameter distributions can provide an insight about the overall 
structure of the model parameter space by suggesting possible correlations between individual 
parameters. Since the distributions of the model parameter values were derived based on the 
experimental data, by analyzing correlations between parameter values one could assess possible 
relationships between various physiological quantities and processes in the in vivo system in which 
the data was measured.  
For example, we consider the correlations between parameters relevant to ERK deactivation 
obtained from fitting the phosphorylation data including signal decay. We find significant negative 
correlation (Pearson correlation coefficient = -0.7882, p-value <10-3) between the concentration of 
ERK phosphatase (c60) and the kcat of its phosphatase (kd57). Such relationship can arise from the 
fact that in order to fit pERK signal decay, both e abundance and the rate of activity of the ERK 
phosphatase can be important, and possibly mutually compensatory. In addition, such information, 
could serve as a validation for our model by confirming various expected relationships between the 
model’s parameters. Lastly, the correlation coefficient between the two pairs of parameters can be 
useful in quantifying the degree of relatedness between the parameters and determine if the 
parameters are significantly or only marginally related, and in what way – positive or negative. 
 
Figure 4.34: Negative correlation between abundance and the rate of activity of ERK phosphatase. 
Individual points represent coordinates of the sampled by MCMC chains in the space of the two 
parameters., ERK phosphatase abundance and its rate of activity. 
 











Section 4.4: Long term responses: perfect adaptation 
Section 4.4.1: Predicted distributions of long term phosphorylation responses 
 
We fit our model to phosphorylation and total EGFR time-courses measured experimentally at several 
time-points within three hours of stimulation with constant doses of EGF (described previously in 
Section 4.2.1). We then predict time-courses of system responses over six hours of continued 
stimulation with EGF (Figure 4.35) and explore possibility of perfect adaptation in phosphorylation 
signals in our system (see Section 2.9 for background on perfect adaptation). To reiterate, perfect (or 
exact) adaptation is a condition in which signal responses at steady state are independent of the 
constant level of stimulus applied and are approximately same as the pre-stimulus level of signal in 
the system. Based on the experimental data of pEGFR, 6 hour time point might be a good 
approximation for system steady state behavior, as most of the pEGFR signaling appears to decay 
sufficiently several hours prior to that time. By analyzing dependence of steady state levels of pEGFR 
signals on the EGF dose applied we want to investigate if it is independent of the EGF doses (thus, 
implying perfect adaptation, by definition), and how this property might be transduced to the level of 
pERK. 
 
Figure 4.35: A fit to the three hour time-course experimental data predicts 6 hour response.Experimental 
data is shown in bold. 
Since we fit our model only to several experimental time points measured between 0 and 3 
hours of EGF stimulation, the predicted fits (individual time-courses of signaling responses of each 







































target at a given dose of EGF) can vary in their overall dynamics, while being similar at the points 
being fitted. For example, the predicted phosphorylation fits to high EGF can vary in times when their 
responses reach the peaks, or speed of the signal decay and behavior at 6 hours of stimulation. 
We obtain a set of probabilistic distributions of phosphorylation responses at six hours of 
constant stimulation with each of the applied EGF doses (Figure 4.36, Figure 4.37). 
 
Figure 4.36: Predicted distribution of pEGFR responses after 6 hours of EGF stimulation. 
 
 
Figure 4.37: Predicted distribution of pERK responses after 6 hours of EGF stimulation. 
The predicted distributions on both, pEGFR and pERK, are monotonically dependent on the 
EGF dose of stimulation, with higher EGF doses applied leading to higher phosphorylation remaining 
by 6 hours of treatment. Then, if such monotonicity is preserved for a given fit, one might expect that 
if phosphorylation response at highest EGF has dropped below certain threshold value, then, most 
likely responses at lower doses are also below that value. We then investigate EGF dose-dependent 




















































dynamics of signal between 3 and 6 hours of stimulation: do signals further decay between 3 and 6 
hours, or are they at steady state by 3 hours, and thus do not change between 3 and 6 hours. For 
this, we examine predicted distributions of phosphorylation signals at earlier time (3 hour) and check 
if the later time (6 hour) distributions have shifted to lower phosphorylation levels. The data shows 
that at EGF up to 20 ng/ml EGF, the distributions shift to lower levels by 6 hours, whereas, at 
100ng/ml the distribution remains similar between 3 and 6 hours (Figure 4.38, Figure 4.39), therefore, 
suggesting that at higher EGF doses signal appears to reach steady state between 3 and 6 hours, 
whereas at lower EGF doses the signal continues to decay. 
 
Figure 4.38: Comparing predicted distributions of pEGFR responses after 3 and 6 hours of EGF 
stimulation. 
 
Figure 4.39: Comparing predicted distributions of pERK responses after 3 and at 6 hours of EGF 
stimulation. 




































































To quantify degree of signal decay across many fits, we consider ratio of 6 hour response at 
high EGF (100ng/ml) to the peak of the high EGF response in the fitted experimental data (in this 
data set Max(pERK)=351+/-32 A.U., Max(pEGFR)=124+/-2 A.U.). Assuming the monotonic 
dependence of phosphorylation signals at 6 hours on the EGF doses, a low ratio of 6 hour response 
at high EGF to the signal peak would suggest that at most EGF doses signal returns close to its pre-
stimulus level. The distributions show that by 6 hours of stimulation with highest dose of EGF, pEGFR 
responses on average have decayed down to 5% of pEGFR maximum, and for pERK the responses, 
on average, have decayed down to 20% of the pERK maximum (Figure 4.40). Therefore, pEGFR 
responses return closer to pre-stimulus level then do the pERK responses; such effect might be 
explained by MAPK cascade signal amplification from pEGFR to pERK. The experimental data shows 
that at various EGF doses most pEGFR signals adapt within the first three hours, and this is captured 
in our model predictions; pERK and pAKT adapt slower than pEGFR does, approaching closer to pre-
stimulus levels only by 6 hours of stimulation.  
 
Figure 4.40: Predicted distribution of the ratio of the pERK 6 hour response to the pERK signal peak. 
We then consider the subpopulation of fits in which pERK signal has a more pronounced 
decay down to 5% of the pERK maximum, which is predicted to happen in approximately 1.63% of all 
fits (Figure 4.40). Plotting average time-course of pERK responses of all predicted fits compared to 
the average of the subpopulation with 5% signal decay, shows that in the subpopulation with stronger 
signal decay, independently of the dose of EGF applied, most signals return to pre-stimulus level by 6 
hours (Figure 4.41). 






















Figure 4.41: Average time-courses of pERK from the overall distribution of fits and the subpopulation of 
fits with a stronger signal decay by 6 hours of EGF stimulation. 
We then plot average dose responses around signal peak (15minutes) as well as at long run (3 and 6 
hours) of the two populations of fits (Figure 4.42). We find that the average dose responses at the 
peak signal agree in the two populations, and that the 3 and 6 hours dose response for both 
populations look significantly flatter than the original peak dose response, suggesting that at long 
term the responses do not show such noticeable dependence on the EGF doses, at least compared 
to dependence observed in the peak responses. Moreover, the average dose response in the 
subpopulation of fits with 5% degree of signal decay appears flatter than the average response of the 
overall distribution and have a more clearer trend for signal decay between 3 and 6 hours across all 
EGF doses. Hence, we conclude that the 5% signal decay fits have adaptation appearing more 
similar to perfect adaptation with signal response at steady state being independent of the constant 
level of stimulus applied and being similar to the pre-stimulus level of signal in the system. 



































Figure 4.42: Average dose responses of the overall population of fits and the subpopulation of fits with 
perfect adaptation in pERK signal (<5% decay from the signal peak). 
To find parameters affecting adaptation on pERK, we investigate shifts in parameter 
distributions between the two populations of fits by comparing averages of the parameter distributions 
from populations of all fits versus from population of the fits with the 5% signal decay. We find that the 
fits where pERK adapts better are predicted to have less EGFR receptors, with slower rate of EGFR 
production and higher rate of degradation of active receptors, and slower rate of activation of pERK 
by pEGFR, faster rate of dephosphorylation of ERK. This result suggests that for pERK signal 
adaptation, not only parameters directly regulating pERK activity are relevant, but also, parameters 
determining long-run equilibrium of number of EGFR receptors are important. In addition, rate of EGF 
binding to dimers and receptors dimerization rate are found to be different in the two subpopulations, 
suggesting that other processes, at the ligand-receptor interaction can also affect pERK long-term 
dynamics. The nature of the processes which have shifted thus points to the importance of pEGFR 
steady state levels to perfect adaptation on pERK, suggesting that a better perfect adaptation on 
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Table 5 : Parameters with most difference in the means of their predicted distributions in fits with 
stronger pEGFR adaptation (<5% from the signal peak). 
Rank parameter 




mean of subset of 
fits with pERK decay 
at 6 hours below 5% 






    'k31' (EGF binding to 
EGFR dimers) -8.91 -7.12 -1.79 
2 
    'kd2' (undimerization of 
receptors) 0.17 -1.62 1.79 
3     'k2' -4.85 -5.90 1.06 
4     'k77'(EGFR production) 0.51 -0.45 0.96 
5 
    'k50' (pEGFR activates 
ERK) -4.86 -3.92 -0.94 
6     'kd91' -3.98 -3.13 -0.85 
7 
    'k60' (rate of pEGFR 
degradation) -3.10 -2.38 -0.72 
8     'c8' 4.32 3.61 0.71 
9     'c531' (EGFR abundance) 4.72 4.25 0.48 
 
The predicted distributions of pERK response suggest that although the predicted time-
courses are similar at early signaling dynamics to which they are fitted to, they vary in their predicted 
response dynamics in the long run. As a metric of degree of adaptation in different fits we use a ratio 
of signal response at 6 hours to the peak of that responses across all doses in that fit. Since all 
predicted time-courses are fitted to the same experimental data point including the peak of 
experimentally measured responses, using such statistic provides allows comparison of property of 
perfect adaptation across different fits. In general, property of perfect adaptation implies two aspects: 
first, at steady state the responses of signal should be similar, and independent of the dose of 
stimulus applied, and second, the steady state responses should be similar to the pre-stimulus levels. 
We have previously observed an overall monotonicity in relationship of steady state signal responses 
and EGF doses. Therefore, the ratio of high EGF response at 6 hours to the peak of the response at 
high EGF is an upper bound on the steady state signal across multiple doses and it can suggest if the 
system has returned close to the pre-stimulus level: lower this ratio, means lower most responses 




To investigate perfect adaptation by degree of independence of the long-term responses of 
EGF doses, we consider flatness of the dose response at 6 hours. We quantify the flatness by taking 
a coefficient of variation (CV) in the 6 hours responses in each fit. Such metric allows to account for 
possibly non-monotonicity in some regions along dose responses, as well as for the fact that different 
fits in long run can adapt to different signal levels. For example, Figure 4.43 and Figure 4.44 show 
two fits with different degrees of adaptation; fits with flatter dose response curve at 6 hours would 
have lower coefficient of variation metric. We then plot the distribution of the CV metric across all fits 
(Figure 4.45) and observe that most of the fits are predicted to adapt imperfectly, with CV on average 
being 0.7, however, some non-zero probability over very low CV values (0.04) suggests existence of 
fits with a more perfect adaptation, similar to example shown in Figure 4.44. 
 
Figure 4.43: Example of a fit without perfect adaptation in pERK responses. 



























Figure 4.44: Example of a fit with perfect adaptation in pERK responses. 
 
Figure 4.45: Predicted distribution of perfect adaptation on pERK across model fits. 
We then look at correlation of the CV perfect adaptation metric and model parameters, thus 
trying to identify what parameters can affect flatness of the long-term dose response on pERK. We 
find that higher the ERK abundance, flatter the pERK dose response (Pearson correlation coefficient 
= -0.67, p-value <10-4); whereas, faster ERK activation by pEGFR is correlated with steeper dose 
response on pERK (Pearson correlation coefficient = 0.41, p-value <10-4). Interestingly, the 
parameters relevant to maintenance of steady state levels of EGFR were found to be correlated with 
flatness of pERK dose response. In particular, significant correlation between flatness of pERK dose 
response and rate of receptors production (Pearson correlation coefficient = -0.46, p-value <10-4), 
basal receptors internalization (Pearson correlation coefficient = 0.42, p-value <10-4) and basal 










































receptors degradation (Pearson correlation coefficient = 0.38, p-value <10-4) suggest that faster 
receptors production and their slower turnover at steady state would produce flatter pERK dose 
responses, more similar to EGF dose-independent adaptation.  
We found significant correlation between flatness of predicted dose responses on pEGFR at 
6 hours and that of pERK (Pearson correlation coefficient=0.9, p-value < 10-3), suggesting that most 
likely perfect adaptation on pERK is contingent on perfect adaptation on pEGFR. However, perfect 
adaptation on pEGFR barely passing a defined threshold of signal decay, for example, 5% of 
maximum signal peak, due to signal amplification in the kinase cascade, could result in no observed 
perfect adaptation on the downstream pERK. 
Due to limitations of our resolution of our experimental assay, small differences in pEGFR 
usually might not be experimentally distinguishable, and thus appear similar in assay readouts. 
However, differences even in hundreds of activated pEGFR molecules through amplification in kinase 
cascade can produce significantly different responses at pERK. Hence, pEGFR responses at long 
run, even though experimentally appearing perfectly adapted, might differ and be amplified at pERK, 
and thus pERK might exceed its threshold of perfect adaptation.  
Overall, the experimental data of long-term phosphorylation measurements of pEGFR and 
pAKT due to experimental errors does not allow to determine if the signals have adapted perfectly 
within 3 hours of constant EGF stimulation. The measurement error at 3 hours is on average 9 A.U. 
on pEGFR and 20 A.U. on pERK, and thus it is not feasible to distinguish how dissimilar are the 
responses at the 3 hours. As the distributions we predict rely on the fits to experimental data, given 
the magnitude of experimental error we cannot conclude if the difference between the averages of the 
predicted 6 hours distributions (Figure 4.36, Figure 4.37) is not significant to claim or refute perfect 
adaptation.  
However, our model can help estimate degree of predicted adaptation and its various 
features, such as steady state levels of responses or EGF-independence of steady state values 
across EGF doses. In addition, our approach can help identify parameters and processes which can 




perfect adaptation, and in Section 4.7.1 we present analytical derivation of mechanisms of 
propagation of perfect adaptation from receptors to downstream signaling targets. 
Section 4.4.2: On experimental validation of perfect adaptation  
 
To experimentally validate the predicted perfect adaptation in ErbB signaling system, pEGFR, 
pERK and pAKT dynamic responses can be measured for several hours of stimulation with constant 
EGF signal. By comparing flatness of the long-term dose responses of each individual target we can 
then assess degree of perfect adaptation. 
Experimental data, namely, phosphorylation time-courses up to three hours of EGF, suggest 
that in response to prolonged stimulations with constant EGF doses, pEGFR returns to its pre-
stimulus level independently of the EGF dose by 1.5 hours of stimulation. Experimental validations 
also show that within the given experimental error in measurements, pEGFR appears to adapt 
perfectly across entire range of EGF doses we tested and that pAKT also is most likely adapting 
perfectly across this range of EGF doses, yet at slower rates. However, by three hours of EGF 
treatment pERK is observed to be adapted only within a 20% of its peak value and appears to 
stabilize at higher than the initial pre-stimulus steady state levels and the model suggests that pERK 
signal at high EGF is not likely to decay further beyond 3 hours. 
Since pERK responses might take longer time to decay due to signal amplification in the 
kinase cascade, the experiments should consider monitoring pERK dose responses at longer times 
even after pEGFR perfect adaptation is detected. In practice, however, it might be infeasible to 
monitor pERK dose responses over extended hours, and hence, a trend suggesting a decreasing 
over time dose responses in pERK should be sufficient to indicate perfect adaptation on pERK. For 
example, pEGFR, pERK, pAKT can be measured within 6 hours of persistent EGF stimulation; even 
though pEGFR is observed to decay perfectly already by 1.5 hours. Interestingly, this observation 
also points out a feature that effect of EGF in a cell can be prolonged through extended duration of 
pERK and pAKT signaling, the downstream targets of pEGFR, even if pEGFR signal duration is 
shorter. 
In the experiments measuring perfect adaptation, it is important to separate cell signaling 




dynamic profile of the stimulus and contribute to signaling responses adaptation. Hence, one needs 
to maintain constant level of stimulus in order to establish existence of machinery for perfect 
adaptation in a signaling system. It is conceivable that at low absolute levels of ligand, signal 
responses to different ligand doses over time might return to pre-stimulus level due to complete 
ligand depleted from the media, independently of the initial dose of the applied ligand. Such scenario 
does not technically correspond to the definition of perfect adaptation, which entails stimulation with 
constant dose of ligand over time. Hence, stimulus should be kept constant to decouple stimulus 
dynamics from response dynamics and thus to better understand specifically functioning of cell 
machinery itself. Interestingly, the importance of separating stimulus dynamics from responses 
dynamics has also been brought up in recent work in olfactory receptors sensory system in 
drosophila (Martelli et al., 2013). 
It will be interesting to explore what molecular factors in signaling cascades are responsible 
for buffering the upstream pEGFR signal and so able to preserve or distort the property of perfect 
adaptation on pERK. For example, among other factors, scaffolding proteins in the signaling cascade 
between pEGFR and pERK might alter the signaling response dynamics (Levchenko et al., 2000) and 
thus influence perfect adaptation. Two-step phosphorylation required for pERK activation might also 
contribute to distorting perfect adaptation between pEGFR and pERK. In addition, the distinction 
between pERK and pAKT perfect adaptation properties might be due to differences in signaling 
cascade components leading to either pERK  to pAKT activation, for instance, pERK is activated 
through the ultrasensitive Raf-MAPK kinase cascade module, whereas pAKT is activated through a 
series of activating reactions involving PIP3 and PI3K. Applying varying inhibitor perturbations and 
measuring long term responses of the target should help elucidate signaling cascade mechanisms 
important for realizing perfect adaptation downstream of receptors level. 
Overall, various biological functions can impose different evolutionary constraints on signaling 
through pEGFR, pERK, and pAKT can thus can lead to the observed distinct rates of perfect 
adaptation of these targets. For example, we observe that pEGFR signal adapts faster than its 
downstream targets, pERK and pAKT.  It might be advantageous for cells to have a more rapid 




signals propagated to the multiple downstream phosphorylation targets. Such scenario might be in 
line with the role of ErbB receptors in cell signaling - to detect extracellular stimulus and transmit the 
signal into the cell, leaving regulation of downstream targets up to other components of cell signaling. 
Recently, a question has been raised if perfect adaptation in cell signaling responses is an 
intrinsic feature of individual single cells, or if it is an emerging property of cell populations (Marquez-
Lago & Leier, 2011). Generally, differences in regulation of signal decay across individual cells can 
arise from single cell variability in gene expression, and thus, might be manifested in different timings 
of signal adaptation. However, our model predicts that signals perfectly adapt with high probability 
within several hours of stimulation, and hence, adaptation might be an essential feature of the ErbB 
signaling. A recent theoretical work has suggested that perfect adaptation is an emerging property of 
cell populations, and that individual cells do not necessarily adapt their signals perfectly (Marquez-
Lago & Leier, 2011). In case we fit our model using population averages data, we find that, in 
agreement with the above-mentioned study, ensemble signaling behavior exhibits perfect adaptation. 
However, contrary to the mentioned study claim, our simulations predict that even though the 
distribution would predict a range of single cell behaviors including ones with saturation, and no 
perfect adaptation, cases where individual cell responses exhibit perfect adaptation are also predicted 
to exist.  
Section 4.4.3: Model simulations suggest that phospho-ERK adapts perfectly 
to constant stimulation with EGF, but not constant levels of pEGFR 
 
We set out to answer if the mechanism of pERK adaptation to EGF is contingent on pEGFR 
adaptation to EGF, or if it can be realized by the downstream signaling components independently of 
perfect adaptation on pEGFR.  
To test this hypothesis, we fit the model to the three hour phosphorylation and total EGFR 
time-courses  and  simulate  system’s  responses  on  pERK  if  pEGFR  is  sustained,  and  not  decaying,  in  
response to stimulation with constant dose of EGF (Figure 4.46). Such pEGFR response dynamics is 
biologically possible in case the ErbB receptors contain an over-activating mutation. We then plot the 
distribution of predicted ratios of pERK response at 6 hours to the peak of that response, a statistic to 




pERK responses do not decay and also remain constant at the levels, dependent on steady state 
pEGFR levels. Hence, the downstream of pEGFR part of a signaling cascade leading to pERK 
activation is not likely have its own mechanism of perfect adaptation and relies on perfect adaptation 
realized on ErbB receptors. 
 
Figure 4.46: Model simulation of pERK responses in fits with and without perfect adaptation on 
pEGFR.Shown are the simulated pERK responses to stimulation with low (blue) and high (red) dose of 
EGF. pERK responses shown in dashed line are obtained by keeping pEGFR stimulation constant over 
time. 
Recent experimental work on optogenetic stimulation of the isolated Ras/ERK module 
suggests that most likely the signaling cascade components which attenuate pERK responses are 
outside of the Ras/ERK pathways (Toettcher et al., 2013). This observation is consistent with our 
hypothesis that downstream signaling cascade does not possess its own mechanism of perfect 
adaptation, and that pEGFR signaling downregulation is a key factor enabling perfect adaptation on 
pERK. 
As a next step it might be interesting to investigate what molecular mechanisms downstream 
of the receptors level can realize perfect adaptation on pERK. For example, can a negative feedback 
loop (NFL) from pERK to an upstream signaling cascade component help to implement perfect 
adaptation mechanism on pERK in response to sustained stimulations at pEGFR? Experimental 
evidence suggests that pERK can phosphorylate and inhibit activity of some of the upstream 
signaling cascade components, such as Sos, and Raf (Chen et al., 1996; Sturm et al., 2010), 
therefore existence of pERK negative feedback loop is a biologically realistic scenario. 
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Interestingly, the overall effect of a NFL on pERK perfect adaptation can be parameter-
depend. For instance, the time of recovery of the NFL target from the inhibition by the NFL can be 
important in realizing perfect adaptation at pERK in the long run. In particular, reversing the effects of 
the negative feedback loop can be relatively fast, if it relies on, for example, dephosphorylation, or 
other post-translational modifications of comparatively short-time scale. In general, rapidly reversible 
protein phosphorylation might not be able to maintain cell memory of previous stimuli. As such, NFL 
acting through inhibiting phosphorylation might not be able to decay pERK signaling in response to 
sustained pEGFR stimulation: in the long run, an equilibrium between steady state levels of pEGFR 
and pERK activation can be established, with sustained activation of pEGFR leading to sustained 
activation of pERK, and the NFL mostly determining the balance between pEGFR and pERK, and not 
realizing the pERK decay. Yet, if recovery of the effects of NFL on its target is slow, the NFL can 
actually insure perfect adaptation on pERK to sustained stimulation on pEGFR. Such scenario might 
occur if the NFL acts through, for example, degradation of its target, and thus recovery of the NFL 
effects requires de novo synthesis of the target. Interestingly, the latter case pERK signaling 
component might be desensitized to changes in the pEGFR signaling until the activity of the NFL 
target is restored. 
Section 4.4.4: Predicted distribution of the number of remaining EGFR 
receptors in the long run of EGF treatment  
 
As described in Section 4.2, we fit our model to time-courses of fractions of initial EGFR 
abundances in response to stimulation with different doses of EGF. Although, an average total 
number of EGFR expressed by cells can vary from day to day due to variations in cell handling, we 
cannot experimentally measure exact number of EGFR present in the cells on every day we collect 
the data. However, we have experimental estimate a range of EGFR abundances in our cells taken 
on one day. Therefore, in our model simulations we do not fix the initial number of EGFR, but impose 
a constraint on a possible range of its values using our experimental estimates and, in addition, 
expanding the range to allow initial levels of tEGFR to vary within approximately 1.5 orders of 




As a result, by fitting the model to the data we obtain a probabilistic distribution of initial 
number of EGFR in the MCF-10A cells, with mean of 198,000 receptors (Figure 4.47). We can also 
predict what absolute amount of receptors would be present in the system after several hours of 
stimulation with a given dose of EGF. However, given flexibility in initial abundances of tEGFR in the 
fits, it might be more informative to predict fraction of initial number of EGFR remains in the cells after 
several hours of stimulation with various constant doses of EGF.  
 
Figure 4.47: Predicted distribution of the initial abundances of EGFR. 
For each fit we can then obtain a dose response of tEGFR after 3 hours of stimulation with a 
range of EGF doses, and plot predicted distribution of the dose response across different fits. The 
predicted dose response of total EGFR remaining after three hours of constant EGF stimulation 
shows negative correlation with EGF dose (Figure 4.48). This result agrees with our experimental 
measurements.  





















Figure 4.48: Predicted dose response of the fraction of EGFR remaining in the cell after 3 hours of 
stimulation with EGF. 
 
Figure 4.49: Predicted distribution of the EGFR abundance remaining at 3 hours of stimulation with EGF 
































































   0
0.16
 0.8







Figure 4.50: Predicted distribution of the fraction of EGFR receptors localized to the cell surface by three 
hours of stimulation with EGF. 
 
Figure 4.51: Predicted distributions of the number of EGFR receptors remaining after three hours of 
stimulation with high or low EGF doses. 
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Along with the total number of remaining receptors, we can predict various attributes of the 
remaining receptors population and quantify relative abundances of various types of receptors in 
each fit. For example, we can predict cellular localization of the receptors, specifically, how many of 
them are on the surface versus in cell interior in response to stimulation with various doses of EGF at 
extended times. We find that after stimulation with high EGF doses, most of the receptors are 
removed from the cell surface, although, on average, about 70% of remaining receptors remain on 
the surface, possibly as a result of a dynamic equilibrium by which residual receptors are being 
activated by the ligand, yet the activation is low enough to trigger receptors removal from the cell 
surface. Whereas, stimulations with various lower doses of EGF show that higher fraction of 
receptors remains on the surface (Figure 4.50). The threshold of EGF doses at which most of 
receptors are internalized occurs approximately between 0.8 - 4 ng/ml EGF, an estimate which 
agrees with previously reported observation that EGFR internalization is being threshold-controlled 
around that range of EGF doses (Sigismund et al., 2013). 
In addition, our model allows to predict relative distribution of remaining receptors among 
different species, and so can answer, for example, what fraction of receptors in the long run is in 
monomers or in dimers, or how many receptors are phosphorylated, and how these fractions change 
depending on ligand dose or time of observation. Such results could be applied to drug design 
methods, as the insight on state of the cell surface receptors and EGF-occupancy in condition of 
chronic EGF presence could inform choice of EGFR inhibitors with various kinetic properties. Overall, 
abundance and state of receptors in the cells prior to ligand stimulation could be important as they 
can determine cell signaling responses to EGF (Macdonald & Pike, 2008). 
Section 4.5: EGF depletion, Cell density, and EGFR expression 
Section 4.5.1: Model predicts significant depletion of EGF from the media at 
low EGF doses and suggests alternative cell density to prevent EGF depletion  
 
Ligand depletion can play an important role in cell signaling. For example, Epo receptors can 
sense a wide range of Epo doses due to their ability to internalize Epo ligand effectively from cell 
media; in addition, Epo depletion contributes to EpoR signaling attenuation (Becker et al., 2010). 




conditions of limited EGF, the extent of EGF depletion can depend on the absolute amount, and not 
the concentration, of EGF in the media; hence, the total volume of the media per cell can influence 
depletion in cell culture conditions (van de Poll et al., 2005). In turn, the total volume of the media per 
cell is determined by the total number of cells incubated in the well, or the cell density. Given that in 
our experimental setup we studied signaling responses to persistent EGF stimulations over extended 
times, we needed to establish if in our system EGF depletion presented a concern at lower EGF 
doses.  
First, we fitted our model (see Section 4.2.1) to the phosphorylation and the total EGFR data 
obtained from wells containing on average 15000 cells. The model predicted that three hours after the 
addition of the lowest EGF dose (0.01 ng/ml EGF), as much as 70% of initial EGF can get depleted in 
certain fits (Figure 4.52). 
 
Figure 4.52: Predicted EGF depletion: time-courses of the fraction of initial EGF remaining in the media 
in a model fit. 
We then validated this prediction experimentally with ELISA assays (Weemen & Schuurs, 
1971). Specifically, we measured the change in EGF abundance in the media in which cells had been 
incubated with EGF for three hours. The EGF depletion was measured for four different doses of 
EGF. We found that in wells where ~15000 cells were plated initially, by the end of three hours of 
EGF stimulation as much as 48% of the initial EGF can be depleted (Figure 4.53). 






































   
Figure 4.53: Depletion of EGF ligand measured experimentally with ELISA assays. Cells were plated at 
15000 cells per well, and EGF depletion was measured three hours after incubation with a given EGF 
dose. Reported are the ratios of the amounts of EGF remaining after three hours to the initial amount of 
EGF. 
We then used our model simulations to identify the range of cell densities which would 
prevent significant EGF depletion from the media. For this, we fitted our model to the phosphorylation 
and the total EGFR data as previously described, however, we also imposed a constraint that at low 
EGF doses no more than 10% of the initial EGF could be depleted after three hours of stimulation. In 
addition, we simulated the number of cells per well as a parameter in our model. Essentially, cell 
density parameter determines the absolute amount of EGF molecules that each individual cell is 
exposed to at a given EGF treatment. 
Model simulations predicted that to prevent EGF depletion, each well should contain on 
average approximately 7,000 cells (median ~ 4,900) and no more than approximately 8,000 cells 
(Figure 4.54). We then adjusted our experimental protocol and decreased the amount of cells seeded 
in each well from ~ 10,000 to ~ 5,000. As controls, in parallel, we also seeded plates with ~10,000 
and ~15,000 cells per well. We then reran all our main experiments at the ~ 5,000 cell density 
suggested by our model. Indeed, we found that the decreased cell density allowed to prevent 





























Figure 4.54: Predicted distribution of the number of thousands of cells per well with limited (<10%) EGF 
depletion by three hours of cell incubation with low dose EGF.Section 4.5.2: Cell density in 
culture affects cell signaling responses 
 
We then wondered if the cell density could influence cell signaling responses to EGF, and if 
so, through which exactly mechanisms? How does cell-density dependent EGF depletion affect EGF 
signaling, if at all?  
Cell-density dependent effects on signaling have been previously reported in cultured cell 
lines with EGFR signaling (Aoki et al., 2013). In a recent work, cells were seeded into the wells at 
various cell-densities ranging across three orders of magnitude and incubated with standard media 
for several hours (Aoki et al., 2013). The authors then investigated the relationship between cell 
density, cell proliferation rate and ERK activity. The proliferation rate was found to be most correlated 
with the ERK activity. The ERK activity was diminished at the lower cell densities and was the highest 
at the medium cell densities. In addition, the basal ERK phosphorylation was shown to be dependent 
on the cell density through the EGFR activation. 
We investigated if in our experimental system cell density could affect cell signaling 
responses to EGF. Specifically, we hypothesized that the cells incubated at distinct cell densities prior 
to EGF addition could produce varying signaling responses to EGF. To test our hypothesis 
experimentally, we measured the phosphorylation and the total EGFR responses to the EGF 




















treatments in the cells plated at three different cell densities, namely, 5000, 10000 and 15000 cells 
per well. All three experiments were conducted on the same day to limit possible biological variations 
in the cells.  
First, we looked at the dose responses of pEGFR, pERK, and pAKT 10 minutes after EGF 
addition in the cell populations incubated at the three different densities (Figure 4.55, Figure 4.56). In 
MCF-10A cells, some dose responses in the cells seeded at higher densities were to some extent 
shifted to the left (pERK), suggesting a higher sensitivity to the low EGF doses. In SKBR3 cells 
(Figure 4.56), the 10-minute dose responses at higher cell densities in addition had higher amplitudes 
of the responses. We also considered the time courses of the phosphorylation signals at various EGF 
doses and found that in the long run, the response dynamics appear similar at all three cell densities. 
Thus, our experiments suggested, that the cell density might affect not only the cell sensitivity to EGF, 
but also the amplitudes of the cell responses. This observation emphasizes the importance of 
maintaining similar cell densities in the experiments measuring EGFR signaling across repeats 
performed on different days, in order to increase the chances of observing a more consistent and 





Figure 4.55: MCF-10A cells: show cell-density dependent variation in dose responses. MCF-10A cells 
were incubated at5,000,10,000 or 20,000 cells per well. On the X axis is shown the dose of EGF in each 



































Figure 4.56: SKBR3 cells: show cell-density dependent variation in dose responses. SKBR3 cells were 
incubated at5,000,10,000 or 20,000 cells per well. On the X axis is shown the dose of EGF in each 
treatment. On the Y axis are shown the responses measured at 10 minutes after EGF addition. 
We then fitted our model to the phosphorylation and the total EGFR data obtained from the 
experiments at ~10,000 cell density (as described in Section 4.5.1) and used the model predictions to 
uncover the differences in the parameters values of the fits predicted to have dissimilar rates of EGF 
depletion.  
We compared the distributions of parameter values between the subset of fits predicted to 
have no significant EGF depletion (<10%) to the subset of fits predicted to have significant EGF 
depletion (>30%). We found that the EGFR abundance was among the top parameters most different 

































cell density: the higher the number of the cells in wells, more EGF receptors the cells are predicted to 
express (Figure 4.57).  
 
Figure 4.57: Predicted distributions of the number of cells per well and the number of EGFR per cell in 
subpopulations with or without significant EGF depletion by three hours of EGF treatment. 
To validate the predicted relationship between the EGFR expression and the cell density, we 
analyzed the raw measurements of the total EGFR abundances at time=0 and no EGF addition 
collected from the cells incubated at different cell densities: 5,000, 10,000 or 15,000 cells per cell. 
Since all the measurements were conducted on the same day, fluorescence scaling and background 
offset were identical in all three conditions, and thus, we could directly compare the tEGFR readouts 
from these three conditions. We found that, indeed, at higher cell densities tEGFR appears to be 
higher (Figure 4.58). Hence, the differences in cell-density dependent responses to EGF could be 
partially explained by the different levels of EGFR expressed in the cells cultured at different cell 
densities. The importance of the levels of EGFR expression in cell signaling responses has been 
previously explored in literature and is reviewed in Section 2.6 of this thesis. 
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Figure 4.58: Experimental measurements of the total EGFR abundance at 10 minutes of EGF stimulation 
in cells plated at various cell densities: 5,000 (red), 10,000(green) or 20,000 (blue) cells per well. On the X 
axis are the EGF doses (ng/ml, log10). Figure on the left shows measurements for MCF-10A cells, figure 
on the right shows measurements for SKBR3 cells. 
Section 4.5.3: The role of EGF depletion in the cell signaling through EGFR 
 
Overall, the EGF depletion might have different effects on cell physiology, depending on the 
cellular context. For example, EGF depletion has been suggested to decrease the effects of the 
EGFR-mediated mitogenic responses (van de Poll et al., 2005). Moreover, studies indicate that it is 
the proportion of ligand to receptor, rather than just receptor abundance, that might influence 
mitogenic responses (van de Poll et al., 2005). Interestingly, in the cells expressing high levels of 
EGFR, such as A431 cells, EGF depletion has been shown to be relevant during the mitogenic 
stimulation, but not during the growth inhibition of these cells (van de Poll et al., 2005).  
In this section we present a mechanistic explanation behind the observed positive correlation 
between the cell density and the EGFR abundance. Our results suggest that at limiting EGF 
concentrations, EGF depletion occurring in the course of cell pre-incubation can affect the EGFR 
expression in a cell-density dependent manner. Prior to the EGF treatment the cells are being 
incubated in a standard starvation media which might contain trace amounts of EGF. The cell density 
effectively determines the absolute number of EGF molecules each cell is exposed to given a certain 
level of EGF in the media. Given the same initial abundance of receptors, a higher number of cells in 
a well would imply a lower number of EGF molecules per cell. Hence, the residual EGF in the 
incubation media of plated cell cultures, over time, can be completely depleted by the cells, if the 
number of cells is sufficiently high. Eventually, ligand depletion from cell media would allow the cells 
to recover and accumulate recycled or de novo synthesized receptors on the cell surface, over time, 
leading to the higher receptors abundances. 













However, if the number of cells in the well is low, the amount of EGF per cell might be 
sufficiently high thus avoiding sufficient ligand depletion. In such case, the EGF presence in the 
media could lead to receptor phosphorylation, followed by their internalization. Therefore, given the 
EGF levels in the media are maintained constant, the receptors will be continually activated and 
internalized. Unless EGF is removed from the media, EGFR abundance on the cell surface would not 
be able to recover. Hence, the cells incubated at low cell densities in the media with traces of EGF 
would maintain low levels of EGFR expression. 
We then ask if ligand depletion is important to immediate-early phosphorylation responses to 
EGF. The model predicts that independently of the cell density, by 10 minutes of stimulation across 
all EGF doses, ligand is not significantly depleted (only in 0.04% of the fits ligand depletion exceeds 
5%). In our model EGF is depleted through a rapid endocytosis of ligand-bound receptors, a process 
which relies on a relatively slow assembly of internalization vesicles. Therefore, by the 10 minutes of 
EGF treatment not many receptors have been internalized yet, and thus, EGF depletion is not 
significant at that time. Therefore, EGF depletion is not likely to play a role in directly shaping the 
signaling responses in the short run.  
Here we suggest an explanation how cell density can affect signaling outcomes through EGF 
depletion and levels of EGFR expression: during incubation with limited amount of EGF in the media, 
higher cell density means less absolute number of EGF molecules per cell, which then allows EGF 
depletion from cell media, leading to higher levels of EGFR expression, which determines signaling 
outcomes. EGF depletion does not affect cell signaling in the short run, however, plays important role 
in regulating number of cell surface EGFR during incubation of cells in limited EGF media before the 
EGF treatment.  
It is important to note that here we considered the effects of EGF depletion on the early 
stages of signaling responses, namely, the pre-incubation of the cells and the short-term (10-minute) 
phosphorylation responses. However, EGF depletion might have a significant effect on the cell 
signaling in the long run. Generally, in physiological context ligand can be depleted through 
receptors-mediated endocytosis, other type of membrane-mediated endocytosis, or through diffusion 




of cell signaling, thereby, effectively, influencing the dynamics of signaling responses. In addition, in 
the receptors sensory systems in which ligand-bound receptors are internalized faster than ligand-
free receptors, ligand depletion could facilitate the recovery of receptors levels after initial stimulation 
with the ligand. The recovered receptor levels could then alter the cell sensitivity to the subsequent 
stimulations with the ligand. Therefore, ligand depletion potentially could have a significant effect on 
the long term cell signaling. 
To summarize, we predict that in the case of limiting initial EGF levels in the cell incubation 
media, the cell density will have an effect on the EGFR expression: higher cell density would lead to 
higher EGFR expression in the cells. We also predict that in conditions when EGF is not limiting in the 
cell incubation media, the cell density should have no effect on EGFR expression in the incubated 
cells.  
To test our hypothesis experimentally we propose the following experiment. On a given day, 
identical cells are being plated in four wells: two wells with low cell density, and two wells with high 
cell density. Two plates of different cell densities are then incubated with standard media, containing 
residual EGF, and two remaining plates are incubated in standard media with addition of a low dose 
EGF. After several hours of incubation, the total EGFR abundance and EGF levels are measured in 
each well. The measurements should be taken between three to six hours of incubation – the time 
frame long enough to allow for ample EGF depletion, yet not sufficient for most cells to undergo cell 
division, and thus significantly change the cell density. In addition, the total EGFR and EGF depletion 
in these four types of wells could be measured at several time points during the extended incubation 
to assess the dynamics of the relationship between ligand depletion and the total EGFR abundance. 
If the suggested hypothesis is true, we would expect to see a positive correlation between the 
average number of EGFR receptors on the cell surface and the incubation cell density. In addition, 
given the two batches of cells incubated at the same cell density, we would expect the cells incubated 
with the additional EGF to have a lower number of the cell surface receptors. 






In Section 4.5.3 we proposed a relatively simple explanation of the cell-density dependent 
effects occurring at the pre-incubation stage on the signaling through EGFR and the role of EGF 
depletion in it. Testing the most parsimonious hypothesis first could yield a valuable insight about the 
biological mechanisms in the EGFR signaling system. However, the proposed explanation is limited 
due to its simplistic view on the behavior of cell populations in the media. In particular, cell-density 
can influence cells in many other ways, not just though EGF and its receptors: at high cell-density cell 
behavior can be affected by cell contact-inhibition (Swat, Dolado, Rojas, & Nebreda, 2009), autocrine, 
juxtacrine and paracrine signaling (Singh & Harris, 2005). Hence, multiple other cell-densities 
dependent factors can affect EGFR expression in the cells.  
Importantly, autocrine secretion of EGF by the cells can influence levels of EGF in the wells, 
and thus, according to our hypothesis, can have effect on EGFR expression levels. However, it is not 
feasible in our experimental system to quantify the extent of autocrine EGF in the media. First, the 
ELISA assays measuring the EGF abundance in the media detect primarily the soluble EGF; whereas 
the autocrine-produced EGF might remain tethered to the cell surface for some time prior to being 
released into the media (Singh & Harris, 2005), and therefore, it could be missed by the ELISA assay. 
Second, the levels of the autocrine-produced EGF in our system can be very low and difficult to 
detect experimentally. Moreover, our experimental handling of the cells prior to the EGF treatment 
ensures that most of the EGF autocrine-produced during the pre-incubation is removed when the 
cells media is replaced with the fresh starvation media. Further, we expect that the three to six hours 
of EGF treatment is not sufficient for the cells to accumulate significant amounts of the autocrine 
EGF. The levels of the autocrine-produced EGF are expected to be much lower compared to the 
doses of EGF in the treatments, and hence, the autocrine signaling is not likely to compensate for the 
EGF ligand depletion or interfere with the EGF dose applied in the treatments.   
Section 4.6: Predicted Weber’s  Law   in  pERK responses and its experimental 
validation 
 
In this section we first present predictions of the extended model of responses to step- inputs 
in EGF doses. The model first is fitted to the 3 hours phosphorylation and total EGFR time-courses, 




of pERK responses to the same x3 fold increase steps across different initial doses of EGF and find 
approximately 1.5 orders of magnitude region of initial EGF doses in which pERK responses to same 
fold increase appear similar.  
We then consider the corresponding total EGFR abundances at three hours of stimulation 
with a constant initial dose of EGF and observe that within a certain range of EGF doses, the total 
EGFR at steady state is negatively correlated with the dose of EGF in the initial treatment. This 
outcome leads us to hypothesize that the total EGFR can store memory of initial doses of EGF, and 
the amount of receptors available for ligand-binding at the time of the EGF step-increase could 
determine the maximum response to step input in EGF and enable sensing relative changes in EGF 
levels. We then present experimental validation of our prediction in Section 4.6.3. Since the results in 
this section were obtained by simulating a detailed ODE model of the ErbB signaling cascade which 
reproduces well the experimental data, but is complex and thus not well suited for intuitive 
understanding of underlying biological mechanisms, in Section 4.7 we develop series of simplified 
analytical models capturing ErbB signaling responses. Further, we explore properties of parameter 
space  at  which  pERK  responses  exhibit  Weber’s  Law  behavior  described  in Section 4.6.1. 
 
Section 4.6.1: Predicted responses of phospho-ERK signals to step inputs in 
EGF are able to discriminate different fold-changes in EGF 
 
We fit the extended to model to phosphorylation signaling time-courses of pEGFR, pERK and 
total EGFR responses over up to three hours of treatment with constant EGF doses as described in 
Section 4.2.1 and at each sampled point in parameter space we simulate model predictions of system 
responses to a 3-fold step increase in EGF concentration added at 3 hours.  
Shown in Figure 4.59, Figure 4.60, and Figure 4.65 are model responses simulated at a point 
in parameter space found by MCMC chains. Responses up to three hours are fitted to the 
experimental data, whereas, the 3-6 hours parts of the time-courses are predicted responses to a x3 
fold step increase in the initial EGF dose. Shown in bold are the predicted time-courses in which peak 
responses in pERK at the 3 hour step increase appear approximately similar to each other. Although 




different pEGFR and pERK responses when added (see amplitude of the first peak in Figure 4.59, 
Figure 4.60), the responses to the same x3 fold increase in EGF dose produces responses with 
strikingly similar peaks. To verify that the observed behavior is not a result of signal saturation, we 
also apply step increases with a higher fold, x5 (Figure 4.61). We observe that at most doses 
(including ones responses to which are shown in bold in Figure 4.59, Figure 4.60) responses to a 
higher step increase have higher amplitudes then the ones to the x3 step increase, suggesting that 
the addition of more EGF molecules could still produce more EGF signal, implying that the system is 
not at saturation. Responses to conditions in which the system has been pre-treated with the highest 
EGF dose, 100ng/ml EGF, show only small signal increase in response to x3 fold step input in EGF, 
with a total of 300ng/ml EGF added (see Figure 4.60, dashed blue), suggesting that after stimulation 
with a high initial dose of EGF the system has possibly lost its sensitivity to the ligand.  
 
Figure 4.59: Predicted pEGFR time-courses in response to step inputs in EGF with different initial EGF 
doses. A x3 fold step input relative to the initial EGF dose (see legend) is applied at each simulated EGF 
dose at 3 hours 




































Figure 4.60: Predicted pERK response to x3-fold step inputs in EGF applied at 3 hours of stimulation. 
 
Figure 4.61: The comparison of pERK responses  at x3 or x9 step inputs in EGF applied after 
three hours of EGF treatment .Responses to x3 step inputs are shown in blue, x9 - in red. 
We then generate dose responses of maximal amplitude to x3 fold increases in EGF across 
all doses of EGF from the posterior parameter distributions obtained by fitting the model to the 
experimental measurements of up to three hours EGF stimulation (Figure 4.62). The predicted 























































distribution is relatively flat in the region of EGF doses approximately between the 0.15-10ng/ml 
range. In the range of high EGF doses (>10ng/ml) the predicted dose response appears to decay, 
possibly due to saturation effects (see below). However, we observe that the flatness of the dose-
response in the 0.15-10ng/ml range is a feature predicted to be observed across the parameter 
space, and not just a characteristic of several selected fits. 
 
 
Figure 4.62: Predicted distribution of the maximal pERK responses to x3 fold step input in EGF dose 
applied three hours after stimulation with EGF. On the X axis are shown the doses of EGF in the initial 
treatment applied at time=0. 
We then investigate if in the selected fit the system can distinguish between different fold 
increases in EGF levels. For this, we plot maximal system responses in that particular fit to different 
fold increases in EGF levels (Figure 4.63, Figure 4.64). The x1 control represents system responses 
if at three hours the EGF concentration was not changed. The dose-response of maximal responses 
to the initial treatment with EGF is plotted for reference (black). We find that, indeed, higher fold-
increases produce responses with higher maximum values across the range of initial EGF doses 
~0.1-3ng/ml. The dose-responses for each fold increase appear non-overlapping and separated from 










































each other, suggesting, that in response to treatment with different fold increases in EGF the system 
can produce distinct responses. However, such property holds only in a limited range of EGF doses, 
as at higher doses responses are not distinguished, whereas, at lower doses responses depend on 
the initial dose of EGF in the pre-treatment. 
 
Figure 4.63: Predicted pEGFR dose-response to different fold-increases in EGF. On the X axis are shown 
the doses of EGF in the initial treatment applied at time=0. 
 
Figure 4.64: Simulated pERK dose-response to various fold change step increases in EGF. On the X axis 
are shown the doses of EGF in the initial treatment applied at time=0. 















































































Peak pERK responses to initial treatment with EGF (black) exhibit saturation at high doses of 
EGF (>10ng/ml) (Figure 4.64), at the same time as the corresponding pEGFR responses are not yet 
saturated (Figure 4.63). Such pERK saturation is a result of ultrasensitivity, whereby the signal at 
pEGFR is amplified through the kinase cascade when transmitted to pERK. The responses to step 
increases in EGF, however, show a different type of saturation. We see that after three hours of 
stimulation with high dose EGF, most of the EGFR are predicted to be degraded (Figure 4.66), and 
therefore, pEGFR even at very high levels of additional EGF would produce responses with only 
small amplitudes (Figure 4.63, responses > 10ng/ml). Therefore, pEGFR response at step inputs in 
these cases is saturated. However, the corresponding pERK responses are still below the possible 
maximum of pERK response (maximum of the dose-response at first step, Figure 4.64), and given 
that the total ERK amount could not be degraded over the time of the signaling, we conclude that 
pERK responses appear to be saturated as a result of saturation on pEGFR due to decreased 
amount of receptors, and not as a consequence of phosphorylation of all possible ERK available.  
The predicted flatness in dose-responses of pERK to EGF step-inputs occurs at EGF doses 
below the estimated constant of equilibrium of EGF unbinding from EGFR (~20ng/ml EGF (Chen et 
al., 2009)). Hence,  to  exhibit  approximate  Weber’s  Law  behavior  EGF  binding  to  the EGFR receptors 
should be below its saturation. 
Therefore, we find that the model fitted to experimentally observed phosphorylation and the 
total EGFR time-courses over three hours of treatment with different EGF doses predicts that in a 
certain  range  of  EGF  doses  the  system  can  exhibit  Weber’s  Law  in  its responses and, hence, be able 
to sense relative changes in EGF doses. 
 
Section 4.6.2: Total EGFR dose-responses to EGF shows negative correlation 
with EGF dose applied  
 
We first computationally investigate what mechanisms in the model might be responsible for 
producing  the  observed  Weber’s  Law  in  pERK  responses  to  fold-changes in EGF levels. For this, we 
consider system output predicted by the model and representing variables other than phosphorylation 




incoming signal, the system should be able to store information about the previous concentration of 
EGF stimulation at the time the EGF step is added, and compare the new level of EGF to the 
previous one. Since the responses to EGF treatments are initiated at the cell surface when EGF is 
detected by the EGFR receptors available for activation on the cell surface, we consider total EGFR 
receptor abundance. 
In particular, we plot the predicted time-courses of total EGFR receptors (Figure 4.65). We 
find that, in agreement with the corresponding experimental data, the predicted total EGFR 
abundances after three hours of stimulation with the constant dose EGF are decreasing with the 
increasing dose of the initial EGF stimulation. In addition, the total EGFR time-courses appear to be 
reaching steady state by 3 hours at some EGF doses. Shown in bold are total EGFR time-courses 
corresponding to the treatments with EGF in which the model predicts  approximate  Weber’s  Law  in  
pERK responses (Figure 4.60).  
We then plot a dose-response of the amount of remaining EGFR after three hours of 
stimulation with each corresponding EGF dose (Figure 4.66). The lower the number of receptors 
remaining, the more of the initial receptors were degraded in the course of signaling. The dose-
response suggests that at lower EGF doses, the number of receptors does not change significantly 
after three hours of EGF stimulation. At the medium range of EGF the total EGFR negatively 
correlates with the dose of EGF in the initial treatment. We then hypothesize that such dependence of 
tEGFR  on   the  EGF   in   the  middle   range  of  EGF  doses  enables   the  mechanism  of  Weber’s  Law   in  
pERK responses. Intuitively, given the system is pre-adapted to stimulations with two different 
constant doses of EGF, 𝑢  and 𝑢  (𝑢 >𝑢 ), the number of EGFR receptors remaining available will be 
higher in the system adapted to 𝑢 . Therefore, to produce responses of similar maximal amplitudes, a 
smaller absolute amount of EGF molecules would have to be added to the system pre-adapted to 
signal 𝑢 , compared to the system, pre-adapted to 𝑢 . This conclusion assumes that the 
phosphorylation response, up to a constant, is proportional to the number of receptors available for 




We then look at the predicted distribution of dose-responses of total EGFR after three hours 
of stimulation with EGF generated by sampling the parameter space of the model fitted to the 
experimental measurements (Figure 4.67). 
The predicted distribution of the dose-responses exhibits a similar trend as seen in Figure 
4.66 with a flat region at lower doses and log-linear behavior in the middle range of EGF.  
Note, that, the model-predicted degradation of EGFR differs from the one observed 
experimentally, although, the time-courses of EGFR abundances were included in model fitting 
(Figure 4.68). It is possible that the quality of total EGFR time-courses was compromised in these fits 
due to the fact that multiple phosphorylation time-courses were fitted in the model simultaneously, 
and thus, significantly constrained the model parameter space. 
Although the model predicts that total EGFR after three hours of EGF treatment is negatively 
correlated with the EGF dose, a trend captured in the experimental measurements of tEGFR fitted in 
the model (Figure 4.3), the model predicts somewhat different then experimentally observed rates of 
degradation at EGF doses above 10ng/ml EGF. Such discrepancy is possibly due to the 
normalization and scaling of total EGFR experimental measurements: in the absence of proper 
control to account for fluorescence background offset in total EGFR measurements, we might have 
over or underestimated the initial abundance of total EGFR in the system (counting fluorescence 
emitted by background as fluorescence due to detected EGFR), and thus, underestimated the 
amount of tEGFR degraded. We address the problem of estimating the total number of EGFR 
remaining in the cells and able to bind ligand in Section 4.7.6. 
 An important difference between model predictions and experimental measurements of the 
total EGFR is that at higher doses experimental data suggests that tEGFR degradation is saturated, 
whereas the model predicts a more gradual receptors decay dose-response at higher EGF doses. In 
EGFR signaling time-courses of total EGFR are related to time-courses of pEGFR, as a higher 
number of phosphorylated receptors means more of them will be degraded in the course of 
stimulation. Our experimental data (Figure 4.3) measures 10 minute responses of pEGFR and does 
not imply that pEGFR responses are saturated. However, the underlying biological responses might 




when measured 10 minutes after the EGF addition. This observation may explain why the total EGFR 
responses after three hours of treatment appear to be saturated whereas; the pEGFR dose- 
responses at 10 minutes did not seem saturated in the experimental data. 
The fits found by the model correctly capture that the pEGFR responses may not necessarily 
be saturated at higher EGF doses, however, do not fit correctly the total EGFR saturation at higher 
EGF doses (Figure 4.68). Overall, the discrepancy in model predictions of total EGFR and their 
experimental validation can be resolved with the improved normalization and scaling procedure of 
tEGFR experimental data, and we believe that that does not disagree with key findings of this work. 
Since model fit to total EGFR varies from experimental measurements, the range of EGF 
doses   in   which   the   model   predicts  Weber’s   Law   might also vary from the one in the underlying 
biological  system.  Therefore,  in  the  experimental  validation  of  predicted  Weber’s  Law  we  test  range  of  





Figure 4.65: Predicted total EGFR time-courses in simulations with x3 fold step inputs in EGF doses 
added at three hours of stimulation with initial EGF.
 
Figure 4.66: Predicted dose-response of tEGFR three hours of stimulation with constant dose EGF. 






































































Figure 4.67: Predicted distribution of the dose-response of total EGFR abundances measured at three 
hours of stimulation with constant dose EGF. 












































Figure 4.68: Dose-responses of total EGFR abundance at three hours of EGF stimulation: predicted vs. 
experimentally measured.  
Figure 4.69: Dose-responses of the total EGFR remaining in the cells three hours after stimulation with 
constant dose EGF. 
Experimental measurements of total EGFR time-courses (Figure 4.3) suggest that by three 
hours of stimulation with constant dose EGF most of the time-courses appear to adapt to their steady 
state levels. We then consider the experimentally measured dose response of amount of total EGFR 
receptors remaining in the system after three hours of stimulation (Figure 4.68, red). We find that at 
EGF doses between approximately ~0.03-10ng/ml EGF total EGFR remaining decreases with 


























































increasing dose of EGF. Interestingly, at low EGF doses number of receptors does not appear to vary 
with different EGF doses; and at high EGF stimulations total number of EGFR remains similar after 
treatments with EGF on the order of 10-100ng/ml EGF. It is plausible that at EGF concentrations 
above 10ng/ml pEGFR signal reaches saturation (which might not necessarily be captured correctly 
by the pEGFR dose-response measured at 10 minutes) and that the maximal amount of EGFR 
receptors capable of participating in signaling is being removed. Therefore, at saturating EGF doses 
total EGFR does not reflect memory of the ligand concentration in the EGF treatment; at lower EGF 
doses the ligand doses are eliciting significant responses in pEGFR signal, and therefore do not elicit 
substantial degradation of receptors; however, for EGF doses in the range of ~0.03-10ng/ml, EGF 
doses appear to be remembered in number of receptors remaining undegraded, in inversely 
proportional to the EGF dose relationship. We plot the log-log plot of number of remaining EGFR at 
three hours of stimulation with EGF (Figure 4.69) and find that within the range of 0.03-10ng/ml the 
predicted and experimentally measured dose responses show negative slope of approximately ~-
0.5..-0.75, suggesting that at steady state tEGFR dependence on EGF functionally might appear like 
Hill function in EGF. 
We then hypothesize that the negative proportionality between EGF doses in the applied 
initial treatments of EGF and the number of EGFR remaining after the cells pre-adapted to the 
treatment with constant dose of EGF, could allow cells to sense relative changes in consequent 
stimulations with EGF and generate responses proportional to fold-changes, and not absolute 
changes, in EGF doses. In the next section we present experimental validation of the predicted 
Weber’s   Law   behaviors in pERK responses and in Section 4.7 we present analytical derivation 
explaining mechanisms of Weber’s  Law  realized  through  number  of  EGFR  receptors remaining in the 
cells in long run of stimulation with constant doses of EGF. 
Section 4.6.3:  Experimental  validation  of  Weber’s  Law  on  pERK  responses  to  
fold-changes in EGF 
 
To  experimentally  validate  predicted  Weber’s  Law  on  pERK,  we  first  have  to  measure  peaks  
of the pERK responses when system pre-adapted to a certain EGF dose, is stimulated with a certain 




EGFR in response to stimulation with range of different EGF doses at the time when EGF step is 
applied, exhibits a negative correlation with the initial ligand concentration, which could then be used 
to explain  
Phospho-EGFR signal at low amount of stimulation even though can produce potent 
downstream signal on pERK is unfeasible to be reliably detected experimentally. Since pERK acts as 
a  linear  amplifier  of  pEGFR  signal  we  can  rely  pERK  levels  for  validation  of  Weber’s  Law  prediction 
on  level  of  pEGFR.  Observing  confirmation  of  Weber’s  Law  at  pERK  level  and  the  accompanying   it  
negative relationship between total EGFR and initial dose of EGF applied could then imply presence 
of  Weber’s  Law  on  pEGFR  responses.   
Based on total EGFR measurements collected at 3 hours of stimulation with range of EGF 
doses (Figure 4.3, Figure 4.68) we observe that tEGFR levels negative correlation with the initial 
doses of EGF applied change more dramatically between 0.03-10ng/ml EGF. Interestingly, this range 
of EGF doses is believed to be physiological in human serum and certain tissues (Rouger et al., 
2014). Since, however, 10ng/ml EGF is on the upper limit of physiological EGF ranges and the fold-
increases applied at 10ng/ml EGF are beyond physiological levels of EGF, we limit the selected 
range of EGF doses to ~0.03-3ng/ml to   validate  Weber’s   Law   experimentally. We measure pERK 
responses to step inputs in EGF with initial EGF doses ranging between 0.03 and 3ng/ml. Note, that 
due to possible variation in number of cells per well between experiments conducted on different 
days, levels of EGFR expression on the cell surface might vary on different days, and this could lead 
to shifts in their dose responses to EGF. Therefore, we expand the range of EGF validation from 
0.016   to  4ng/ml   to  ensure  we  cover   the  Weber’s  Law  region  and  possibly  detect   the   limits  where   it  
ends. 
We treat the system with EGF dose shown on the X axis for three hours, and at 3 hours dose 
in the media is increased by a certain fold (x3, x6, x9, x16 of the initial EGF dose). We then measure 
pERK responses 10 minutes after the step increase in EGF (Figure 4.70). For comparison, we plot 
the 10 minutes pERK dose response at the initial treatment with EGF. We find that within ~0.03-0.3 
ng/ml EGF range the dose responses to same fold-changes appear flat, whereas dose responses to 




not overlapping in that region of EGF, suggesting that system responses to step increases in EGF 
depend on the ratio of EGF increase and not on its absolute level. 
Note that the maximum pERK response detected in the dose response to initial EGF 
stimulation appears to be below the maximum response detected at the step increases, which seems 
controversial as in this experimental data set pERK responses appear to reach saturation in pERK in 
their initial EGF pre-treatments at ~  3ng/ml,  and  over  time,  system’s  sensitivity  is  expected  to  decay,  
not increase. We believe that in the responses in which 10 minute measurements pERK were 
obtained, the maxima were possibly achieved prior to 10 minutes and thus were missed by the 
experimental measurements. Whereas, at lower levels of stimulations (e.g. Figure 4.3, pERK 
response at 0.03 ng/ml EGF) pERK responses decay from their peak at a slower rate, and thus, the 
pERK measurements at second step of EGF addition most likely do capture the peak responses. 
 
Figure 4.70: Experimental validation of Weber's Law at pERK responses: pERK responses measured 10 
minutes after corresponding step inputs in EGF were applied three hours after stimulation with constant 
dose EGF. 
The experimental data suggests (Figure 4.70) that although the initial EGF doses in the 0.03-
0.3 ng/ml range vary almost by one order of magnitude and produce significantly different initial 
responses in pERK (relative difference ~700A.U.), when treated with same fold-changes in EGF 
doses at 3 hours, the system produces very similar responses, which differ only within ~ 100 A.U. 

































Three-hour time interval between initial EGF treatment and the fold-increase steps in EGF 
was chosen for the following reasoning. We aimed to minimize the time interval between the initial 
treatment and the step-increase to limit possible gene expression which might occur in response to 
initial stimulation with EGF. However, prior to step increases in EGF the system needed to be more or 
less adapted to the initial EGF stimulation. Based on the experimental data, pEGFR signal adapts to 
its pre-stimulus level within 1.5hrs of stimulation at highest doses of EGF. In addition, time of 
adaptation appears to be inversely dependent on the EGF dose: higher dose of EGF elicits 
phosphorylation response of higher amplitude, and decays faster. Such effect can be explained by 
rapid receptors internalization and degradation at higher EGF doses. However, at level of pERK, 
signal decays at a slower rate compared to the pEGFR rate of decay. Such difference in observed 
rate of signal decay can be partially due to signal amplification in MAPK kinase cascade, and due to 
differences in phosphatases acting on phospho-ERK and on phospho-EGFR. We observed that 
experimentally measured pERK by 1.5 hours of stimulation with  highest EGF doses drops to 30-60% 
of its peak level, whereas by 3hrs it reaches anywhere between 10-40% of the peak level. Hence, as 
duration for treatments, we chose 3 hour time interval between the initial EGF treatment and time of 
addition of EGF fold increases. Based on our model simulations (results not shown) of comparing 1.5 
hours interval to 3 hours interval, the 3 hour interval provided more time for the system variable of 
total EGFR to reach nearly steady state across most EGF doses; in addition, by 3 hours of stimulation 
with EGF, pERK responses decayed more significantly then by the 1.5 hours, and thus, responses to 
step-increases in EGF at 3 hours were more distinguished from the pERK levels before the step-
increases in EGF. 
We tried multiple distinct fold-increases in EGF doses to make sure the behavior we observe 
is not due to saturation of EGF ligand binding to available receptors. Since up to ~ 0.3 ng/ml EGF 
(Figure 4.70) higher fold-increases produce higher responses, the system is below saturation, as it is 
able to distinguish between different fold increases. In addition, we observe that at pre-treatments 
with EGF doses above 0.3ng/ml the system might be unable to discriminate between different folds 




Section 4.7: Analytical derivation of perfect adaptation and approximate 
Weber’s  Law  in  a simplified kinetic model 
 
Fitted to the experimental data, our detailed dynamic ODE model (see Section 4.4) suggests 
a possibility of perfect adaptation on phospho-EGFR   signal   and   approximate   Weber’s   Law   on  
phospho-EGFR and phospho-ERK. However, the main model is too unwieldy to explain the 
underlying causes of these phenomena. In order to understand what biological mechanisms are 
responsible   for  producing  perfect  adaptation  and  Weber’s  Law  on  phospho-EGFR, we developed a 
smaller kinetic model using simplifying assumptions on EGFR biology. In particular, the simplified 
analytical model focuses on the EGFR receptor layer and encompasses only the most essential 
interactions: ligand binding to the receptors, basal synthesis of receptors, their activation, 
dephosphorylation by phosphatases and degradation. The simplified analytical model can be 
considered as a reduction of the detailed model onto a parameter values subspace limited by the 
simplifying assumptions. As we demonstrate, the simplified model does allow a more intuitive 
understanding of the  interplay  between  complex  dynamic  processes  responsible  for  Weber’s  Law  and  
perfect adaptation in ErbB signaling pathway.  
We derive the models based on a generally applicable mass action kinetics formalism (Chen 
et al., 2010).  
In Section 4.7.1, we describe the simplified model and present an analytical explanation of 
perfect adaptation on pEGFR. This is done by deriving analytical expressions for phospho-EGFR and 
total EGFR at steady state in response to stimulation with certain constant level of EGF.  We thus 
show that perfect adaptation on pEGFR is a feature inherent to the topology of the simplified model 
and is independent of the parameters of the simplified model. Then, in Section 4.7.2, we examine the 
functional dependence of the steady state expression of tEGFR on the dose of applied EGF 
stimulation. Next, we sample probabilistically the parameter space of the simplified model, imposing 
Weber’s   Law   in   the model response over a certain physiological range of EGF stimuli. Using the 
resulting distributions of parameters, we show that at parameter values where the system exhibits 
approximate  Weber’s  Law,  tEGFR  depends  on  the  EGF  dose  through  function   inversely proportional 




computation of ratios of EGF doses at step inputs and thus leading to responses dependent on fold-
changes, rather than on the absolute changes in EGF levels. 
It is important to note that we did not fit the simplified model to the experimental data that we 
use to fit our detailed ODE model. Instead, we imposed certain requirements on the simplified model 
to capture general features of the signaling responses, such as, achieving perfect adaptation within a 
given  time  frame,  and  others.  The  simplified  model  can  produce  fits  with  the  Weber’s  Law  behavior,  
and thus can be used to provide a more intuitive way to understand mechanisms behind perfect 
adaptation  and  Weber’s  Law in the EGFR signaling. 
Section 4.7.1: Derivation of perfect adaptation of phospho-EGFR and 
phospho-ERK signals 
 
In this section we present a simplified analytical model to derive perfect adaptation on 
pEGFR and pERK signals. The simplified model assumes that EGF binding to a receptor is rapid and 
leads to its dimerization with an unoccupied receptor, followed by activation of the dimer. For 
simplicity, we assume that the abundance of dimers fully occupied by EGF is negligible in the system. 
Such assumption relies on the suggested decreased affinity of the second EGF molecule to a dimer 
with one EGF molecule (Macdonald & Pike, 2008). We omit the basal degradation of inactive 
receptors from the simplified model, as it is significantly slower than the degradation of active 
receptors. Given there is no basal degradation of inactive receptors in this model, its main limitation is 
that at steady state total number of receptors in the absence of ligand cannot be constant unless the 
basal rate of receptor production is very low. 
The following are the variables in the simplified model: 
 𝑅 is the total number of inactive EGFR receptors present in the cell.  
 𝑢 is the concentration of EGF which is being maintained in the course of stimulation.  
 𝐵 is the number of EGF-bound inactive receptors. 
 𝐷 is the number of one-EGF-bound inactive dimer.  
 𝑃 is the number of active (phosphorylated) receptor dimers. 



















⎧𝑑𝑅𝑑𝑡 = 𝑘 − 𝑘 𝑢𝑅 + 𝑘 𝐵   − 𝑘 𝐵𝑅 + 𝑘 𝐷  
𝑑𝐵
𝑑𝑡 = 𝑘 𝑢𝑅 − 𝑘 𝐵 − 𝑘 𝐵𝑅 + 𝑘 𝐷
𝑑𝐷
𝑑𝑡 = 𝑘 𝐵𝑅 − 𝑘 𝐷 − 𝑘 𝐷 + 𝑘 𝑃
𝑑𝑃
𝑑𝑡 = 𝑘 𝐷 − 𝑘 𝑃 − 𝑘 𝑃
 (1) 
 
Figure 4.71: A simplified analytical model of EGFR signaling for the derivation of perfect adaptation on 
pEGFR responses. 
 
The total number of EGFR present in the system is the sum of all monomers and dimers remaining 
non-degraded and can be expressed as  
 𝑇 = 𝑅 + 𝐵 + 2𝐷 + 2𝑃   (2) 
We then write down an expression for dynamics of 𝑇 by summing up expressions of dynamics for 
each of its component to obtain: 
 𝑑𝑇




This suggests that at steady state, when total number of receptors remains constant over time, 
equilibrium between constitutive receptor production and degradation of active receptors is reached. 
The same expression (3) suggests that the number of active receptors at a steady state is 
 𝑃 = 𝑘2𝑘  (4) 
and is independent of ligand concentration 𝑢, which, by definition, implies that 𝑃 adapts perfectly. 
Note  that  the  model’s  conclusions  regarding  perfect  adaptation  of  signal  𝑃 do not change with 
a more elaborate implementation of receptors dimerization which would include formation of double-
occupied with EGF dimers. Expression (3) also shows that the total number of receptors 𝑇 , is 
controlled by an integral of 𝑃over time. Such mechanism in engineering is known to as integral 
feedback control (Alon et al., 1999). Hence, in the long run, integral of phospho-EGFR signal over 
time determines change in the total number of EGFR receptors remaining in the system.  
We then derive perfect adaptation on pERK based on perfect adaptation on pEGFR and 
assumed linearity of pERK responses on EGF doses. We can write down the equation of dynamics of 
pERK via its activation through upstream kinase 𝑌  and deactivation by ERK phosphatase as follows: 
 𝑑(𝑝𝐸𝑅𝐾)
𝑑𝑡 = 𝑘 ∙ 𝑌 − 𝑘 ∙ 𝑝𝐸𝑅𝐾 (5) 
where 𝑘  is kcat of ERK phosphorylation and 𝑘  is kcat rate of ERK phosphatase. Given the 
linearity in signaling cascade between pEGFR and downstream kinases leading to activation of 
pERK, steady state equation for levels of activated kinase 𝑌  can be expressed as 𝑌 = 𝑐 ∙ 𝑃, where 𝑐 
is a constant and 𝑃 is activation on pEGFR. In this model EGF is acting on pERK only through 
pEGFR and, hence, is not affecting directly any intermediate components in the cascade.  
We obtain that at steady state 𝑝𝐸𝑅𝐾 = 𝑐 ∙ 𝑃 Therefore, given exact adaptation on pEGFR and 
linearity of the downstream signaling cascade we obtain that perfect adaptation on pERK follows. 






Section 4.7.2: Steady state analysis of the EGFR signaling system and 
responses to step input in EGF: monomer-activated EGFR signaling model 
 
In Sections 4.7.2 and 4.7.4 we consider simplified analytical models of EGFR signaling and 
conduct analysis of steady state behavior of the EGFR system in response to chronic stimulation with 
constant dose of EGF. The existence of steady state in mammalian cells in response to chronic 
stimulation with EGF has been previously reported  and validated experimentally (Wiley & 
Cunningham, 1981).  
In this section we consider analytical model of EGFR signaling with the assumption that 
ligand-driven dimerization of receptors happens instantaneously, and therefore, the unphosphorylated 
dimers could be neglected. This model assumes that phosphorylated receptor cies 𝑃are monomers, 










⎧𝑑𝑅𝑑𝑡 = 𝑘 − 𝑘 𝑢𝑅 + 𝑘 𝐵     − 𝑘 𝒐𝑅
𝑑𝐵
𝑑𝑡 = 𝑘 𝑢𝑅 − 𝑘 𝐵     − 𝑘 𝐵 + 𝑘 𝑃
𝑑𝑃






We then apply a simplifying assumption that ligand binding to receptors is very rapid, therefore, the 
reaction of ligand binding and unbinding from the receptor can be assumed to be at quasi-
equillibrium, and hence the amount of bound receptors can be expressed as follows: 
 𝐵 = 𝑘𝑘 𝑢𝑅 (7) 
The simplified model can then be rewritten through dynamics of activated receptor 𝑃, ligand-free 








𝑘 𝑢𝑅 − 𝑘 𝑃 − 𝑘 𝑃
𝑑𝑇
𝑑𝑡 = 𝑘 − 𝑘 𝑃 − 𝑘 𝑅
 (8) 
We then solve the system at steady state and express variables through 𝑅: 
 𝑅 = 𝑘 (𝑘 + 𝑘 )
(𝑘 + 𝑘 )𝑘 + 𝑘 𝑘𝑘 𝑢𝑘
𝐵 = 𝑘𝑘 𝑢𝑅
𝑃 = 𝑘𝑘   −
𝑘
𝑘   𝑅




𝑘   𝑅 =
𝑘





       (9) 
Based on the established fact that for the EGFR receptors the internalization and degradation of 
inactive receptors is significantly slower than the internalization and degradation of EGF-bound 
receptors (Sigismund et al., 2012), we have: 
 1 ≪ 𝑘𝑘  (10) 
Note that since in the simplified model receptors internalization, the step preceding receptors 
degradation is known to be significantly faster for EGF-bound receptors (Becker et al., 2010), 𝑘   and 
𝑘  represent effective constants of receptors downregulation, and therefore can differ by more than 
the corresponding internalization rates do. 




 𝑇 = 𝑘𝑘 + 𝑅 1 −
𝑘
𝑘 𝑢  (11) 
In the limit when ligand concentration 𝑢 is low, most of the receptors will be in the inactive, ligand-free 
form 𝑅, and thus the total number of receptors could be expressed as 
 
 𝑇 = 𝑘𝑘 + 𝑅, 𝑢~0 (12) 
In case 𝑢 is very large, all receptors will be ligand bound or phosphorylated, and therefore 𝑅 will be 
close to 0. Therefore, we obtain 
 𝑇 = 𝑘𝑘 , 𝑎𝑠      𝑢 → ∞ (13) 
We then consider the case when 𝑢  is not within these two limiting conditions. The steady state 
solution for 𝑅 is given in (9) and we rearrange rate constants as follows: 
𝑅 = 𝑘 (𝑘 + 𝑘 )
(𝑘 + 𝑘 )𝑘 + 𝑘 𝑘𝑘 𝑢𝑘
=
= 𝑘 (𝑘 + 𝑘 )/𝑘
(𝑘 + 𝑘 )𝑘 /𝑘 + 𝑘 𝑘𝑘 𝑢
=
= 𝑘 (1 + 𝑘 /𝑘 )/𝑘
(1 + 𝑘 /𝑘 )𝑘 /𝑘 + 𝑘 𝑘𝑘 𝑢/𝑘
 
Since for pEGFR rate of phosphatase activity has been shown to be significantly faster than the 
degradation (Kleiman et al., 2011), we can assume 1 ≫ 𝑘 /𝑘  and therefore the expression for 𝑅 can 
be simplified to: 
𝑅~ 𝑘 /𝑘
𝑘 /𝑘 + 𝑘 𝑘𝑘 𝑢/𝑘
 
In addition, dephosphorylation of EGFR by phosphatase was shown to be faster than the activation of 
the receptor, and we can consider such range of EGF doses, 𝑢, in which the following holds: 
 1 ≪ 𝑘
𝑘 𝑘𝑘 𝑢




We apply the assumption (10) to derive a simplified expression for 𝑅 and substitute it into expression 
(11) for 𝑇:  
 𝑅 = 𝑘 /𝑘



















Applying the left-most inequality in (14) we obtain: 





Therefore in the considered region of 𝑢 the total number of remaining receptors, 𝑇, will be inversely 
proportional to ligand dose 𝑢 up to a constant. We then consider a scenario in which the system has 
reached steady state to stimulation with constant dose of EGF 𝑢  and the EGF dose is increased in a 
step input to 𝑢  where 𝑢 > 𝑢 . We derive expression for the maximum of the response 𝑃  , 
representing total maximal phosphorylation of the receptors the system could produce in response to 
the step input 𝑢 → 𝑢 .  The dynamics of phosphorylated receptors to the step input in EGF is given 




𝑘 𝑢 𝑅 − 𝑘 𝑃 − 𝑘 𝑃 (17) 
We consider phosphorylation response right after the system adapted at steady state to 𝑢  is treated 
with input step increase 𝑢 → 𝑢 . At the time the signal reaches the maximum, 𝑃 , derivative (17) is 
0 and can be written as: 
 0 = 𝑘 𝑘𝑘 𝑢 𝑅 − 𝑘 𝑃 − 𝑘 𝑃  (18) 
Since at early times of signaling response, degradation of active receptors is insignificant and most of 
signal downregulation happens through dephosphorylation by strong phosphatases, we can simplify 




 𝑘 𝑘𝑘 𝑢 𝑅 − 𝑘 𝑃 = 0 (19) 
 𝑃 = 𝑘 𝑘𝑘 𝑘 𝑢 𝑅 (20) 
Since we assume that while signal response reaches its peak   𝑃 , no significant degradation of 
receptors occurred and that the total number of receptors is as at steady state in response to  𝑢  we 
have:   𝑃 +𝑅   = 𝑃 +     𝑅 . Therefore, when the response reaches   𝑃  the number of ligand 
unbound receptors 𝑅 , assuming   𝑃        was negligible at steady state, is      𝑅   = 𝑅 − 𝑃 , and 
applying assumptions from (14) we get: 
           𝑃 = 𝑘 𝑘𝑘 𝑘 𝑢 𝑅 − 𝑃 ∗ 𝑘
𝑘
𝑘 𝑘 𝑢  (21) 
 
 𝑃 = 𝑘 𝑘𝑘 𝑘 𝑢 𝑅/((1 + 𝑘
𝑘
𝑘 𝑘 𝑢 ))~  𝑘
𝑘
𝑘 𝑘 𝑢 𝑅   (22) 
 
𝑅  is given by expression (15): 
𝑅 = /
/     
Substituting it into (22) shows that 
 












We showed that maximum of the signal in response to step input 𝑢 → 𝑢  up to a constant is 
proportional to the fold-change in the ligand doses of this step increase,  , and therefore implies that 
phosphorylated  responses  exhibit  Weber’s  Law  in  ligand  concentrations. 
Given Equality (23), we can then compare maximum signal responses if the system is treated 
















Therefore, the difference between the amplitudes of the system responses to two step inputs in EGF 
is proportional to the difference in fold-changes in the two inputs, given that before the step inputs the 
system was pre-adapted to steady state at basal stimulation with ligand concentration 𝑢 . 
Interestingly, expression (24) also suggests that higher the rate of basal EGFR production, or, slower 
the rate of degradation of active receptors, higher the resolution between different folds that the 
system can sense. 
It is important to emphasize that the current derivation relies on the assumptions (10) and 
(14),  from  which  we  can  derive  limits  on  ligand  concentrations  at  which  we  would  expect  Weber’s  Law  




𝑢 ≪     =   𝐾  
Therefore, given the ligand concentration is sufficiently low, and below   𝐾 , where  𝐾  is 
equilibrium rate constant of EGF unbinding from receptors, conditions (14) are satisfied. In other 
words,  Weber’s  Law  will  hold  in  the  range  of  EGF  doses  at  which  there  is  no  saturation  of  EGF  ligand  
binding to the receptors, and the phosphorylation response 𝑃  will increase proportionally to the 
increase in ligand dose 𝑢. 
For EGFR signaling at EGF doses below 𝐾  equilibrium unbinding constant, most of 
signaling occurs through EGFR dimers with only one EGF bound molecule, supporting plausibility of 
signaling being linear in EGF dose of stimulation in that regime. 
Note that the simplified model considered in this section omits internalization of active and 
inactive   receptors.   However,   the   overall   results   regarding   Weber’s   Law   in   the system responses 




ligand-free and phosphorylated receptors in the model with internalization have been previously 
derived (Zi & Klipp, 2007). 
The simplified model shows that information about EGF dose of current stimulation is stored 
in the number of EGFR receptors remaining at steady state. According to the derived formula for the 
number of receptors at steady state, the higher the initial EGF treatment, lower the amount of 
receptors remaining. Overall, cell response to EGF treatment depends on the actual EGF dose 
applied and on the amount of available EGFR receptors present at the time of step input. If initial 
dose of EGF was not very high, fewer receptors get activated and removed from the cell; whereas at 
initial treatment with high EGF, more receptors are removed from the cell. Intuitively, to elicit a certain 
level of response to a step input in EGF, in cells adapted to low initial EGF, one would have to apply 
relatively less EGF, than if the cells were adapted to high initial EGF and thus had less receptors. 
This reasoning helps to understand how system in states adapted to stimulation with two different 
doses of constant EGF, could have very different number of receptors at steady state, however, if 
treated with very different absolute amounts of EGF, yet, same fold changes, could produce similar 
responses. 
In  the  fits  where  Weber’s  Law  is  observed  in  analytical  model, total EGFR stores memory of 
previous EGF doses, which could enable the system to compute a ratio of the step increase in EGF 
concentration, and thus generate a fold-change dependent response in a certain range of EGF 
doses. Therefore, the memory of EGF doses retained in total number of receptors might be 
instrumental in realizing  the  Weber’s  Law  in  EGF  in the EGFR signaling pathway.  
Section 4.7.3: Experimental validation of predictions of the monomer-activated 
EGFR signaling model 
 
In this section we show predictions and experimental validations of the simplified analytical 
model of EGFR signaling derived in Section 4.7.2. We extend the analytical model presented in 
Section 4.7.2 of linear-activated EGFR signaling to include internalization and recycling of active and 
inactive receptors. Given that the rate of recycling of receptors is negligible, the results obtained from 
this model do not differ significantly from the model presented in Section 4.7.2 and are consistent with 




To generate predictions of the analytical model we substitute parameter values derived from 
literature (Table 6) into the analytical solutions of the steady state values for total EGFR in response 
to stimulation with constant dose EGF across a range of EGF doses. The rate of EGFR production is 
taken such that the number of receptors at 0 EGF stimulation at steady state agrees with our 
experimental estimate of EGFR abundance in MCF-10A cells and is on the order of 3x105 - 6x105  
receptors per cell. The parameter 𝑘     for the rate of EGF binding to receptors represents a 
compounded value of the product of rate of binding, phosphorylation of receptors and EGF unbinding; 
reaction of EGF binding and unbinding is assumed to be at quasi equilibrium. We plot the predicted 
normalized dose response of total EGFR (Figure 4.72) and compare it to the experimentally 
measured total EGFR abundance in MCF-10A cells treated with EGF dose for three hours. The 
resulting model predictions at the literature-derived parameter values agree with the experimentally 
measured dose response of total EGFR. 
Table 6: Literature-derived parameter values of the analytical model. 
Parameter  Description Value Reference 
𝑘  rate of EGFR production 1.1220 rec* sec-1 (fitted) 
𝑘  effective rate of EGF binding to EGFR and 
activation of receptor 
19.0546 nM-1 sec-1 (fitted) 
𝑘  rate of EGFR internalization 0.00033 sec-1 (Zi & Klipp, 2007) 
𝑘  rate of EGFR recycling 0.0033 sec-1 (Zi & Klipp, 2007) 
𝑘  rate of EGFR degradation 1.6834e-05 sec-1 (Zi & Klipp, 2007) 
𝑘  rate of EGF-EGFR internalization 0.0025 sec-1 (Wiley et al., 1991) 
𝑘  rate of EGF-EGFR recycling 0.0033 sec-1 (Zi & Klipp, 2007) 
𝑘  rate of EGF-EGFR degradation 1.7783e-04 sec-1 (Zi & Klipp, 2007) 
𝑘  rate of EGF-EGFR dephosphorylation by 
phosphatases 






Figure 4.72: Experimentally measured dose response of the total EGFR abundance three hours of EGF 
stimulation in MCF-10A cells and the prediction of the analytical model.  Plotted on the Y axis is the 
normalized amount of total EGFR obtained by subtraction of total EGFR measured at saturating EGF 
doses (100ng/ml) and normalization of the obtained curve by its maximum. 
We then use the simplified analytical model with the substituted literature-derived parameter 
values to numerically compute transient dynamic responses to step-inputs in EGF applied when 
system is at steady state to chronic stimulation with EGF. Since the analytical model predicts 
phosphorylation responses of EGFR, we use a transfer function to map the corresponding pEGFR 
response to pERK responses. pERK responses are feasible to validate experimentally compared to 
the pEGFR responses, and are possibly more relevant directly to the cell fate decisions. The pEGFR-
pERK transfer function is obtained by fitting a Hill function from the dose responses of pEGFR and 
pERK measured in MCF-10A cells (Figure 4.4).  
We numerically simulate pEGFR responses to step inputs in EGF with various fold increases 
(x1.5, x2, x3, x6) in EGF doses, compute the maximal values of the transient pEGFR responses and 
convert them into the corresponding pERK responses using the transfer function. We plot the dose 
response of pERK to the initial EGF treatment applied to system at steady state with 0 EGF (green) 
(Figure 4.73) and the dose responses of maximal pERK to a given fold-change increase in EGF. For 
comparison we also show the predicted and experimentally measured total EGFR dose response. 
Model predicts that in the physiological range of EGF doses (approximately 0.03-3ng/ml EGF), 




































maximal dose responses of pERK to step inputs with the same fold change appear flat across at least 
an order of magnitude of initial EGF doses. In addition, the model predicts the dose responses to 
different fold-changes to be distinct from each other in this range. 
 
Figure 4.73: Predicted dose responses of the maximal pERK responses to step-inputs in EGF at a given 
step increase in EGF. 
We then experimentally validate these predictions of the analytical model and measure pERK 
responses in MCF-10A cells treated with EGF for three hours and at three hours treated with a step 
input in EGF with the same fold-change across all the doses. Figure 4.74 shows experimentally 
measured time-courses of pERK responses in MCF-10A cells, which were incubated at 0 EGF and at 
time=0 were treated with physiological levels of EGF( 0.16 or 0.8 ng/ml). At time=3 hours in each 
case EGF concentration was increased 5-fold. The data demonstrates that despite significant 
difference in transient initial responses in pERK to the two different concentrations of EGF, given the 
fold-change in the step input is the same, the peaks of the produced responses are strikingly similar. 
Such result further  supports  presence  of  Weber’s Law in EGFR signaling system in the physiological 
range of EGF. 
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Figure 4.74 Experimentally measured pERK responses in MCF-10A cells treated with a x5 fold step input 
in EGF applied three hours after initial EGF addtion. At t=0 cells were treated with 0.16 ng/ml (blue) or 0.8 
ng/ml EGF (red) and at t=3 hours EGF concentration in each case has been increased x5 fold. Most of the 
points represent the averages and the standard errors of duplicate experiments; 0.8ng/ml EGF 
treatments after three hours were measured in one replicate.  
 
We  further  validate  the  predicted  Weber’s  Law  in  the  EGFR  system  and  measure  pERK  responses  to  
different step inputs in EGF. In particular, we measure pERK responses at 10 minutes after 3-fold and 
6-fold step increase in EGF applied at 3 hours of stimulation with initial dose of EGF from the 
physiological range. Given our previous experimental observations, pERK response at 10 minutes is 
close to the maximal response of pERK to the step input.  Figure 4.75 shows numerically computed 
10 minute dose response and peaks of the pERK responses to 3-fold and 6-fold step increase in EGF 
with initial EGF stimulations within a physiological range and the corresponding experimentally 
measured pERK dose responses at 10 minutes. Model simulations ( Figure 4.75) suggest that at 
higher EGF doses, transient responses might reach their peak faster, therefore, the measured 10 
minutes dose response might differ from the maximal response. Still,  the  fact  that  model’s  predictions  
of the 10 minutes pERK dose response agree reasonably well with the experimentally measured 
values, suggests that the maximal dose responses of pERK to different fold increases will be distinct 
and flat in the physiological range of EGF. The fact that the predicted dose responses at 6-fold 
increase are distinct from the 3-fold increase eliminates possibility of flatness of the pERK response 

























at 3-fold increase to be caused by the saturation of pERK responses, as higher fold-increase in EGF 
can still produce a higher pERK response. 
   
         
 Figure 4.75: Experimental validation of Weber's Law in pERK responses. 
Section 4.7.4: Probabilistic parameter scan of simplified analytical model  
 
We explore parameter space of the presented in Section 4.7.2 simplified model implementing 
monomer-activation of EGFR receptors. We run MCMC simulations as described in Section 3.2.1, 
with   the   goal   of   finding   parameter   dependencies   which   guarantee   Weber’s   Law   in   the   system’s 
responses to fold-increases in EGF. We do not fit the simplified model to the full experimental data; 
instead, we fit the analytical model to the total EGFR dose response (Figure 4.72) and compute the 
coefficient   of   variation   in   maximal   peak   of   system’s   responses   to   step inputs with the same fold 
changes in EGF and initial levels of EGF from the physiological range (0.1-3ng/ml). More specifically, 
we simulate a scenario in which system pre-adapted to stimulation with a constant level of EGF,  𝑢 , at 
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time=0  is treated with a step input in EGF 𝛼 × 𝑢  (where 𝛼 > 1, 𝑢 > 0). We require that the system’s 
responses decay from their maximal peak.  We  simulate  system’s  responses  to   three  steps  with  the  
same fold increase, 𝛼 = 5, at different initial EGF doses in the physiological range 0.1-3ng/ml. In all 
fits  we  require  that   the  model’s  phosphorylation  responses  to  each  of   the  step   inputs  are  non-trivial 
and rise at least 5% above its initial steady state level. Objective function used to perform MCMC 
simulations computes the distance between the peaks of the responses to the three step inputs and 
is described in Section 3.2.3.The more similar the peaks are, the lower the distance between them 
and the higher the value of the objective function. The MCMC chains are preferentially sampling 
model’s  parameter  space  with  higher objective function. It is important to note that we do not require 
that the timing of the peaks of the responses at the EGF steps inputs of the simplified model are the 
same, we only require that their values are similar 
We derive  parameter  distributions  in  which  Weber’s  Law  holds for the simplified model. Priors 
on the parameter values were derived based on literature estimates (see Table 6), however we allow 
parameters to vary within 1-2 orders of magnitude from these estimates. We then plot the ratios of 
parameter values     and  in the sampled points and highlight the points with better  Weber’s  
Law score in the peaks of responses (Figure 4.76). The results suggest that in the fits with more 
similarity  in  the  peaks  of  their  Weber’s  Law  responses  (shown  in  magenta,  Figure 4.76), the ratio of 
degradation of active receptors to the rate of degradation of inactive receptors ( ) has to be high 
and exceed the ratio .  In  addition,  in  the  fits  with  best  Weber’s  Law  score,  the  latter  ratio  has  to  
exceed  1.  Therefore,   the  model   simulations   demonstrate   that   the  Weber’s   Law   conditions,   derived  
analytically, are indeed reflected in the relationships  in  model’s  parameter space.  
We find that Weber’s  Law  holds  in  less  than  1%  of  the  fits  and  that  this  number  is  significantly  
smaller compared to the number of fits in which nearly-perfect adaptation holds. This result is 
consistent with similar studies which reported that approximate  Weber’s   Law   holds   only   in   about  




used a less constrained requirements  for  Weber’s  Law  and  imposed  it  across  a  narrow  range  of  initial  
ligand doses). 
Overall, we find that even in the parameter space of the simplified analytical model, fraction 
of   fits  with  Weber’s   Law   is   very   low.  Therefore,  working  with   a  more   detailed ODE model of ErbB 
signaling with a larger parameter space would not necessarily allow us to find parameter values 
which  would  fit  well  experimental  data  and  demonstrate  Weber’s  Law  in  phosphorylation  responses.  
Hence, a strategy of using smaller, analytical model with literature-derived parameters is more 
suitable  to  explore  Weber’s  Law  in  the  EGFR  signaling  system.   
 
 
Figure 4.76: Relationship between parameters in the fits  with  Weber’s   Law.    Plotted are the ratios of 
phosphatase activity to the term representing effective activation of receptors (X axis) and ratio of 
degradation of active receptors to inactive (Y axis). Points shown in blue are all simulated fits. 
Highlighted in different colors are the fits  ranked  by  their  Weber’s  Law  score in responses to step inputs 
in EGF with initial dose being in a physiological range of EGF. 
Section 4.7.5: Regimes of the total number of EGFR receptors at steady state 
in chronic stimulations with EGF 
 
In Section 4.7.2 we analytically derived expressions of total EGFR number of receptors at 













unfeasible to precisely quantify abundances of receptors available for ligand binding on the cell 
surface, and thus establish the number of receptors actively participating in cell signaling. Moreover, 
quantifying amounts of the available receptors is obscured partially due to problem of subtracting 
background fluorescence offset from measurements of total EGFR abundances. Our theoretical 
analysis allows to estimate abundances of receptors available for ligand binding in cells adapted to 
treatments with chronic EGF doses. Moreover, our analysis allows to derive analytical expressions of 
abundances of active receptors through various cell parameters, such as, receptors production or 
basal degradation. We then consider the resulting regimes in dependencies of total EGFR available 
for ligand binding and the doses of the applied EGF stimulation (Figure 4.77). 
If EGF concentrations were very low, we derive that most of the receptors should be ligand-
free and available for ligand binding and their total number is given as 
 𝑇 = 𝑘𝑘 + 𝑅, 𝑢~0 (25) 
 In the case when 𝑢 is very large, all receptors will be ligand bound or phosphorylated, and 
therefore 𝑅 will be ~0. Then  
 𝑇 = 𝑘𝑘 , 𝑎𝑠      𝑢 → ∞ (26) 
We showed that In the middle range of EGF doses number of receptors remaining in the cell 
will always be a decreasing function of the EGF dose, suggesting that the higher the EGF dose was 
applied, the lower the number of receptors remains at steady state: 





Mechanistically, this is explained by the fact that at higher initial EGF treatment more receptors can 
get activated and be removed from the cell.  
Overall, the dependence of total EGFR steady state levels on EGF doses described by (25), 
(26), and (27) agrees well with the experimentally measured tEGFR dose-response curve at 3 hours 




EGFR time-courses have decayed to 0 and the system can be assumed to be approximately at 
steady state. 
 The presented here analytical derivation can then be used to estimate, for example, number 
of receptors actively participating in cell signaling by subtracting the amount of total EGFR measured 
at chronic stimulations with saturating doses of EGF from the measured steady state total EGFR 
abundances at no EGF stimulation. Such method allows to quantify fluorescence corresponding to 
the receptors actively participating in signaling, while eliminating the necessity of establishing precise 
amount of fluorescence corresponding to the background offset, which might be challenging 
experimentally (see Section 4.1.3). 
   
Figure 4.77: Three regimes in the total EGFR remaining at steady state to chronic stimulations with EGF. 
    
Section 4.7.6: Steady state analysis of the EGFR signaling system and 
responses to step input in EGF: dimer-activated EGFR signaling model 
 
In this section we derive a simplified analytical model of EGFR signaling which implements 
dimerization of receptors to demonstrate mechanism and conditions under which system responses 
would  exhibit  Weber’s  Law.  We  do  this  through  first  deriving  steady  state  expressions  of  ligand-bound 
and ligand-free receptor species and considering maximal responses of system which has been pre-
adapted to stimulation with a constant stimulus and is then treated with a step-input in EGF. The goal 
is to quantify amounts of total receptors remaining when system has reached steady state to 
stimulation with constant dose of ligand and investigate under what parameter constraints and ligand 
doses   the   system’s   response   to   step   input   applied   to   pre-adapted system is proportional to fold-





























change in that step-input. We apply simplifications to the model expressions based on known 
biochemical properties of ErbB receptors and their downregulation processes and limit EGF ranges to 
physiologically relevant regions. 
Other works have previously derived steady state expression for total unbound EGFR and 
activated receptors in simplified analytical models (Zi & Klipp, 2007). We specifically use the steady 
state expressions for amount of EGF-free receptors to derive estimates of peak responses to step 
increases in EGF concentrations applied when system has pre-adapted to non-zero EGF stimulation. 
The model encompasses the following processes: basal receptors production 𝑘  and 
degradation of inactive receptors, reversible ligand binding of EGF (𝑢) to receptors (𝑘 , 𝑘 ), receptors 
dimerization (𝑘 , 𝑘 ), activation (𝑘 ) and deactivation through phosphatase (𝑘 ) and degradation of 
active receptors (𝑘 ). We assume in the model there are only dimers with one EGF bound, an 
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𝑑𝑡 = 𝑘𝑝𝑟𝑜𝑑 − 𝑘1𝑢𝑅 + 𝑘𝑑1𝐵   − 𝑘2𝐵𝑅 + 𝑘𝑑2𝐷   − 𝑘𝑑𝒐𝑅
𝑑𝐵
𝑑𝑡 = 𝑘1𝑢𝑅 − 𝑘𝑑1𝐵 − 𝑘2𝐵𝑅 + 𝑘𝑑2𝐷
𝑑𝐷
𝑑𝑡 = 𝑘2𝐵𝑅 − 𝑘𝑑2𝐷 − 𝑘𝑎𝐷 + 𝑘𝑝𝑃
𝑑𝑃




The total number of receptors can be written as follows: 
𝑇 = 𝑅 + 𝐵 + 2 ∗ 𝐷 + 2 ∗ 𝑃                       
and its dynamics is described by the following expression: 
 𝑑𝑇
𝑑𝑡 = 𝑘 − 2 ∗ 𝑘 𝑃 − 𝑘 𝒐𝑅 (29) 
Note, that if signal activation is weak, at steady state most of receptors will remain unphosphorylated 
and therefore 𝑃~0. In the case of strong activation in the pathway, at steady state all receptors will be 
phosphorylated and 𝑅~0 and, hence, 𝑃 = ∗ . However, this condition might not in fact be perfect 
adaptation, but merely a result of signal saturation at higher EGF doses. In all other cases, given that 
the rate of degradation of activated receptors is significantly higher than the rate of degradation of 
inactive receptors 𝑘 ≫ 𝑘 𝒐, neglecting the term 𝑘 𝒐𝑅 in (29) and leading to 𝑃 = ∗ . This suggests 
that steady state value of 𝑃  will be independent of ligand concentration, which by definition is perfect 
adaptation of signal 𝑃.  
We then apply series of simplifying assumptions, namely, that EGF binding to monomers is 
fast and thus can be assumed to be at quasi-equilibrium: 
 𝑘 𝑢𝑅 = 𝑘 𝐵 (30) 




 𝑘 𝐵𝑅 − 𝑘 𝐷 − 𝑘 𝐷 = 0 (31) 
From (30)and (31) we can express 𝐵 and 𝐷 as: 
𝐵 = 𝑘𝑘 𝑢𝑅     
𝐷 = 𝐵𝑅= 𝑢𝑅  
















𝑘 𝑢𝑅 − 𝑘 𝑃 − 𝑘 𝑃
 (32) 
If we assume that at certain range of 𝑢 at steady state degradation of inactive receptor is negligible 
compared to its consumption through the activation step, 𝑢 ≫ 𝒐  ,   we can drop 𝑘 𝒐𝑅  term 
in (32) and solve for 𝑅 at steady state: 
 
𝑅 = 𝑘




Substituting (33) and solving the steady state equation for 𝑃 we have: 
𝑃 = = =  






𝑘 𝑘𝑘 + 𝑘
𝑘
𝑘 𝑢
𝑃 = 𝑘𝑘 + 𝑘
 
Therefore, when the system has reached steady state to stimulation with constant dose of EGF, 𝑢 , 
the model can show 𝑅~
  
 dependence of the amount of unbound receptor on EGF concentration, 
and perfect adaptation on the signal 𝑃. We then derive expression for maximal signal 𝑃          when the 
system adapted to steady state to stimulus 𝑢  is being stimulated with step increase in input 𝑢    → 𝑢   . 




maximum 𝑃𝑚𝑎𝑥, degradation of active receptors is insignificant, compared to their dephosphorylation 
by phosphatases, thus preserving total number of receptors before the signal reaches the maximum. 
Then we can assume that 𝑅~𝑅𝑜         and rewrite  𝑃          as follows:  






Substituting expression (33) of 𝑅         at steady state we obtain: 
















 Hence, we showed here that the maximum response of the phosphorylated signal up to a constant is 
proportional to the fold increase in the step input   
  
,  where 𝑢    ≫ . 
We presented two analytical models of ErbB   signaling   able   of   exhibiting   Weber’s   Law  
responses under certain conditions. The model presented in this Section 4.7.2 assumes 
simplifications in receptors dimerization and activation steps and suggests that tEGFR memory can 
be stored as ~  in the region of EGF  doses  with  Weber’s  Law. The model presented in this section 
implements  receptors  dimerization  step  and  suggests  that  the  system  responses  can  exhibit  Weber’s  
Law in certain region of EGF doses in which the memory of the EGF dose,  𝑢, will be stored in the 
number of EGFR receptors remaining in a functional form ~ . Our experimental data suggests that 
functional dependence of tEGFR at steady state on the EGF dose can be a mixture of the two 
possible proposed relationships (Figure 4.69). 
Section 4.7.7:  Extrapolation  of  Weber’s  Law  on  pEGFR  to  pERK  and  pAKT 
 
Our detailed kinetic model (Section 4.6.1) shows that at certain parameter assignments and 
range of initial EGF  doses  pERK  can  exhibit  Weber’s  Law.  We extend our simple analytical model to 
include pERK activation. We implement the signaling from pEGFR to pERK through one intermediary 
kinase which is activated by pEGFR and performs two phosphorylation steps needed to activate 
pERK. The extended analytical model can reproduce qualitative features of signals on both pEGFR 




constraint   of  Weber’s   Law   on   pERK   can   find regions of parameter space in which pERK shows 
Weber’s  Law.  Moreover,  the  simulations  suggest  that  the  Weber’s  Law on pERK responses depends 
on  Weber’s  Law  at  pEGFR.   
In the extended analytical model pERK is separated from pEGFR only by one intermediate 
kinase and reactions of phosphorylation and dephosphorylation. The intermediate component thus 
has no molecular mechanisms to implement memory of EGF doses on its own, and yet, pERK can 
exhibit  Weber’s   Law   even   in   such   simplified   network   topology.   Therefore,   it   is  most   likely   that   the  
Weber’s  Law  on  pERK  is  a  result  of  linear  amplification/transmission  of  the  Weber’s  Law  present  on  
pEGFR. The simplified analytical model thus demonstrates one parsimonious topology to realize 
Weber’s   Law   on   pERK   and   suggests   that  Weber’s   Law   at the receptors level can be propagated 
throughout the signaling kinase cascades.  
Indeed, dose responses of pEGFR and pERK from our experimental data suggest that pERK 
acts as linear amplifier of signal on pEGFR: pERK dose response is shifted and somewhat scaled 
compared to pEGFR dose response (Figure 4.4). It is possible that if in the course of the signaling no 
significant changes occur in the intermediate signaling component (such as irreversible modification 
or degradation), the dose response relationship between pEGFR and pERK activation could remain 
more or less preserved over time.  Hence, if pEGFR responses to step inputs with different initial 
levels of EGF but same fold-changes have similar amplitudes, it will result in responses with similar 
amplitudes on the pERK as well (except for the regions of pERK signal saturation).  
Recent studies indicate that the signaling components downstream of Sos do not retain 
memory of previous stimulations (Toettcher et al., 2013). Without molecular mechanism to remember 
past doses of stimulus, the downstream kinase cascade would not be able to compare doses of 
incoming stimuli to doses in the past stimulations, and thus, would not be able to realize responses 
with   Weber’s   Law. This observation further supports the hypothesis that in the EGFR signaling 
system,   Weber’s   Law   to EGF stimulation is most likely implemented at the pEGFR level, the 







Chapter Five: Discussion and Future Directions 
 
In this chapter we present discussion on the results of this work (see Chapter Four) as well 
as the future directions of this research. Previously,  Weber’s  Law  in  mammalian  signaling  cascades  
has been reported at the level of transcriptional networks (Goentoro & Kirschner, 2009; Lee et al., 
2014).   To   the   best   of   our   knowledge,   Weber’s   Law   has   not   been   explored   in   mammalian  
phosphorylation signaling cascades. One of the key contributions of our work is the discovery of the 
EGFR receptors-based   mechanism   enabling   Weber’s   Law   in   phosphorylation   responses   sensing  
relative changes in levels of extracellular EGF. Most importantly, we suggest that the discovered 
Weber’s  Law  mechanism can be ubiquitous to other receptor sensory systems. Overall, the proposed 
receptors-based  mechanism   of  Weber’s   Law   in   signaling   pathways may be a result of convergent 
evolution in mechanisms of cell signaling. Regarding the topology of signaling networks exhibiting 
Weber’s   Law,   we   believe   that   Weber’s   Law   in   mammalian   signaling networks is parameter, not 
topology dependent. Therefore, signaling network reduction into a smallest unique network motif 
responsible   for   Weber’s   Law   in   a   given   system may not necessarily be possible for mammalian 
signaling cascades.  
 
Section 5.1: Theoretical insight on properties of network topologies capable of 
Weber’s  Law  in  mammalian  signaling  networks 
 
Recent works on biological networks were informed by physics outlook and set out to find the 
simplest topologies capable of various specific system properties, such as Weber’s  Law  or  perfect  
adaptation. For example, such approaches have helped to elucidate mechanism of perfect adaptation 
in bacteria chemotaxis (Alon et al., 1999) and   explore  Weber’s   Law   in   transcriptional networks in 
mammalian cells (Goentoro & Kirschner, 2009; Goentoro et al., 2009; Lee et al., 2014). In general, in 
the course of evolution, bacterial genomes have experienced selection pressure to optimize cellular 
functions, while also to have smaller genomes. Thus, bacterial genomes may have simpler molecular 
networks which could have been advantageous for their species survival in light of large population 




topologies of signaling networks could have been not that pronounced, given there were no 
significant selection pressure on the genome size, possibly due to genome recombination and much 
smaller population sizes in mammals. Hence, we believe that mammalian phosphorylation signaling 
cascades might not necessarily have simplest unique underlying network motifs which would enable 
them to  realize  Weber’s  Law.  In fact, we think that driven by evolution of signaling components which 
might thrive to optimize the function, but not necessarily care for the simplicity of the resulting 
network, their architecture may have more complicated network   modules   responsible   for  Weber’s  
Law.  
This work raises an important question concerning the topologies of mammalian 
phosphorylation  signaling  networks  exhibiting  Weber’s  Law.  More  specifically,  our  work  suggests  that  
mammalian kinetic signaling networks may exhibit  Weber’s  Law  in  a  parameter-dependent manner.  
For example, the simplified analytical model presented in Section 4.7 is just one possible 
incarnation of a simplification of a more detailed kinetic ODE model we derived (Section 3.1.2). This 
simplified analytical model relies on several specific assumptions which effectively impose constraints 
on   model’s parameter space. In principle, we could have derived several alternative simplified 
models, each with its own set of simplifying assumptions constraining the model to a specific region in 
the parameter space of the larger model. Hence, the simplification of a more detailed mechanistic 
model   might   produce   several   smaller   topologies   with  Weber’s   Law.   Each   such   simplified   network 
topology could have its own mechanism of Weber’s  Law.  It  might  be  possible  to  distinguish  between  
the true and the incorrect schematics only through experimental work. Thus, Weber’s   Law   in   the  
kinetic model we derived (see Section 4.7) is contingent on parameter assignments, and holds only at 
a certain range of ligand doses. Therefore, the model topology alone does  not   guarantee  Weber’s  
Law, implying that there can exist parameter assignments at which the model would not exhibit 
Weber’s  Law  at  any  range of EGF doses. 
In the future, properties  of  mammalian  signaling  networks  exhibiting  Weber’s  Law could be 
explored further. It will be interesting to see a theoretical methodology to check the possibility of 
reducing a given complex signaling network with approximate  Weber’s  Law  property   into  a  simplest  




In  addition,  it  is  conceivable  that  the  same  complex  signaling  network  could  realize  Weber’s  
Law through different molecular mechanisms, specific to the parameter space and regions of ligand 
doses. For example, in addition to the EGFR receptors-based  mechanism   of  Weber’s   Law,   pERK  
responses  might   realize   its  own  mechanism  of  Weber’s  Law   through  a  negative   feedback   loop,   for  
instance, through activating its own negative regulators (such as DUSP phosphatases). The various 
mechanisms   of   Weber’s   Law   might   be   apparent   at   the   same   or   different   ranges   of   extracellular  
ligand, therefore providing cell signaling pathways with a more elaborate control on their information 
processing.  
Lastly,  different  types  of  mechanisms  of  Weber’s  Law  can  exist  at  different  levels  in  signaling  
cascades and even complement each other. For example, the receptors-mediated mechanism of 
Weber’s  Law  can   realize  pERK responses dependent on relative changes in levels of extracellular 
stimuli, whereas a transcription-network based mechanism (such as described in Goentoro et al., 
2009) can detect relative changes in pERK levels and generate transcription activation responses 
based on the relative changes in pERK. 
Section 5.1.1: Previous theoretical studies on topologies of biological 
networks with Weber’s  Law   
 
Recent theoretical studies explored properties of topologies of biological networks capable of 
fold-change detection (FCD) (Shoval et al., 2010). By definition, a system exhibits fold-change 
detection, if dynamic responses of the system to step inputs with the same fold change, yet different 
absolute levels of the stimulus, are identical. The FCD property entails both, perfect adaptation and 
Weber’s  Law  on  the  responses,  and,  in  addition,  requires  that  their  timing  and  dynamics  be  the  same.  
Overall, perfect adaptation constraints the long-term steady state system behavior; whereas, Weber’s  
Law imposes limitations on the maximal amplitudes of the responses. FCD concerns systems 
responses on both the long-term and the immediate time scales, and in fact, applies to the entire 
time-course of the responses. Hence, fold-change detection imposes very stringent constraints on the 
underlying network topology.  
It is important to note that the authors in Shoval et al., 2010 used a limited interpretation of 




the most general definition of Weber’s  Law does not impose constraints on the timing of the maximal 
amplitudes of the responses. 
The authors derive theoretical conditions necessary and sufficient for a system to show FCD 
and present several examples of simplified network topologies capable of achieving FCD. In addition, 
they present variable-substitution methods for transforming one type of topology into another, and so, 
to be able to better understand relationship between different classes of topologies. 
The authors describe three simplest network topologies capable of FCD: incoherent feed 
forward loop, nonlinear integral feedback, and logarithmic input topology with linear integral feedback, 
and a more general class of network topologies with log-linear input systems (Figure 5.1). 
In brief, the incoherent feed-forward loop (IFFL) topology entails simultaneous stimulus-
induced activation of an output target and of a repressor of that output target. Recent work explored 
properties of the parameter space of the IFFL topology which would allow fold-change detection 
(Goentoro et al., 2009). In particular, the authors find that the IFFL is capable of FCD only when the 
activator is in its linear regime and the suppressor acts in saturation. Several experimental studies 
suggested that an IFFL at the transcriptional level could allow fold-change detection in mammalian 
cells ( Goentoro & Kirschner, 2009; Lee et al., 2014).  
The nonlinear integral feedback topology described in (Shoval et al., 2010) essentially is a 
modification of a well-known integral feedback topology, in which, a deviation of an output variable 
from its intended steady state value is integrated over a certain time and is fed back to control this 
output variable. By non-linearizing the feedback expression and using a ratio-based activating 
controller one obtains a FCD-capable topology referred to as a nonlinear integral feedback. 
Interestingly, with a variable transformation in the nonlinear integral feedback topology one can derive 






Figure 5.1: Suggested mechanisms of fold-change detection: incoherent feed-forward loop, nonlinear 
integral feedback, linear integral feedback with log input. Reproduced from (Shoval et al., 2010) 
In addition,  Shoval et al., 2010 present experimental strategies to validate the presence of 
fold-change detection in biological systems. They suggest investigating the input-output relationship 
of the system, checking if the biological system has one of the enabling network topologies; and 
lastly, testing if the system can perform scale-invariant searches. However, whereas perfect 
adaptation  and  Weber’s  Law  are  easier   to  validate individually, verifying fold-change detection may 
require comparing not just the peaks, but entire dynamical profiles of system responses, which may 
be experimentally unfeasible in certain systems. This leads to a broader, philosophical question 
whether the biological systems may even be required to exhibit exact fold-change detection at all. 
Often operating in environments with molecular noise, biological systems perhaps may have 
developed mechanisms which rely only on certain features of responses, rather than on the entire 
shape and the amplitude of the signaling response. 
Notably, most of the simplest network topologies capable of FCD presented in the study by  
Shoval et al., 2010 concern transcriptional regulation networks, which operate via different 
mechanisms and on a different time scale then the phosphorylation signaling networks. Overall,  
Shoval et al., 2010 main goal was to find the simplest network topologies with FCD. This approach 




smaller genomes, could have evolved to have smaller signaling networks. However, this assumption 
may not be relevant in the case of complex mammalian signaling networks. 
A recent study addressed a possibility   of  Weber’s   Law   specifically   in   enzymatic   signaling  
networks (Skataric & Sontag, 2012). The theoretical work explored all possible three-node enzymatic 
topologies  with  adaptation  which  also  exhibit  Weber’s  Law. Necessary and sufficient conditions for a 
topology  to  be  capable  of  Weber’s  Law  are  derived  (Skataric & Sontag, 2012). In addition, the authors 
make  a  point  that  most  enzymatic  networks  would  possess  only  approximate  Weber’s  Law,  and  that  
under  a  certain  simplifying  transformation,  larger  kinetic  networks  with  approximate  Weber’s  Law  can  
be transformed into smaller topologies   with   exact   Weber’s   Law.   However,   we   find   several  
shortcomings of the study. First, the study relies on a not quiete valid in vivo Michaelis-Menten 
formalism to encode enzymatic reactions. Next, to assess   Weber’s   Law   responses   the   authors 
consider very similar inputs (i.e. within one order of magnitude) and only low fold increases (within 
20%), thus leaving a possibility that the observed  approximate  Weber’s  Law  is  a result of comparing 
systems responses on very similar inputs and trivial step perturbations. Most importantly, the 
transformation applied to obtain simplified network topologies   is   very   constraining   to   model’s  
parameter space. In particular, the authors impose that the model’s  output  variable  reaches  steady  
state much faster than the other internal variable. Such constrain would hold only in a limited 
parameter subspace. Hence, the described above studies of network topologies capable of FCD 
(Shoval et al., 2010; Skataric & Sontag, 2012) demonstrate that even the simplest enzymatic 
networks  with  Weber’s  Law  are  not,  in  fact  topology-, but parameter-dependent. 
 
Section 5.2: Receptor-mediated mechanism of Weber’s   Law   in   sensing EGF 
levels at pERK responses may be advantageous to cell information 
processing 
 
Dynamics and amplitude of phospho-ERK signal are known to play an important role in cell 
fate decisions, such as cell growth, division, and proliferation (see Section 2.8.4). Ligand stimulation 
of cells might produce different signaling outcomes at phospho-ERK level, depending on the cell type 
and context of gene expression in the cells (Ebisuya et al., 2005). Currently, the relationship between 




actively investigated (Albeck et al., 2013). Many studies focused on understanding the relationship of 
steady-state pERK levels to growth factor stimulation and cell responses (Goldbeterl & Koshland, 
1984; Blüthgen, 2006). However, it is likely that both, the steady state as well as the dynamics of 
pERK responses affect cell fate decisions (Sasagawa et al., 2005, Selimkhanov, Taylor, Yao, & Pilko, 
2014). 
Hence, given that pERK dynamics matters to cell fate decisions, it is biologically plausible 
that to produce a coordinated cell response to ligand stimulation neighbouring cells in a tissue may 
need to generate similar responses at their pERK levels, thus justifying the need  to  exhibit  Weber’s  
Law at pERK.  
Our experimental data as well as our model suggest that pERK can exhibit Weber’s  Law  in  
sensing EGF doses. We find that Weber’s  Law  at  pERK   responses   is  most likely realized through 
Weber’s  Law  at  pEGFR  responses,  and  that  possibly  pERK  does  not  possess  its  own  mechanism  of  
Weber’s   Law.   pERK is known to be activated by a series of kinase cascades via two-step 
phosphorylation. Another downstream target of pEGFR important to cell fate, pAKT, is known to be 
activated via the PIP3 activation. Unlike ERK, AKT requires only one phosphorylation to be fully 
activated. It will be interesting to explore if despite such distinctions in activation, pAKT is also 
capable of Weber’s  Law. Such observation could then allow us to hypothesize that other targets of 
pEGFR,  not  explored  in  this  work  might  also  exhibit  Weber’s  Law,  given  that  the  pathway  leading  to  
the target is linear and there are no irreversible inhibitory loops or degradation of intermediary 
components. In case some intermediary components are degraded in the course of ligand 
stimulation, the downstream signaling cascade may become insensitive to the repeated stimuli, 
unless the pools of the functioning intermediate component are restored.  
Having a single unified control over the information transmitted down into the cell interior can 
allow cells to better regulate the interaction between the cell environment and the cell signaling 
responses. In addition, such unified control may help to achieve coherence in activation and 
regulation of downstream components between themselves: in the case when each intracellular 
signaling component implemented its own regulation mechanism, different components could 




first to closely regulate signalling at the upstream receptor level, as the effects of such regulation 
would then be propagated to the downstream targets. Therefore, relying on intricate regulation of the 
number of functional cell surface receptors could provide cells with a more effective way to adjust and 
dynamically maintain their sensitivity to extracellular stimuli. Given that the number of functional cell 
surface receptors can be regulated through multiple mechanisms, such as, for example, receptors 
endocytosis, or inactivating post-translational modifications, receptors synthesis and others, the cells 
would thus have versatility in its mechanisms to control and fine-tune the number of cell surface 
receptors and to ensure cells sensitivity to consequent stimuli.  
The MAPK signaling cascade, which leads to pERK activation, is one of the most ubiquitous 
and well-studied signaling cascades in mammals (Chen et al., 2009). MAPK signaling can be 
activated through a variety of cell surface receptors, such as, for example, the ErbB receptors, and 
the G-protein coupled receptors (Goldsmith & Dhanasekaran, 2007). Therefore, it is plausible that the 
mechanism  of  Weber’s  Law   in pERK responses presented here could be generalizable to signaling 
through many other receptors sensory systems. Relying  on  Weber’s  Law   in  receptors  responses  to  
relative changes in levels of extracellular stimuli and on the linear propagation of the receptors 
activation to their downstream signaling targets, such schematics represents a versatile tactic of the 
cells to be able to respond to relative changes in levels of extracellular stimuli.  
Section 5.3: Comparing parameter distributions between normal and cancer 
cell lines 
 
We obtained experimental measurements of EGF signaling in three different mammalian cell 
lines: MCF-10A – an immortalized normal mammary epithelial tissue, MCF-7 and SKBR3 two breast-
cancer derived tissues. Dose-responses of pERK measured over 1.5 hours after EGF addition show 
that in the three cell lines pERK decay has different dynamics: after reaching the peak response 
around 10 minutes, in MCF-7 pERK decays rapidly, in MCF-10A the decay is slower, whereas in 
SKBR3 after transient peak the signal remains unchanged between 30 minutes and 1.5 hours (Figure 
5.3). We then also consider dose-responses of other targets in these cell lines (Figure 5.7). The data 
for all three cell lines was collected on the same day. The fluorescence measurements most likely 




differences in the off-target binding specific to each cell line. However, we observed that the same 
primary antibodies are used to measure each of the three targets and the “no primary” control 
measurements were similar between the three cell lines. Therefore, we can compare the 
fluorescence data obtained in three different cell lines. 
In agreement with our prior estimates of total EGFR abundances, the dose responses of 
tEGFR show that MCF-10A contains a higher number of receptors, with SKBR3 containing less 
receptors, and MCF-7 having a low number of receptors. The corresponding experimental estimates 
suggested that MCF-10A had approximately 3x105-6x105, SKBR3 ~ 2.5 x105 and MCF-7 5x104 EGFR 
receptors per cell. The time-courses of total EGFR abundances in response to treatment with 
different doses of EGF over up to three hours show that in SKBR3 and MCF-7 total number of EGFR 
does not change significantly, even at higher concentrations of EGF doses. However, MCF-10A total 
EGFR measurements show that at higher EGF doses significant amount of receptors is degraded. 
This observation is in agreement with the pEGFR phosphorylation measurements – higher activation 
of EGFR leads to more of the receptors being degraded. 
We observe that MCF-7 cells in response to EGF treatment did not show significant pEGFR 
activation; whereas in SKBR3 pEGFR signal increased with higher EGF doses and decayed over 
time. In MCF-10A pEGFR at higher doses was more pulse-like with a faster rate of decay compared 
to the signal decay rate in SKBR3 cells. The data also suggests that across all three cell lines pEGFR 
signal did not exhibit saturation, a feature which is manifested by flatness of dose-responses at higher 
EGF doses, as in example of pERK and pAKT signal saturation in dose responses shown in Figure 
5.3. 
We fit the model separately to each of the cell line-specific experimental data set. We impose 
the same priors on the parameters in model simulations for each of the three cell lines. With distinct 
parameter assignments, the model can fit reasonably well the experimental data for each of the three 
cell lines (Figure 5.4, Figure 5.5, and Figure 5.6). We then conduct a preliminary MCMC sampling of 
parameter space for data of each of the three cell lines. Although the MCMC chains in the preliminary 
simulations have not converge and need longer simulation time, we could draw some preliminary 




Obtaining the properly converged MCMC chains would then allow to better understand what basic 
signaling processes are fundamentally different between the cell lines.  
 
 
Figure 5.2: Experimentally measured pERK dose-responses over 1.5 hours of EGF treatment in three 
different cell lines MCF-10A, MCF-7, SKBR3. 
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Figure 5.3: Experimentally measured phosphorylation dose-responses over three hours of EGF 
treatment in three cell lines MCF-10A, MCF-7, SKBR3. Measurements are reported in arbitrary units of 
fluorescence. The data shown is not normalized to allow for the comparison between the cell lines. 
However, even from the preliminary MCMC chains we observe that the model correctly 
predicts difference in the average EGFR abundance in MCF-10A and MCF-7 cell lines (Figure A-6). 
Note that we did not impose different priors for each of these cell lines, although, we know that on 
average MCF-10A cells express about an order of magnitude more EGFR then do MCF-7 cells. 
Fitting the phospho-EGFR and tEGFR dynamic responses to different EGF doses allowed the model 
to recover this aspect of cell lines difference and to predict EGFR abundance in MCF-10A cells to be 
~2.09 x 105 and in MCF-7 ~ 104  EGFR receptors per cell. The model failed to correctly estimate the 







































EGF,  ng/ml  
5.0752    5.9899   
11.0000 
  
  5.2292    





experimental measurements estimated EGFR abundance in SKBR3 cells to be on the order of 105-
106. It is possible that the SKBR3 signaling dynamics is significantly influenced by the overexpression 
of ErbB2 receptors, which we do not implement in the current model. 
We conduct a preliminarily analysis to find the differences in model parameter space 
obtained by fitting the model to the cell-line specific experimental data sets. We first look at 
parameters related to maintaining the basal levels of EGFR in the absence of EGF to try to explain 
the observed differences in EGFR abundances. We find that in MCF-10A cells the rate of basal 
EGFR production is higher than in the other two cell lines, in addition, the rate of degradation of basal 
receptors is slower than their recycling, thus allowing their accumulation on the cell surface. For MCF-
7 cells, the rate of production of EGFR is low, and although the rate of receptors internalization is 
slower than in MCF-10A, internalized inactive receptors would preferentially be degraded, rather than 
recycled. The fraction of internalized receptors which is degraded is determined by the corresponding 
rates of recycling to degradation of inactive receptors. Overall, the steady state level of the total 
number of receptors can be shown to be as follows: 
 𝑇 = (𝑘 + 𝑘 + 𝑘 ) 
where 𝑘   is the rate of basal degradation of receptors, 𝑘  – rate of recycling of inactive receptors, 𝑘  
– the rate of internalization of inactive receptors, 𝑘  – rate of EGFR synthesis. Therefore the 
differences in the rates of EGFR synthesis predicted for MCF-10A and MCF-7 cells, and preferential 
degradation of receptors over their recycling in MCF-7, versus preferential recycling over degradation 
of receptors in MCF-10A cells, could explain different predicted levels of the initial EGFR in these two 
cell lines. Here we show how the model can help to explain the differences in the initial abundances 
of cell surface EGFR based on predicted parameters related to receptors turnover. 
We find that kcat of activity of EGFR phosphatases in MCF-7 is predicted to be lower than in 
MCF-10A cells, as signal downregulation is possibly compensated by more rapid internalization and 
degradation of activated receptors. Therefore, one might hypothesize that signal downregulation in 
MCF-7 happens mostly due to rapid removal of activated receptors from the cell surface and their 




can explain the observation that experimental measurements of tEGFR appear to be constant over 
time and doses. In fact, our results suggest that in MCF-7 cells the number of receptors does 
decrease over time at stimulation with higher doses of EGF, yet absolute amount of degraded 
receptors is low to be detected by experiments. It is possible, in the MCF-7 cells given the number of 
EGFR is low, total number of activated receptors is also low, which could lead to their rapid removal 
through the internalization machinery which is not-saturated. Saturation of cell internalization 
machinery by the overabundance of activated receptors has been previously reported in the literature 
(Sigismund et al., 2008). 
We also find that compared to MCF-10A cells, in MCF-7 the rate of ERK phosphatase activity 
(kd5) is predicted to be lower, whereas the rate of activation of ERK (kd51) was predicted to be as 
high as in MCF-10A cell lines. A significantly higher rate of activation over deactivation rate, thus 
could explain the observed high amplification on pERK responses in MCF-7 experimental 
measurements, which could be a result of an overactivating mutation in this breast cancer derived cell 
line. Therefore, it is plausible that rapid pERK signal decay observed in MCF-7 is most likely due to 
rapid attenuation of signal at the EGFR receptors level. 
The experimental data collected in SKBR3 cells show slow EGFR receptors degradation and 
somewhat sustained pEGFR and pERK responses. pEGFR signals in SKBR3 cells had lower 
amplitudes than in MCF-10A cell. The preliminary model parameter scan predicts that in SKBR3 cells 
the rate of degradation of active receptors (k60) is slower than the rate of receptors recycling (kd91), 
possibly explaining slow pEGFR signal downregulation observed in SKBR3 cells. Interestingly, it is 
known that overexpression of ErbB2 in SKBR3 cells can lead to their dimerization with EGFR, and 
that the formed dimers are internalization-impaired compared to the EGFR homodimers (Hendriks, 






Figure 5.4: Predicted fit to the MCF-10A experimental measurements. 
 
Figure 5.5: Predicted fit to the MCF-7 experimental measurements. 


















































































































Figure 5.6: Predicted fit to the SKBR3 experimental measurements. 
Our model and probabilistic framework can be used to comprehensively sample model 
parameter space which agrees with the experimental data from each of the three cell lines. The 
obtained parameter distributions can then be compared to identify what fundamental signaling 
processes are disrupted in cancer cell lines and what are their possible implications to cell signaling.  
We find that in all three cell lines, after transient increase pEGFR signal decays nearly to its 
pre-stimulus level. It is interesting to investigate how differences in receptors down-regulation 
dynamics although all produce signal decay at pEGFR levels, could determine different system 
responses to repeated stimulations with EGF. One next step in this direction could be to investigate 
experimentally if MCF-7 and SKBR3 cell lines also are able to sense relative, not absolute, changes 
in EGF levels in downstream kinase cascades leading to ERK activation. Do cancer cells adjust their 
sensitivity to EGF after they were exposed to chronic stimulation with EGF? What are the quantitative 
features of EGF memory in cancer cells and what possible impact such memory might have on the 


























































cancer   cells’ ability to process important EGF signals? These are some questions which could be 
interesting to investigate with the experimental measurements in cancer cells. 
Table 7: Parameter’s description 
 
Section 5.4: Fitting the model to single cell distributions of cell responses 
Most of the results presented throughout Sections 4.2 - 4.6 were obtained by fitting the model 
to experimental data representing average cell response to a particular ligand treatment. Each 
experimental point to which the model is fitted was obtained by taking the average of the averages of 
single cell distributions of responses across several independent biological replicates of the 
experiments. To minimize contribution of experimental error and to derive the most probable system 
responses of the overall ensemble of cells, the biological replicates of the experiment were repeated 
on different days. The error used to fit such experimental data is standard error in the mean. Such 
error reflects uncertainty in detecting the average cell population behavior between different 
replicates. The error is most likely to be attributed to the experimental error of measuring day-to-day 
variability in average cell population responses and is assumed to be normally distributed. To 
summarize, fitting the model to averages of the distributions of single cell responses allows to derive 
    k1/ kd1 EGF binding/unbinding from EGFR monomers
    k31/ kd31 EGF binding/unbinding from EGFR dimers
    k2/kd2 EGFR dimerization with one EGF molecule bound
    k2a/kd2a EGFR dimerization with two EGF molecule bounds
    kd123 kcat of EGFR phosphorylation
    kd950 kcat of EGFR dephosphorylation
    k60 degradation of activated EGFR
    k77 basal production of EGFR
    k910 basal internalization of EGFR
    kd910 recycling of inactive EGFR
    k91 internalization of EGF-bound receptors
    kd91 recycling of EGF-bound receptors
    k61 degradation of inactive EGF
    k50 binding of kinase activating ERK
    kd50 unbinding of kinase activating ERK
    kd51 kcat of activation of pERK by pEGFR




knowledge about most likely behavior of cell population and is a good approximation if single cell 
distributions appear to have Gaussian shape. 
The variability in the predicted distributions of responses in model fits to the ensemble 
averages data captures the variation arising due to day-to-day variability in measurement error in the 
experimental data of average cell behavior. In addition, the variability in produced fits arises due to 
unidentifiability in model parameters space – multiple parameter assignments can fit the data similarly 
well with some deviation in certain predicted points. 
It can be interesting to understand how responses of individual cells can vary between within 
cell population and to gain an insight about the cell-to-cell variability in the underlying parameter 
values. To the best of our knowledge, fitting mechanistic models to dynamic data of single cell 
distributions has not been previously done, most likely due to the experimental challenge it presents, 
but also, due to the absence of a principled computational and probabilistic framework that the 
interpretation of such data and the results require. 
Most of the single cell distributions we obtain can be approximated with the Gaussian 
distribution. However, in some cases the distributions of single cell responses might deviate from the 
normal distributions in their shape (Figure 5.7), and hence, other than the normal distributions might 
be better for approximating single cell responses. The Gamma distribution has been proposed to 
approximate skewed single cell distributions as in Figure 5.7B(Birtwistle et al., 2012). 
Our experimental data shows that distributions of single cell responses of the same target 
can vary in shape depending on EGF dose of stimulation and time when response is measured. For 
example, the variance of pERK responses to EGF tends to be smaller at earlier times (Figure 5.12) 
compared to later times. Interestingly, for pEGFR response (Figure 5.14) variances in single cell 
distributions increase with time of measurement of the response and are the highest at the peak of 
the cell responses, decreasing to the variances in the pre-stimulus single cell responses distributions. 
Shapes of single cell distributions at a given time point might depend on EGF dose of the treatment 
(Figure 5.9). For example, we observe that at lower EGF early pERK responses might be double-
peaked in distributions, suggesting heterogeneity in the rates of ErbB signaling pathway activation 




single cell distributions may provide a valuable insight into cell population behaviors which can be 
important in the context of cells functioning in tissues in an organism. 
In practice, there are certain possible limitations to using the distributions of single cell 
response data. For example, at certain conditions the distributions of single cell responses may be 
spread in shape due to the fact that the single cell response distributions might have large variances 
compared to the usually lower errors in the mean used in the ensemble averages data. Therefore, the 
parameter distributions predicted by fitting the model to single cell responses distributions may be not 
as constrained as they may be in case the model is fitted to the cell population ensemble averages 
data. Still, such distributions could be informative about the degree of cell-to-cell variability in values 
of various parameters, such as, for example various protein abundances. 
Overall, the predicted distributions of single cell responses obtained from fitting the model 
directly to single cell responses distributions allows to capture the true cell-to-cell difference in their 
gene expression, as well as differences in their other parameters (such as, for example, effective in 
vivo kinetic rate constants of reactions), and an experimental error due to detection error of the 
phosphorylation of the single cell data.  
In this work we obtained experimental measurements of single cell responses to EGF 
treatments in cancer cell lines and developed a principled method to normalize and scale 
independent biological replicates (see Section 4.1). The data can then be used to fit the kinetic ODE 
model of ErbB signaling we implemented using probabilistic framework (Section 3.2) to derive 
posterior parameters distributions that are most consistent with the observed experimental data. It 
can be interesting to explore how various subpopulations of cells with different signaling dynamics 
map onto the subregions of model parameter space. In addition, the predicted distributions can then 
be used to generate distributions of single cell responses to various perturbations, such as, for 





Figure 5.7: Examples of experimentally measured single cell distributions of the phosphorylation 
responses. For comparison, shown in black are normal Gaussian distributions. Each distribution is 
plotted normalized to its own mean and standard deviation. Data is derived from MCF-10A cells treated 
with EGF. 
 
Figure 5.8: Single cell distributions of the pEGFR dose-responses 10 minutes after treatment with EGF of 
MCF-10A cells. The distributions are standardized to the corresponding 0 EGF control distribution. 
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Figure 5.9: Single cell distributions of pERK dose-responses 10 minutes after treatment with EGF of 
MCF-10A. The distributions are standardized to the corresponding 0 EGF control distribution.  
 
Figure 5.10: Single cell distributions of pEGFR dose-responses three hours after EGF addition in MCF-
10A cells. The distributions are standardized to the corresponding 0 EGF control distributions. 
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Figure 5.11: Single cell distributions of pERK dose-responses after three hours of EGF treatment.  The 
distributions are standardized to the corresponding 0 EGF control distribution. 
 
Figure 5.12: Time-course of single cell distributions of pERK responses to 0.0316 ng/ml EGF treatment in 
MCF-10A cells. 































































Figure 5.13: Time-course of single cell distributions of pEGFR responses to 1 ng/ml EGF in MCF-10A 
cells. 
 




















































Section 5.5: Exploring  effects  of  Weber’s  Law in sensing relative EGF signals 
on cell phenotype 
 
How can the ability to decode relative changes in EGF by the phosphorylated targets affect 
cell  behavior?  The  hypothesis  that  Weber’s  Law  in  the  phosphorylation  responses  is  important  to  cell  
functioning could be validated through observing and quantifying various cellular phenotypes directly 
controlled by the considered phosphorylation targets. The phenotypic features can be directly 
regulated (or strongly influenced) by the downstream targets of pEGFR signaling through regulating 
gene transcription.  
For   example,   some   studies   of   Weber’s   Law   in   other   biological   systems   have   reported   a 
correlation between fold-change responses of the target of interest, namely b-catenin levels, and cell 
phenotypes related to development (Goentoro & Kirschner, 2009). Similar approach could be applied 
to explore the relationship   between   the   Weber’s   Law   in phospho-ERK responses and cellular 
behavior.  
For instance, cells relying on EGF-induced MAPK signaling for proliferation could be 
subjected to various fold-changes in EGF, starting with the pretreatments with EGF doses from the 
reported  here  range  likely  to  exhibit  Weber’s  Law  (0.03-0.3ng/ml EGF). The correlation between cell 
proliferation rate and the response to the applied fold-change in EGF dose could then be assessed. If 
it is found that the cell proliferation rate does not depend on the initial dose in the EGF pretreatment, 
but instead, on the fold-change of the EGF applied at the step increase, this could suggest that 
indeed, fold-changes, and not absolute levels, in EGF are important for cell proliferation. To establish 
that the observed effect is mediated through pERK, the pERK responses would also need to be 
quantified in these experiments. However, cell proliferation is a process shaped by multiple 
regulators, and thus, the effect of pERK may not be uniquely determining cell decisions.  
A possible method to assess physiological consequences of pEGFR signaling in cells treated 
with EGF could be to quantify protrusions of lamellipodia, feature of cell-migration initiation. It has 
been shown that lamellipodia protrusion occur rapidly in MCF-10A cells in response to EGF treatment 
and are mediated through phosphorylation of EGFR, ERK and Akt (Kleiman, 2010). Since lamelipodia 




treatment and the elicited cellular response (lamellipodia protrusion) this cellular phenotype may be 
convenient to explore the effects  of  Weber’s  Law   in phosphorylated responses to step-inputs in EGF 
on cell behaviors. 
Section 5.6: Comparing apples and oranges: cell memory of multiple ligands 
and multiple receptors  
 
Section 5.6.1: How EGFR can store the memory of combinations of different 
ligands 
 
EGFR can bind multiple types of ligands, such as, EGF and TGF-alpha, heregulin (HER or 
Neu) and others (Zahnow, 2006). It can be interesting to investigate how EGFR receptors can 
remember treatments of combinations of different types of ligands, especially, given that in in vivo 
cells are usually exposed to multiple different stimuli over time. EGF and TGF-alpha have been 
suggested to co-occur in human mammary epithelium and to play an important role in development 
(Fisher & Lakshmanan, 1990). 
How can cells remember and discriminate between different types of ligands? For example, it 
has been suggested that yeast is able to compare relative ratios of glucose, its preferred nutrient, to 
galactose, and the ratio between the levels of two nutrients then determines cell state (Savir et al., 
2005). Similarly, since EGFR can bind multiple ligands which can co-occur together in vivo, it can be 
interesting to study what strategies receptors use to remember the combinations of the ligands and 
what affects these strategies have on cell responses to repeated stimulations with these ligands. 
A recent theoretical work modeled system responses to simultaneous fold-change increases 
in two different ligands in a system capable of fold-change detection in levels of each of the two 
ligands (Hart et al., 2013). The study suggested that under certain circumstances, the generated 
response would be proportional to the product of the two fold changes, implying that the system 
would compare change in each ligand to its own background level and then respond proportionally to 
the product of the two folds. However, the presented theoretical study analyzed ligand-receptor 
interactions via Monod-Wyman-Changeux model (Changeux, 2012), a model which may not be 




Contrary to the suggestions of Hart et al., 2013, that the combinations of ligand may be 
processed by comparing each corresponding ligand dose to its own background, and the resulting 
response would be proportional to the product of the two fold-changes, it is possible that for EGFR 
measuring fold-changes in multiple simultaneous signals is more complicated. Although the modes of 
EGFR activation by various ligands may be similar (through induction of receptors dimerization and 
phosphorylation), the kinetic properties of ligand-receptor interactions may differ and thus may 
produce different physiological outcomes of signaling. 
For example, both EGF and TGF-alpha can bind and activate EGFR. However, unlike EGF, 
TGF-alpha is known to dissociate from the internalized ligand-receptor complex in the endosomes 
which have lower pH levels compared to the pH levels on the cell surface. Rapid ligand unbinding in 
endosomes then leads to preferential EGFR recycling rather than its degradation (Ebner & Derynck, 
1991). Therefore, TGF-alpha, compared to EGF, induces lesser receptor degradation, and thus can 
be a more potent mitogenic stimulant. However, some studies show that EGF and TGF-alpha can 
elicit similar mitogenic responses, even though, the dynamics of receptor activation they induce differ 
(Reddy et al., 1998). 
Hence, kinetic properties of ligand-receptor interactions can affect not only the immediate 
signaling responses, but also the number of receptors which remain on the cell surface after several 
hours of persistent ligand stimulation. Thus, unlike the case of EGF stimulation, in which the number 
of EGFR receptors remaining on the cell surface displays the memory of EGF doses, TGF-stimulated 
system might not exhibit the memory of ligand dose through the number of cell surface receptors. 
Alternatively, the memory of the two ligands might have different time-span, as replenishment of 
degraded receptors (as in the case of EGF signaling), may require more time for de novo synthesis of 
receptors, compared to replenishment of receptors removed through internalization, which would rely 
on their recycling to the cell surface. 
We can use our model to simulate phosphorylation responses to treatments with various 
combinations of different fold-changes in EGF and TGF-alpha. We can then compare how EGFR 
stores the memory of EGF and TGF-alpha separately and explore the time-scales of each of these 




responses to the combinations of doses and fold-changes predicted to be most informative by the 
model. To have significant predictive power, the model may need to be fitted to the two types of time-
courses of signal responses to the treatments with either EGF or TGF-alpha. The model allows to 
implement several possible modes of action of the two ligands: for example, the interactions of each 
of the ligands with receptors can be assumed independent, mutually exclusive, or negatively co-
operative. The experimental measurements of cell responses to combinations of treatments with 
different fold-changes in ligand doses could then help to identify the correct mode of interaction. 
Another possible example of combinations of ligands to verify fold-change detection 
properties could be EGF and HRG. Such combinatorial treatments have been previously modeled in  
Birtwistle et al., 2007, however the study did not consider repeated stimulations with different fold-
changes in ligand combinations. 
Our model can be used to study the effects of various other ligand mixtures, and is not limited 
to EGF and TGF-alpha, as the identity of the ligand in the model is encoded mainly through 
parameters of its binding and unbinding to receptor on the cell surface, and in the endosomes. 
Section 5.6.2: How ErbB and other receptors together can remember the same 
ligand 
 
It can be interesting to investigate how various receptors of the ErbB family, namely ErbB1, 2, 
3 and 4, co-expressed on the cell surface can together remember the same ligand and if having 
multiple types of receptors involved in responding and memorizing one ligand could provide any 
advantages in cell signaling.  
For example, EGF binding to EGFR can lead to formation of dimers not only between EGFR 
receptors themselves, but also lead to heterodimerization with other members of the ErbB family, 
such as ErbB2, ErbB3, ErbB4. Therefore, in the course of EGF stimulation, not only EGFR levels may 
be affected, but the number of receptors co-dimerizing with EGFR can change as well through 
receptors trafficking and degradation. As a result of initial stimulation, changes in the numbers of 
different types of cell surface receptors could then alter cell sensitivity to consecutive stimulations with 




Another scenario to consider is when different receptors can directly bind the same ligand. 
For instance, ErbB3 and ErbB4 can bind heregulin, a growth factor molecule important in cell 
proliferation, invasion, and differentiation (Breuleux, 2007). Although ErbB3 receptors themselves are 
kinase-impaired, they can form dimers with EGFR and thus lead to activation of EGFR 
phosphorylation signaling cascade in response to heregulin (Chen et al., 2009). One can explore how 
the memory of heregulin stimulations could be distributed between ErbB3 and ErbB4 (receptor 
species able to bind heregulin) and what implications this can provide for cell responses to 
consequent stimulations with heregulin.  
Section 5.7: Generalizing   mechanism   of   Weber’s   Law   to   other   receptors  
sensory systems 
 
The ubiquity of EGF molecule throughout multiple tissues in the organism suggests that the 
presented here Weber’s   Law in sensing relative changes in EGF levels discovered in mammalian 
epithelial cells could be generalizable to many other types of cells relying on EGF-activated EGFR 
signaling. In addition, EGFR receptors can be activated by multiple other ligands (Birtwistle et al., 
2007) and therefore, the discovered  here  Weber’s   Law   could facilitate sensing relative changes in 
levels of many other agonists of EGFR. Moreover, other receptors signaling cascades for which the 
derived here conditions hold (rapid endocytosis of activated receptors and a fast post-translational 
inactivating mechanism) could potentially realize receptors-mediated relative sensing of extracellular 
stimuli. Overall,  the  discovered  here  mechanism  of  Weber’s  Law  could be very general and represent 
a result of convergent evolution in cell functioning.  
In particular, the presented here mechanism of  Weber’s  Law   in  sensing  relative  changes   in  
EGF concentrations relies on general enough assumptions about EGFR receptors signaling, 
specifically, that ligand-bound receptors are internalized significantly faster than ligand-free receptors, 
and that activated receptors are deactivated by a rapid post-translational mechanism, such as 
dephosphorylation by phosphatases. Given that endocytosis is a general enough cell mechanism 
which can internalize various other receptors (Sigismund et al., 2012), and that various receptors can 
be rapidly inactivated via multiple other post-translational modification mechanisms (methylation, 




requirements  for  Weber’s  Law  can be applicable to other receptors sensory systems, and therefore, 
the   discovered  Weber’s   Law  mechanism  may be generalizable from EGFR receptors signaling to 
other mammalian receptor-signaling systems with rapid endocytosis of activated receptors.  
For example, relative sensing in extracellular stimuli levels can be present in signaling 
through the G-protein coupled receptors (GPCR). GPCR receptors constitute a large and diverse 
family of cell surface receptors and in mammals are responsible for various senses (Kobilka, 2007), 
including vision (Luo et al., 2008). In vision, dependence of the GPCR receptors sensitivity on 
background   light  has  been  suggested   to   follow  Weber’s  Law   (Luo et al., 2008), however, there are 
not many quantitative studies on the role of the GPCR receptors in this phenomenon. Since, the 
GPCR receptors can be desensitized through many various mechanisms, including endocytosis of 
receptors (Ferguson & Caron, 1998) and their rapid deactivation by phosphorylation, the mechanism 
of  Weber’s   Law   derived   in   this   work   (Section 4.7.2) may be applicable to relative sensing of light 
through GPCR in mammalian vision. Moreover, given the expanse of GPCR in realizing multiple other 
functions of perception,  the  same  Weber’s  Law  mechanism  may apply to other human senses. 
Another   interesting   example   where  Weber’s   Law   in   sensing   relative   changes   in   levels of 
extracellular stimuli can be realized through the presented in this work mechanism, is signaling 
through opioid receptors and the associated with it opioid tolerance and addiction (Nestler & 
Aghajanian, 1997). Opioid receptors belong to the GPCR family of receptors (Al-Hasani, Ream, 
2011). The opioid receptors can be rapidly desensitized via phosphorylation and arrestin binding, 
preventing activation of G proteins. Endocytosis of the opioid receptors has been implicated in the 
development of tolerance to analgesic drugs (He et al., 2001). Although, the tolerance may arise 
through multiple other mechanisms, downstream of the receptor-level, endocytosis of receptors may 
play an important role in regulating cell sensitivity to the stimulant. Given that the assumptions used 
to   derive   Weber’s   Law   mechanism   presented   in   this   work apply to the regulation of the opioid 
receptors, the opioid receptors may realize Weber’s  Law  through  the presented here receptors-based 
mechanism. A quantitative experimental validation of this phenomenon potentially could have 




Lastly, degradation of ligand-bound internalized receptors may not be required for realizing 
Weber’s  Law   through  a   receptors-dependent mechanism. Biochemical properties of ligand-receptor 
interactions can determine the fate of internalized ligand-bound receptors, by direct them either to the 
lysosomal degradation (as is the case of EGFR and opioid receptors) or to recycling to the cell 
surface (EpoR) (Alberts B, Johnson A, Lewis J, et al, 2002). It is possible that the removal of ligand-
bound receptors from the cell surface could alter cell sensitivity to consecutive stimulations with the 
same ligand, and the fate of internalized receptors (degraded or recycled) and speed of recovery of 
functional receptors to the cell surface could influence the duration of the cell memory of past ligand 
doses  and  thus  the  ability  to  realize  Weber’s  Law  in  sensing relative changes in stimulus levels. 
Going beyond the receptor-mediated   mechanisms   of   Weber’s   Law   in sensing relative 
changes in extracellular stimuli, one might explore other methods of cellular memory of past stimuli 
treatments and a consequent possibility of the relative sensing in the stimuli levels. For example, one 
may investigate the presence  of  Weber’s  Law  in  signaling  through  Epo  receptors,  which  activate  red  
blood cell production and can distinguish the levels of Epo ligand across several orders of magnitude. 
A recent study (Becker et al., 2010) indicated that the Epo receptors signaling may rely on efficient 
depletion of the extracellular Epo from the cell surface via ligand binding to receptors and subsequent 
internalization of the molecule-bound receptor. If this is a prominent mechanism of EpoR signaling 
attenuation, the Epo receptors in this way erase the memory of the ligand stimulation from their cell 
surface, and therefore would not be able to retain the memory of ligand concentration through 
establishing the equilibrium in the number of receptors on the cell surface which would be related to 
the Epo dose. The Epo signaling leads to mobilization of pools of Epo receptors to the cell surface if 
high doses of ligand are   present.   Hence,   if  Weber’s   Law   is   indeed   present   in   EpoR   signaling,   its  
ligand memory would have to be realized through a mechanism distinct from the cell surface 
receptor-based mechanism presented here for the EGFR system. 
A more general direction of inquiry could be to investigate how physiological environment of 
specific cells and their biological functions shape the receptors sensory mechanisms realized in the 
cells. In  particular,  this  work  demonstrates  that  the  discovered  here  Weber’s  Law  in  EGFR  signaling  




possibly other mechanisms of regulation of the EGFR signaling system, arose under evolutionary 
pressure to be attuned to the EGF levels characteristic to various tissues in vivo. 
Section 5.8: Endocytosis in the context of cell signaling - a mechanism to 
integrate information about cell environment into cell fate decisions 
  
In vivo cells are being constantly exposed to various stimuli over time. How cells process 
multiple stimuli from their environment and integrate them into their cell fate decision making remains 
an active area of research (Albeck et al., 2013). This work emphasizes the role of endocytosis as a 
mechanism by which the cells can regulate abundances of their cell surface receptors in response to 
stimuli exposure, therefore, adjusting their sensitivity to consequent ligand stimulations. Thus, in the 
context of cell signaling endocytosis can be considered as a mechanism for cells to integrate the 
information about their past stimuli exposures into their cell fate decisions. 
Traditionally, endocytosis has been considered as a tool to terminate cell signaling through 
EGFR and to render cells unresponsive to consecutive stimulations with EGF (Kholodenko et al., 
2010). However, such view was derived based on experiments with bolus-stimulations of cells with 
very high, non-physiological levels of EGF which lead to saturation of EGFR phosphorylation 
responses and therefore removal of most of the functioning EGFR receptors from the cell surface 
(Becker et al., 2010). An alternative view suggests that the role of endocytosis may be to deliver 
signaling closer to the downstream signaling targets, such as, for example, phospho-ERK 
(Kholodenko, 2009). The presented here results suggest a more nuanced role of endocytosis: in 
particular, we think that endocytosis is instrumental in regulating and maintaining the dynamic steady 
state of the cells and their sensitivity to the time-varying environment. By adjusting the number of 
functioning cell surface receptors according to the dose of the applied chronic ligand stimulation, 
endocytosis thus affects cellular signaling responses and ultimately, cell fate decision making. 
Interplay of endocytosis with other mechanisms of receptors signalling downregulation 
provides the cells with flexibility in regulating their sensitivity to repeated extracellular stimuli. In 
particular, using solely receptors endocytosis and degradation to terminate signalling would render 
cells unresponsive to consequent ligand stimulations and cells resensitization would then rely on a 




of receptors downregulation, in addition to receptors endocytosis would allow cells not to completely 
degrade the receptors in response to initial pre-stimulation with EGF, but to maintain a certain 
number of ligand-binding ready receptors on the cell surface, ensuring the cells are sensitive to ligand 
restimulations. As an alternative to receptors degradation, activation of transcription of various 
negative regulators of EGFR (such as phosphatases) could be a more advantageous strategy of 
signalling downregulation for the cells in the context of time-varying ligand concentrations. 
In vivo, the stimuli to which the cells are exposed may not necessarily have a constant profile 
over time. For example, due to molecular noise, the stimulus level can fluctuate around a particular 
constant value. Since, the process of endocytosis is not instantaneous and operates with a certain 
time delay, it allows the cells to integrate the applied stimulus over a certain time frame and thus 
adjust the number of cell surface receptors according to some average value of the applied stimulus, 
allowing robustness against the noise in stimulus levels. 
The solutions of the analytical model in Section 4.7.2 can be modified to replace chronic 
stimulation with a constant dose of EGF, 𝑢, into a time-varying function of time 𝑢 → 𝑢 + 𝑓(𝑢, 𝑡), where 
the term  𝑓(𝑢, 𝑡) represents the noisy fluctuations which, for example, could be modeled by a sinusoid 
function. In such case, given that the activation term of the derivative of the total number of receptors 
(Section 4.7.2, expression (8)) is linear in 𝑢, the phosphorylation term will linearly depend on 𝑢 +
𝑓(𝑢, 𝑡).  The total number of remaining receptors still depends on rapid endocytosis of activated 
receptors (Section 4.7.2, expression (8)), and therefore, the information about ligand stimulation will 
still be reflected in the number of remaining receptors, controlled via integral of the produced 
phosphorylation signal over time. Therefore, if the stimulus is given as 𝑢 + 𝑓(𝑢, 𝑡), endocytosis would 
integrate the applied signal for some time and the contribution of the sinusoid noise term 𝑓(𝑢, 𝑡) would 
be insignificant compared to the integral of the signal in 𝑢. In case the ligand input profile deviates 
from step-input in constant levels of EGF, the cells ability to respond to fold changes in the average 
levels of the extracellular stimuli would be preserved, given the change in the averages happens 
sufficiently fast, and the cells do not slowly adjust their sensitivity to the change, but rather rapidly 






 This work presents an experimental evidence of the ability of EGFR expressing cells to sense 
relative changes in levels of extracellular EGF. In addition, we reveal a mechanism behind such 
property. The phenomenon of relative sensing in stimuli levels is  referred  to  as  Weber’s  Law.  For the 
first time, this  work  addressed  Weber’s  Law  in relative sensing of extracellular ligands in mammalian 
phosphorylation signaling cascades. We find that the relative sensing in EGF ligand in MCF-10A cells 
occurs exactly within the reported physiological range of EGF doses. Given the ubiquity of EGF and 
of the EGFR receptors throughout mammalian tissues, the presented here mechanism might exist 
across many mammalian cell signaling systems. The discovered mechanism of  Weber’s  Law   relies 
on fast endocytosis of ligand-bound receptors and on additional rapid deactivation of receptors 
through a post-translational modification. Such  Weber’s  Law  enabling  features  of  receptors  regulation  
are common to many receptors sensory systems and therefore the discovered mechanism of relative 
sensing might be generalizable to many other mammalian receptors sensory systems. For example, 
for the G-protein coupled receptors responsible for multiple human senses there is an evidence of 
relative sensing of light stimuli. The key challenge in the future will be to quantitatively validate this 
phenomenon in the GPCR and other mammalian receptor sensory systems. If applicable to multiple 
receptor signaling systems, the receptor-mediated mechanism of relative sensing of stimuli could 
then present a result of convergent evolution in functioning of cell signaling cascades.  
In addition, the importance of the EGFR receptors endocytosis in the discovered mechanism 
of  Weber’s  Law  suggests a novel, unconventional framework of understanding the role of endocytosis 
in cell functioning in vivo: enabling cells to dynamically adjust and maintain their sensitivity to time-
varying stimuli, endocytosis allows cells to incorporate the information about their environment into 
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Section A.1: Model Equations, Parameter descriptions, Priors on the 
parameter values 
 
This section provides description of model parameters, differential equations, and initial conditions, 
for the ErbB signaling model.  
 





Figure A-2: Simplified analytical kinetic ODE model of the ErbB signaling: linear in EGF activation of 
EGFR. 
 





Figure A-4: Simplified analytical kinetic ODE model of the ErbB signaling: two types of EGFR dimers. 
 
Figure A-5: Simplified analytical kinetic ODE model: two types of EGFR dimers, kinase cascade leading 
to activation of ERK simplified into one effective component. 
 
Section A.1.1: Description of model parameters and imposed priors   
 
This section presents a list of protein species, their corresponding variable names and initial 
conditions (in number of molecules) and a list of parameters in model’s differential equations, and 









k1 EGF binds to ligand-unbound monomer [-14..-4] 
kd1 EGF unbinds from ligand-bound monomer [-3..1] 
k31 EGF binds to one-EGF bound dimer [-14..4] 
kd31 EGF unbinding from two-EGF bound dimers [-3..1] 
k2 
dimerization of one-EGF bound and one free 
monomers [-8..-2] 
kd2 
undimerization of one-EGF bound and one free 
monomers [-2.5..2] 
k2a dimerization of two EGF-bound monomers [-8..-2] 





Description priors (bounds in log-
uniform space) 
c1 variable  EGF   
 c531 c531  EGFR [4..6.5] 
 c10 0  EGF   
 c3 0  EGF:EGFR   
 c4 0  EGF:EGFR:EGFR   
 c2 0  EGF:EGFR:EGF:EGFR   
 c5 0  EGF:EGFR#p:EGF:EGFR#p   
 c6 0  EGF:EGFR#p:EGFR#p   
 c5312 0  EGFR   
 c22 0  EGF:EGFR:EGF:EGFR   
 c42 0  EGF:EGFR:EGFR   
 c52 0  EGF:EGFR#p:EGF:EGFR#p   
 c62 0  EGF:EGFR#p:EGFR#p   
 c86 0  degraded receptors   
 c61 0  EGF:EGFR#p:EGF:EGFR#p:ERK   
 c63 0  EGF:EGFR#p:EGFR#p:ERK   
 c610 0  EGF:EGFR#p:EGF:EGFR#p:ERK   
 c630 0  EGF:EGFR#p:EGFR#p:ERK   
 c612 0  EGF:EGFR#p:EGF:EGFR#p:ERK#p   
 c632 0  EGF:EGFR#p:EGF:EGFR#p:ERK#p   
 c6102 0  EGF:EGFR#p:EGF:EGFR#p:ERK#p   
 c6302 0  EGF:EGFR#p:EGFR#p:ERK#p   
 c8 c8  ERK, cytoplasm [3..7] 
 c80 0  ERK#p, cytoplasm   




kd123 kcat of EGFR activation [-4..2] 
kd950 kcat of EGFR dephosphorylation [-1.75..-1.15] 
k60 degradation of active receptors [-6..-2] 
k77 production of monomers [-2..2] 
k910 internalization of inactive receptors [-8..-4] 
kd910 recycling of inactive receptors [-4..-2] 
k91 internalization of active receptors [-4.5..-2] 
kd91 recycling of active receptors [-4.5..-2.5] 
k61 degradation of inactive receptors [-6..-2] 
k50 activated receptors binding to inactive ERK [-8..-4] 
kd50 unbinding of activated receptors from inactive ERK [-2..0] 
kd51 kcat of ERK activation  [-3..-1] 




Section A.1.2: Equations of the detailed dynamic ODE model of ErbB signaling  
 
Differential equations of the ErbB model: the left-hand side of an equation is the time derivative of the 
number of molecules of a species. The right-hand side is a collection of first or second order mass 
action reaction terms between species that contribute to the generation or degradation of the species 
on the left-hand side. 
dc531/dt =k77 - vk1 * c1  * c531 + vkd1 * c3  -k2 *c531 *c3 +kd2 *c4-k910*c531 + 
kd910 *c5312  
dc3/dt = vk1 * c1  * c531 - vkd1 * c3-k2 *c531 *c3 + kd2 *c4  -2*k2 *c3 *c3 +2* 
kd2a *c2   
dc4/dt =k2 *c531 *c3 -kd2 *c4 -vk31*c1 *c4 +  vkd31*c2 - kd123 *c4 +kd950 *c6-k91  
*c4  + kd91  *c42 
dc2/dt = k2 *c3 *c3 -  kd2a *c2 +vk31*c1 *c4 -  vkd31*c2-kd123 *c2 +kd950 *c5 -k91  
*c2  +kd91  *c22 
dc5/dt = -kd950 *c5 +kd123 *c2 +vk31*c1 *c6 - vkd31*c5 -k91  *c5 + kd91  *c52 -k50 
*c8 *c5  + kd50 *c61+kd51 *c61  -k50 *c80 *c5 + kd50 *c612 +kd51 *c612   
dc6/dt =  kd123 *c4  -kd950 *c6-vk31*c1 *c6 - vkd31*c5 -k91  *c6 + kd91  *c62  -k50 
*c8 *c6 + kd50 *c63  +kd51 *c63  -k50 *c80 *c6+  kd50 *c632  -kd51 *c632    
dc5312/dt  = k910  *c531 - kd910 *c5312-k61 *c5312  
dc22/dt  = - k61 *c22  +kd950 *c52 -kd123 *c22  +k91  *c2  -kd91  *c22 
dc42/dt  = +k91  *c4  - kd91  *c42   -kd123 *c42  +kd950 *c62  
dc52/dt  = -k60 *c52 +k91  *c5 - kd91  *c52  -kd950 *c52 +kd123 *c22 - k50 *c8 *c52  
+ kd50 *c610 +kd51 *c610  -k50 *c80 *c52 + kd50 *c6102 +kd51 *c6102     
dc62/dt  =  - k60 *c62 +k91  *c6 - kd91  *c62  -kd950 *c62+kd123 *c42 -k50 *c8 *c62 
+ kd50 *c630+kd51 *c630 -k50 *c80 *c62  + kd50 *c6302 +kd51 *c6302   
dc86/dt  = k60 *c52 + k60 *c62+ k61 *c22   
dc61/dt  = k50 *c8 *c5  - kd50 *c61-kd51 *c61 
dc63/dt  = k50 *c8 *c6 - kd50 *c63- kd51 *c63   
dc610/dt  = k50 *c8 *c52  - kd50 *c610-kd51 *c610  
dc630/dt  = k50 *c8 *c62 - kd50 *c630-kd51 *c630  
dc612/dt  = k50 *c80 *c5 - kd50 *c612 -kd51 *c612  
dc632/dt  = k50 *c80 *c6-  kd50 *c632 -kd51 *c632  




dc6302/dt  =k50 *c80 *c62  - kd50 *c6302+kd51 *c6302  
dc8/dt  =-k50 *c8 *c5  + kd50 *c61-k50 *c8 *c6 + kd50 *c63 - k50 *c8 *c52  + kd50 
*c610-k50 *c8 *c62 + kd50 *c630+kd5 *c80   
dc80/dt = +kd51 *c61 +kd51 *c63 +kd51 *c610-k50 *c80 *c5 + kd50 *c612  -k50 *c80 
*c6+ kd50 *c632 -k50 *c80 *c52 + kd50 *c6102-k50 *c80 *c62  + kd50 *c6302   + kd5 
*c800  -kd5 *c80  
dc800/dt =kd51 *c612  +kd51 *c632+kd51 *c6102+kd51 *c6302 -kd5 *c800    
 
Algebraic variables for counting total amount of species:  
total_egfr= 2*c612 +2*c632 +2*c6102 +2*c6302 +2*c61 +2*c63 +2*c610 +2*c630 
+ c531 +c5312 +c3 +2*c2 +2*c4 +2*c5 +2*c6 +2*c22 +2*c42 +2*c52 +2*c62   
total_egfr_surf=2*c612 +2*c632 + 2*c61 +2*c63 +  c531 +c3 +2*c2 +2*c4 
+2*c5 +2*c6   
total_pegfr= 2*c612 +2*c632 +2*c6102 +2*c6302 + 2*c61 +2*c63 +2*c610 
+2*c630 +2*c5 +2*c6 +2*c52 +2*c62   
total_egf =c1   
total_pperk = c800   
total_perk =  c6102 +c6302 +c80   
total_erk = c612 +c632 + c8   
  
Section A.1.3: Detailed model of ErbB signaling from Chen et al., 2009 
  
The detailed model of ErbB signaling simulated in Section 4.2 has been previously published 
in (Chen et al., 2009) and can be found at: 
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2644173/bin/msb200874-s2.zip 
Section A.2: Gelman-Rubin criterion for MCMC chains convergence 
 To assess convergence of MCMC chains we apply Gelman and Rubin criterion for multiple 
sequence diagnostic (Gilks, Richardson, and Spiegelhalter, 1996). The criterion is applied to 
trajectories of MCMC chains in each individual parameter dimension. 
The following algorithm steps (for each parameter): 
1.   Run   m   ≥   2   chains   of   length   2n   started   from   overdispersed   starting   points found by 
simulated annealing 
2. As a burnoff, discard the first n steps in each chain 
3. Calculate the within-chain and between-chain variance as follows:  
Compute within chain variance for the jth chain, sj, and obtain W, the mean of the variances 




                      
4. Estimated variance of the parameter as a weighted sum of the within- 
chain and between-chain variance: 
 
5. Compute the potential scale reduction factor, Rhat: 
 





Section A.3: Preliminary comparison of predicted parameter distributions of 
cell lines MCF-10A, MCF-7, SKBR3 
 
Figure A-6: Comparison of the preliminary predicted distributions of parameters obtained from fitting the 
model to the experimental data from three different cell lines: MCF-10A, MCF-7, SKBR3. 
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